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Mining deeper into the proteome: computational strategies for improving depth 
and breadth of coverage in high-throughput protein identification studies 
by 
Peter J. Ulintz 
 
 
Chair: Philip C. Andrews 
 
 
  The proteomics field is driven by the need to develop increasingly high-
throughput methods for the identification and characterization of proteins. The overall 
goal of this research is to improve the success rate of modern high-throughput proteomics 
studies.  The focus is on developing computational strategies for increasing the number of 
identifications as well as improving the ability to distinguish new forms of proteins and 
peptides.  Several studies are presented, addressing different points in the proteomics 
analysis pipeline.  At the most fundamental data analysis level, methods for using modern 
machine learning algorithms to improve the ability to distinguish correct from incorrect 
peptide identifications are presented.  These techniques have the potential to minimize the 
need for manual curation of results, providing a significant increase in throughput in 
addition to increased identification confidence.  
Non-standard types of mass spectrometry data are being generated in specific 
contexts.  Specifically, phosphoproteomics often involves the generation of MS
3
 spectra.  
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These spectra alleviate problems associated with MS
2
 fragmentation of phosphopeptides, 
but utilizing the additional information contained in these spectra requires novel 
informatics.  Several strategies for accommodating this additional information are 
presented.  A statistical model is developed for translating the information contained in 




 spectra into a more accurate peptide 




 data are 
explored.   
A newer mass spectrometry methodology useful for phosphoproteomics has 
recently been introduced as well, termed multistage activation (MSA).  A comparative 
study of this and other methods is presented aimed at determining an optimal method for 
generating phosphopeptide identifications, focusing not only on data analysis techniques, 
but also on the mass spectrometry methodologies themselves. 
A dataset is presented from a differential study of a human cell line infected with 
the dengue virus.  The study explores the complementarity of different fractionation 
methods in generating more unique protein identifications.  A discussion of a statistical 
mixture model that utilizes relative quantification information to classify identified 
peptides into two categories based on their membrane topology is given in the final 












1.1 A brief history 
 
History may very well remember the past fifty years, and the dawn of the 21
st
 
century, as being primarily characterized by two major technological revolutions: those 
of computers and life science.  The discovery of the structure of DNA in 1953, and the 
subsequent understanding that DNA nucleotide sequence completely specifies the amino 
acid sequence of proteins, laid the foundation for the modern understanding of how living 
systems function.  Concordantly, IBM shipped its first stored-program computer, the 701, 
in 1953, and the first FORTRAN program was successfully run the following year.  By 
the time the genetic code was elucidated in the early- to mid-sixties, IBM‘s annual sales 
revenue for computer-based products exceeded $1 billion dollars.
1
  Microsoft was 
founded in 1975, the year Sanger and his colleagues developed their DNA sequencing 
methods.  The year 1983, marked by the advent of the polymerase chain reaction (PCR) 
technique for amplification of DNA that brought genetic studies to the benches of so 
many more scientists, was matched by computers achieving the one billion floating point 
computation per second benchmark, and the distribution of personal computers to the 
mass market was well underway.   
                                                          
1
 And the first Computer Science Ph.D. was granted in 1965 at the University of Pennsylvania. 
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The genetic code not only provided a conceptual framework for understanding the 
function and evolution of living organisms, but provided a basis for representing the 
information content of a biological entity as essentially text: a linear string of a small 
alphabet of symbols.  As soon as protein and nucleotide sequences started being known, 
methods for comparing these sequences to derive their evolutionary history started to be 
developed. In addition to constructing the first phylogenetic model of a protein family, 
Margret Dayhoff formulated the first probabilistic distance matrices for comparing amino 
acid sequences, and published the Atlas of Protein Sequences and Structure in 1965 (1).  
The Atlas was one of the first collections of sequence information to be assembled, and 
evolved into to the first public repository of sequence information: the Protein 
Information Repository (PIR).  1981 marked the publication of the first sequence 
alignment algorithm (2), and the GenBank repository was founded the following year.  
Following the breakthrough of PCR and modern sequencing, vectors for large scale 
genomic sequencing were established by the late eighties.  The first physical map of the 
genome of an organism (E. coli) was generated in 1987 (3), and the question of ‗How 
much information is necessary to encode an organism?‘ began to be addressed.  The 
disciplines of computer science and molecular biology thus became inextricably married, 
and the field of bioinformatics was born out of the necessity to manage, mine, and 
compute upon the large amount of biological information that was being generated at an 
increasing rate.  One final landmark pivotal in the foundation of bioinformatics came in 
1994, when Netscape Communications released the first version of the Navigator web 
browser, establishing the Web as the primary global information infrastructure necessary 
for publishing and sharing information.  Almost a decade after that first physical map of 
E. coli, modern databases containing assemblies of entire genomes began to become 
available (4), culminating in the human genome assemblies in 2001 (5,6). 
More directly related to the problem at hand, the late eighties also marked a major 
advance in the field of protein chemistry: the ability of proteins to be effectively ionized 
in an intact form without extensive fragmentation.  The establishment of two ionization 
methods in particular, electrospray ionization (ESI) and matrix-assisted laser desorption 
and ionization (MALDI), heralded the beginning of large scale protein identification by 
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mass spectrometry.  ESI quickly established itself as a popular technique due to its ability 
to be easily interfaced with liquid chromatography (LC) fractionation systems.  Also, the 
fact that the technique resulted in multiply charged analytes allowed higher mass species 
to be detected in instruments with smaller mass ranges.  In contrast, MALDI instruments 
typically had larger overall mass ranges, a feature of the relatively simple time-of-flight 
(TOF) mass analyzers most often coupled with the source.  The characteristic of MALDI 
analytes to be singly charged also simplified the interpretation of the resulting spectra.  
Both types of instruments quickly became established as reliable means for identifying 
proteins and are still the dominant ionization techniques used for protein analysis.  The 
importance of these techniques for protein elucidation is reflected by the awarding of the 
Nobel Prize to John Fenn for ESI and Koichi Tanaka for MALDI in 2002.  With the 
establishment of these techniques, all the key components were in place for the 
foundation of proteomics research. 
1.2 Proteomics, Past and Present 
The term ‗Proteomics‘ can be defined in many ways, but if one considers the term 
to apply narrowly to the ability to identify and quantify proteins in a high-throughput 
manner, then not only is it a means to quickly generate the necessary data but also a 
means to interpret it effectively.  The field of proteomics was born not only from the 
ability to generate protein identification information in high-throughput provided by mass 
spectrometry, but also by the availability of public repositories of genome sequence 
information and a means to utilize this information for the interpretation of mass spectra.  
The third major component in the proteomics equation was that of robust protein 
separation technologies.  In the early years, the term ‗proteomics‘ was almost 
synonymous with two-dimensional gel electrophoresis (2DE), a separation method first 
developed in the mid-seventies (7, 8).  The paradigm of focusing proteins from complex 
mixtures on 2D gels, excising the spots on those gels, digesting the proteins and 
analyzing the resulting peptides in a (MALDI-TOF) mass spectrometer became a default 
standard method for early proteomics research (9).  In fact, it was at the first 2DE 
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meeting in Siena, Italy in 1994 that the term ‗proteome‘ was first coined, by the 
Australian PhD student Marc Wilkins
2
.   
Since that time, proteomics has seen significant refinement in all three of these 
key areas.  Perhaps the most significant shift, however, has occurred in the separations 
domain.  Although 2DE is still extensively used, it has limitations.  Not only is it labor-
intensive (and thus time-consuming and costly, and more difficult to scale up), but it also 
can have reproducibility issues, and the fact that multiple proteins often fractionate in an 
individual spot on a gel creates interpretation and quantification problems.  There are also 
solubility issues associated with gel-based approaches, and staining and extraction 
efficiencies can limit the sensitivity of the method.  These reasons have resulted in a shift 
away from gel-based fractionation methodologies to other LC-based methods for groups 
requiring higher throughput.  Early work by Donald Hunt‘s group (10), and subsequent 
automation and refinement by Yates et al. (11), demonstrated the power of the LC 
method in rapidly identifying a large number of proteins in a sample.   
The digestion of complex protein extracts into even more complex peptide 
mixtures followed by the coupling of single- or multi-dimensional fractionation of 
complex protein mixtures to mass spectrometry (LC-MS/MS) has been termed ―Shotgun 
Proteomics‖, coined in reference to the genomics analogy of assembling a large number 
of random pieces of overlapping DNA.  The term ―MudPIT‖ is often used in a 
synonymous manner, originally suggested by Yates et al. as an abbreviation of the term 
―multidimensional protein identification technology‖, and referring specifically to a 
tandem LC separation followed by mass spectrometry and database searching (12).  This 
technology proved scalable and demonstrated the potential for a significant increase in 
identification rate over 2DE approaches, with the ability to identify hundreds or 
thousands of proteins in a single experiment (13-16).  
Although shotgun proteomics analysis has now established itself as the de facto 
standard methodology for rapidly identifying proteins in complex mixtures, it is far from 
routine, and not without its own set of issues.  The higher throughput of the technique has 





been won at an increase in the complexity of data analysis.  Also, the difficulties of 
dealing with the very large number of components in a whole proteome were perhaps 
underestimated.  Not only does this complexity create a resolution problem in 
fractionation space, but a dynamic range issue as well.  Unlike the genomics area, in 
which DNA can be amplified many-fold for simplified analysis with technologies like 
PCR, proteomics must cope with naturally-occurring abundances of proteins in a sample.  
The proteins expressed in an organism, tissue, or cell at any given point in time vary 
dramatically in their levels of expression. The variation in expression of proteins in 
biological samples has been estimated as being as much as 10
6
 orders of magnitude in 
yeast (17).  In human serum, the most abundant protein (serum albumin) occurs at 
roughly 50 mg/ml. whereas the estimated level of lower copy number proteins such as 
transcription factors can be in the pg/ml range, a dynamic range of 10
10
.  This massive 
difference in expression creates a problem for any detection methodology. 
Quantification, in fact, is one of the advantages the 2DE approach has over the 
LC-MS/MS approaches.  Relative quantification information was available using image 
analysis on 2D gels.  Mass spectrometry is not inherently quantitative, and the intensities 
of peaks in a spectrum are not necessarily an indication of the abundance of an analyte in 
a sample.  Quantification information was thus lost in moving from 2DE to an LC-based 
fractionation approach.  However, a number of techniques for deriving relative 
expression information in LC-MS/MS experiments have been developed.  One such 
method is isotope-coded affinity tagging (ICAT), in which a labeled pair of reagents of 
differing isotopic mass are bound via an alkylating group to the cysteines of all proteins a 
population (18).  The tag also contains a biotin group (in the earlier incarnation), 
permitting the targeted binding and selection of only the labeled peptides from the 
complex digested mixture.  A similar and arguably preferable method to ICAT when 
applicable is the SILAC approach, in which isotopically-labeled amino acids are added to 
cell culture media deficient in those amino acids, growing the targeted cell system in the 
media.  This latter method avoids chemical labeling or potentially noisy affinity 
purification steps, and provides a means of multiplexing beyond two labels by utilizing 
more than one amino acid.  A newer methodology was developed by Darryl Pappin using 
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a set of stable isotope labeling reagents known as iTRAQ (19).  Unlike the ICAT or 
SILAC reagents, iTRAQ labels are isobaric: the mass of any one labeled species is 
identical in the first dimension of mass spectrometry.  Only when MS/MS fragmentation 
occurs on the isobarically labeled analyte mixture does the relative expression 
information become available.  iTRAQ has the advantage of being a four-plex set of 
labels as originally developed, and an eight-plex set has become recently available (20).  
A large number of other stable isotope labeling methods have been developed for 
quantification in proteomics (21, 22) but for the sake of brevity are not discussed in detail 
here.  Also, methods have been developed to quantify proteins without the use of labeling 
techniques, the so-called ‗label free‘ approaches (23, 24).  These methods exploit the fact 
that the total number of peptides that are identified for a protein correlates well with the 
protein abundance.  In all, these quantification approaches allow LC-MS/MS approaches 
to be quantitative, and offer a more complete alternative to 2DE methodologies. 
As mentioned, the ICAT labels have an additional advantage of allowing selective 
pull-down of the labeled peptides, greatly simplifying the overall protein mixture and 
therefore potentially providing for a deeper look into the proteome.  More directed 
approaches which target specific subsets of the proteome have in general been 
increasingly adopted as ways of addressing the dynamic range issue.  These approaches 
seek to utilize a discriminative feature of a set of proteins, such as the presence of a 
cysteine residue (18, 25), a glycosylation site (26), or a phosphate group (discussed 
below).  Affinity tag- bait-based strategies have been particularly powerfully employed in 
high-throughput as a means to generate large and rich datasets for studying protein 
complexes, pathways, and protein-protein interactions (27, 28).  More recently, targeted 
reaction monitoring methodologies are becoming more prevalent, in which the mass 
spectrometer is directed to look specifically for particular peptide masses or 
peptide/fragment-ion transitions in a biological sample (29, 30).  This approach is 
quantitative when used in conjunction with isotopically labeled standard proteins.  The 
methodology requires an advanced knowledge of specific peptide or protein forms, but 
allows a potentially dramatic increase in sensitivity, with the advantage of having much 
of the computational analysis done during assay development rather than being reliant on 
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large scale post-acquisition data analysis.  Overall, directed studies focusing on specific 





With the possible exception of glycosylation, phosphorylation is the most highly-
studied protein modification in proteomics research.  Phosphorylation on serine, 
threonine, and tyrosine residues is generally held to be one of the most prevalent and 
biologically important post-translation modifications (PTMs).  A primary role of 
phosphorylation is to act as a biological ―on‖/‖off‖ switch for a protein activity or a 
cellular pathway in a specific and reversible manner (31, 32).  The modification can alter 
the function of a protein in a number of ways: by affecting its activity, its stability, its 
subcellular localization, its ability to complex with other proteins, or by marking the 
protein for degradation (32).  The fact that there are an estimated 518 protein kinases in 
humans (33) and 540 in mice (34), a number that is likely doubled in plants (35), and that 
at least one in three proteins are estimated to be phosphorylated at some point during 
their life cycle (32, 36), underscores the biological importance of this modification.  
Alterations in normal phosphorylation patterns have been implicated in a number of 
diseases, including cancer (37-39), diabetes (40), and Alzheimer‘s (41).  The 
identification of phosphoproteins, and understanding the dynamics of this modification in 
response to cellular and environmental factors, is thus critical for elucidating the systems 
biology of complex disease mechanisms and global regulatory networks.   
Prior to targeted proteomics technologies, detection of protein phosphorylation 
was somewhat low-throughput, conducted using approaches such as site-directed 
mutagenesis, Edman degradation, or two-dimensional thin layer chromatography and/or 
protein autoradiography of 
32
P-labeled phosphoproteins (42).  In fact, even with the use 
of mass spectrometry, it is only recently that larger numbers of phosphopeptides are 
beginning to be identified.  A recent survey found that in 203 publications in which mass 
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spectrometry was used for phosphoprotein analysis between 1992 and 2003, only 1281 
total phosphorylation sites were reported (42).  Contrasted with more recent studies such 
as Li et al. which identified 2288 unique phosphorylation sites from 985 proteins in yeast 
(43), another yeast study by Donald Hunt‘s group identifying 1252 phosphorylation sites 
on 629 proteins (44), or a study by Molina et al. on human embryonic kidney 293T cells 
which produced 1435 unique phosphorylation site identifications from 500 proteins (45), 
it can be seen that the ability to rapidly identify many more phosphorylated protein forms 
is increasing rapidly. 
There are several features of phosphoproteome analysis that needed to be 
overcome to achieve higher success rates in high-throughput studies.  The primary 
difficulty is one that has already been mentioned: stoichiometry and dynamic range.  
Phosphoproteins are often expressed in relatively low amounts in a cell, and relatively 
few of these proteins exist in a phosphorylated form at any one time.  Enrichment 
strategies are therefore necessary to identify the modified forms of these proteins in high-
throughput.  Initially, these strategies were sub-optimal, but more recent implementations 
are performing much better and are now at the point where an 80-90% enrichment can 
reliably be achieved (45, 46).  There are several primary strategies for phosphopeptide 
enrichment: strong cation exchange (SCX), immobilized metal affinity chromatography 
(IMAC), titanium dioxide (TiO2) and zirconium dioxide (ZnO2) affinity, immunoaffinity, 
and chemical derivatization.  The sensitivity of these strategies differs and depends on the 
specific method and the complexity of the sample.  A recent comparison by Bodenmiller 
et al. of IMAC, TiO2, and chemical derivatization using phosphoramidate chemistry 
found IMAC and the chemical derivatization methods to perform best, although all 
methods seemed to uniquely identify a large number of peptides suggesting that the 
techniques may be complementary (46). 
A second major challenge for phosphoproteomics is that phosphopeptides can 
exhibit poor fragmentation in a mass spectrometer.  This is due to the fact that the 
phosphate moiety is often the most labile element on the peptide.  In the case of collision-
induced dissociation (CID), much of the fragmentation energy used to produce a tandem 
(MS/MS or MS
2
) mass spectrum often is absorbed in the dissociation of the phosphate 
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group.  The resulting spectrum is often dominated by one or several peaks corresponding 
to the neutral loss of phosphoric acid, with little other fragmentation information useful 
for identification of the peptide sequence (47).  This issue has been addressed using data-
dependent MS
3
 methodologies for generating mass spectra, typically on ion-trap 
instruments.   Subjecting neutral-loss fragment masses to a further cycle of fragmentation 
often produces a spectrum with much more useful structural information on the peptide 
(48).  Therefore, phosphopeptides have often been analyzed by automated data-dependent 
triggering of MS
3
 acquisition whenever the neutral loss ion of the appropriate mass is 
detected in an MS
2
 spectrum as a dominant peak (49-56).  Although CID is by far the 
most commonly used methodology for peptide fragmentation, an alternative methodology 
is proving to be very useful for phosphoproteomics, electron transfer dissociation (ETD).  
This method functions by transferring electrons to the protonated peptide ions, with 
resulting fragmentation that is significantly different than CID.  ETD spectra in general 
yield much more extensive backbone fragmentation than CID spectra, and have the 
property that labile PTMs are often preserved in the process (57).  ETD has been 
demonstrated to be particularly effective for phosphopeptide analysis (44, 45). 
A third source of difficulty for large-scale phosphoproteomics is one of data 
analysis.  Informatics approaches for processing the results of phosphopeptide mass 
spectrometry data are not yet routine in many cases, specifically in the handling of non-
standard types of spectra such as MS
3
 or ETD spectra.  As a result, manual curation and 
validation were often necessary for the spectra generated in phosphoproteomics studies, a 
significantly rate-limiting step.  One of the major goals of this thesis is to address these 
particular issues. 
 
1.4 Proteome Informatics 
 Informatics and protein mass spectrometry have been closely linked from the 
earliest days of proteomics.  As soon as mass spectrometry began to be widely used for 
protein work, the need for automated software to assist in data analysis became apparent.  
Early algorithms had been developed for interpretation of the fast atom bombardment 
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(FAB) ionization spectra that preceded MALDI and ESI (58, 59).  When these more 
successful ionization methods became available, other software quickly followed.  By 
1994, two classes of algorithms had already begun to be distinguished, corresponding to 
the types of spectra that these two ionization methods generated.   
As mentioned earlier, initially MALDI was frequently matched with TOF mass 
analyzers, whereas ESI was most often paired with triple-quadrupole or ion-trap 
analyzers.  In the MALDI-TOF approach, the paradigm for analyzing single protein 
isolates was to digest the protein with a proteolytic enzyme (typically trypsin) and 
measure the masses of the resulting fragments.  The mass resolution of MALDI was 
sufficiently high to be able to uniquely identify a protein by the characteristic set of 
masses. This process came to be known as ―peptide mass fingerprinting‖ (PMF).  
Algorithms were developed which took as input a ―database‖ of known protein sequences 
and performed a theoretical digestion for each protein.  Given an experimental mass 
spectrum, these algorithms would return the database proteins which generated a list of 
digestion masses best explaining the spectrum (60-64).   
ESI spectra are fundamentally different than MALDI, in that the masses measured 
can be multiply charged.  Moreover, the triple-quadrupole and ion-trap analyzers coupled 
with ESI sources have the capability of isolating specific fragment ions and subjecting 
them to further fragmentation (MS/MS, MS
2
, or tandem spectra).  Peptides fragment in 
predictable, sequence-dependent ways, and the resulting spectra can be interpreted to 
infer the amino acid sequence of the peptide.  Algorithms that could match experimental 
MS/MS spectra to sequences in a database began to be published (65, 66).   
Various components of these original scoring approaches for both types of spectra 
still exist, albeit enhanced in their current implementation: e.g. the MOlecular Weight 
SEarch (MOWSE) scoring model, the first to account for peptide length (62), was later 
developed into the Mascot algorithm (67).  The original algorithm developed to perform 
an automated interpretation of MS/MS spectra, SEQUEST (65), is still arguably the best 
in its class, and represents the most successful single piece of software in proteome 
informatics.  It functions by also performing a theoretical digestion of protein sequences 
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in a database, selecting a list of peptides with masses most similar to the parent mass that 
generated the MS/MS spectrum being analyzed.  For each of these peptides, a theoretical 
fragmentation spectrum is generated and matched to the experimental spectrum.  A set of 
scores is produced for each match, and the ranked list of matching peptide sequences is 
returned.  SEQUEST was the first algorithm that was designed to take a large number of 
spectra as input and search them in an automated manner.  The analysis paradigm that 
was established with the SEQUEST algorithm has been immensely successful, and is as 
fundamental to MS-based proteomics research as BLAST is to sequence alignment in the 
genomics field. 
As the Web began to be established, various incarnations of MS interpretation 
software began to be made available via a web server.  As the nineties progressed, the 
MOWSE functionality was rewritten to include MS
2
 searching and was commercialized 
as Mascot.  SEQUEST had been commercialized early on, controversially in that 
intellectual property rights had been established around the idea of MS
2
 database 
searching, limiting the ability of other groups to develop similar tools.  A number of other 
groups did ultimately develop significant tools, however, for both MS
2
 and PMF spectra, 
including ProteinProspector (68), Profound (69), and PeptIdent/MultiIdent (70).  The 
fundamentals of database searching strategies and scoring had been established, and 
attention began to shift to automation and throughput.  Instrumentation had developed to 
the point that an increasing number of spectra were being generated, and researchers 
required more automated ways of searching collections of spectra rather than searching 
on a spectrum-by-spectrum basis.  The software packages that were able to do this 
successfully, permitting local installations that could be scripted or take batch input, 
survived. 
 Another class of algorithm had begun to be defined as well, the so-called de novo 
algorithms for interpretation of MS
2
 data (71-74).  The goal of these algorithms is to infer 
the sequence of a peptide directly from the spectrum without the aid of a sequence 
database.  Once the sequence is extracted, standard sequence alignment algorithms could 
be used to obtain the identity of the originating protein.  De novo interpretation of an 
MS/MS spectrum is a challenging problem, however, albeit a seductive one from an 
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informatics perspective.  A number of elegant algorithms have developed for de novo 
sequence analysis, but have never been able to achieve the success rate in a production 
environment that their database search equivalents have for known protein sequences.  
Nevertheless, some of the techniques used in these approaches have found their way into 
more standard approaches, and have led to the development of ―hybrid‖ strategies for 
mass spectrometry data interpretation, as well as approaches for aligning and clustering 
mass spectra (75, 76).   
By the turn of the century, PMF had declined as an overall approach in 
relationship to MS
2
 approaches, since a tryptic mass fingerprint did not typically contain 
sufficient information to uniquely identify a protein, particularly for complex genomes 
and also as the sizes of the commonly-used public sequence repositories got larger.  A 
notable exception to this fact is the use of the accurate mass tagging (AMT) approach 
pioneered by Dick Smith, which takes advantage of the high mass accuracy available on 
high-end Fourier Transform (FT) instruments as well as other information such as 
retention time on a column to uniquely identify peptides (77, 78).  Instrumentation had 
continued to improve the rate at which spectra were being generated as well.  The rate-
limiting step in high-throughput proteomics projects was no longer the rate at which 
spectra could be acquired, but the rate at which it could be interpreted.  The database 
searching strategies would almost always produce a set of ―hits‖, a list of matching 
peptides, for each spectrum.  The issue became one of whether these top scoring peptide 
assignments were correct or not.  Straightforward thresholding methods for selecting 
correct hits above a specified cutoff score were simply not performing as adequately as 
desired for most researchers:  many correct hits were falling below threshold values and 
being lost, while many incorrect assignments were being retained.  Also, the 
heterogeneity of the various search algorithm scoring methods made comparison of 
results from different approaches more difficult, and biological researchers had trouble 
knowing which scoring thresholds could be relied upon as a discriminator for a confident 
assignment.  Methods to put search results on a more firm statistical basis began to be 
developed.  Intuitively, biologists are familiar with measures such as a probability score 
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or an expectation value; such scores needed to be defined for the proteomics domain as 
well.   
The statistical approaches for data validation tend to follow two general strategies, 
termed single-spectrum and global strategies (79).  Single-spectrum results compute an 
expectation value from the distribution of all scores produced by searching that spectrum 
against a database (80-83); this approach is exemplified by the X!Tandem and OMMSA 
search engines.  Global strategies model the distribution of (typically) top-scoring hits 
from all spectra in the dataset rather than scoring search results individually.  This 
approach is exemplified by the PeptideProphet and decoy database methods (84-87).  
PeptideProphet is particularly relevant to the work discussed here.  It functions by fitting 
―correct‖ and ―incorrect‖ distributions to the overall distribution of database search 
scores, calculating a Bayesian probability score based on these distributions.  The 
Bayesian scoring framework is such that additional information that may be useful for 
discrimination of correct from incorrect peptide identifications can be modeled and 
accommodated into the score.  The complementary tool to PeptideProphet, 
ProteinProphet, implements this scoring framework by utilizing peptide probabilities and 
other discriminatory information (such as the ‗number of sibling peptides‘, NSP) in the 
calculation a probability for a protein identification (88).  Recent work combining the 
decoy-database strategy with PeptideProphet has been published, and should provide a 
significant performance increase (85).  Also, the global and single-spectrum approaches 
can in fact be complementary, and utilized within the same framework (79). 
Recent years have seen an explosion in the number of proteome informatics 
publications.  A number of new approaches to interpreting large-scale data have been 
developed, such as spectral library searching (89-91) and spectral clustering (92-95), with 
exciting results.  Blind searching (96, 97) and top-down strategies (98, 99) show promise 
for expanding the typical search space to accommodate new or rare PTMs.  Platforms 
such as Tranche
3
 that permit simplified data management, integration, storage and 
dissemination, and provide a framework for mining very large collections of data from 





multiple sources, promise to provide new insights and dramatically improve the 
accessibility of both data and software tools to many more users.  Finally, the 
development of standardized data representations and openly available code libraries 
(100-102) should facilitate the development of increasingly advanced applications for 
protein and peptide identification. 
1.5 Overview of Projects 
 Although there are a large number of disparate technologies that can be classified 
under the domain of proteomics, most work in the area follows a somewhat standard 
protocol.  The method of high-throughput protein identification using LC-MS/MS can be 
defined by a number of well-defined steps, exemplified by the workflow in Figure 1-1.  
Proteins must be extracted from a biological sample and prepared for analysis by 
removing unwanted contaminants, or treating with inhibitors or phosphatases, etc., 
depending on the requirements of the experiment.  The proteins are then digested with a 
site-specific protease to make the mixture components more amenable to mass 
spectrometry, and also more soluble.  An enrichment step may occur: ion metal affinity 
chromatography (IMAC) or strong cation exchange (SCX) chromatography, for example, 
may be used to enrich phosphopeptides from non-phosphopeptides.  The resulting 
mixture of peptides is then resolved into simpler components, typically by one dimension 
or two dimensions of fractionation.  The final dimension is most typically reversed-phase 
high-performance liquid chromatography (RP-HPLC), separating the component peptides 
based on their hydrophobicity.  The RP-HPLC column is often connected directly online 
to the mass spectrometer, such that the separated peptides eluting off the column are 
measured directly by the instrument.  The instrument generates a collection of spectra for 
the experiment, which must be processed and analyzed.  There is a computational 
pipeline associated with the final data analysis procedure that is not outlined, but involves 
extracting the spectra from the instrument, selecting a list of peaks for each spectrum, 
searching the spectum using a database search platform such as SEQUEST, and 




Figure 1-1.  Outline of a standard LC-MS/MS proteomics analysis methodology.  
Protein samples are digested with a proteolytic enzyme, typically trypsin.  The resulting 
peptide mixture may be optionally (indicated with a ‗*‘) enriched for a particular class of 
peptide, e.g. phosphopeptides.  The mixture is then separated into simpler fractions using 
one or more dimensions of separation.  Note that enrichment and fractionation steps can 
be interchanged, or even precede digestion.  The resulting fractionated mixture is then 
introduced into the mass spectrometer, generating a collection of spectra that must be 
interpreted in an automated way.  The location of particular research topics that are 
explored are illustrated in the schematic.  The projects listed in bold are given particular 
attention, corresponding to chapters in this thesis. 
 
 The overall goal of the work presented in this thesis is to utilize informatics 
strategies to improve upon the proteomics production pipeline with the intent of 
enhancing the depth and breadth of proteome coverage.  Informatics tools were used to 
both evaluate efficacy of specific strategies and technologies in this regard and also 
suggest additional strategies.  Moreover, new informatics approaches were developed to 
improve the quality and extent of information available from existing technologies.  
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Outlined on the figure are the set of individual studies that were conducted, diagramming 
the specific areas being addressed in the proteomic production ‗pipeline‘.  The studies 
indicated in bold are the ones that will be discussed in detail and form the bulk of the 
research effort.  The other studies will be touched upon in less detail.   
 The research discussed in Chapter Two of this thesis addresses the area of 
statistical learning briefly introduced in section 1.4.  As mentioned, the PeptideProphet 
publication was the first to develop the notion of global statistical analysis of scoring, 
implementing a model which fits ―correct‖ and ―incorrect‖ distributions to the 
distribution of scores and utilizing these distributions to derive a probability score (78).  
The work outlined in Chapter Two addresses a similar issue but in a different manner.  
The problem of whether a hit is correct or incorrect is formulated as a strict classification 
problem, a well-defined area of machine learning.  Using various data attributes produced 
by a search algorithm, the work evaluates the performance of standardized and optimal 
pattern classification algorithms in classifying mass spectrometry database search results.  
The work explores these methods as flexible frameworks that are somewhat independent 
of not only the search engine used but also the specific attributes and scores produced by 
the individual search engines.  Moreover, the methods are able to provide data on which 
attributes produced by a scoring approach are most discriminative in selecting a correct 
hit from an incorrect hit.  Results are presented on a standardized dataset of SEQUEST 
results generated on an ESI ion-trap instrument, as well as a set of standardized results 
generated in our research lab on a MALDI-TOF/TOF instrument searched using 
SpectrumMill, a current implementation of the ProteinProspector suite of programs 
further developed by Karl Clauser at Millennium Pharmaceuticals and commercialized by 
Agilent Technologies
4
.   
 There is a heavy focus in this research on phosphoproteomics, which begins to be 
addressed directly in Chapter Three.  This is primarily for the reasons indicated above.  
LC-MS/MS phosphopeptide analysis methodologies most typically generate MS
3
 spectra, 
yet these spectra are not optimally utilized by current data processing methods.  The work 





in Chapter Three outlines a computational framework for processing MS
3
 data in 
conjunction with MS
2





 scans.  This information is translated into an adjustment to the 
probability score for a peptide identification.  The methodology defined need not be 
solely used for phosphopeptide data however; MS
3
 data is often generated in other 
contexts as well.  The methods developed are demonstrated first on a digestion of known 
standard proteins (not-phosphorylated), then demonstrated on a complex phosphopeptide 
mixture.  Overall, the resulting probabilities demonstrate an improvement in the ability to 
discriminate correct identifications from incorrect, a particularly important problem given 
the difficulty of identifying phosphopeptides. 
 Another topic is addressed in Chapter Three, and further expanded upon in 
Chapter Four:  the issue of the relative merit of generating MS
3
 data at all for 
phosphopeptide analysis.  Despite the fact that it is an approach chosen by many if not 
most of the investigators in this area, there is controversy as to the value of these spectra 
in providing more information for peptide identification than simply generating MS
2
 
spectra alone.  It had been suggested that the duty cycle time spent generating MS
3
 
spectra on the instrument results in fewer unique identifications than an equivalent run 
generating MS
2
 spectra only.   
 Chapter Four presents a full analysis of several methods for analyzing a highly 
phosphopeptide-enriched sample on an ion-trap instrument with a high-accuracy Fourier 
transform ion cyclotron resonance (FT-ICR) mass spectrometer, a Thermo LTQ-FT.  The 







methodology, and a more recent Multistage Activation (MSA) methodology that is 
beginning to become more widely available.  The project is the first critical comparison 
of these methodologies, assessing their relative performance using several metrics: the 
number of unique peptide identifications (phospho and non-phospho), the ability of the 
various methods to localize specific sites of phosphorylation, and whether method choice 
has an impact on the overall mass accuracy of data produced.  Also compared are three 




 spectra.  Overall, the 
18 
 
study attempts to define an optimal instrument and computational approach for 
phosphopeptide analysis. 
 Proteomics is a rapidly-changing area of research.  Newer instrumentation 
methodologies and types of data are continually being produced, requiring different and 
increasingly sophisticated analysis methodologies.  Overall, the work presented here 
demonstrates that informatics approaches are critical for effectively utilizing high-
throughput mass spectrometry data.  These results suggest that current popular software 
tools for analyzing these data are only using a portion of all the available information 
contained in spectra, and that there is significant potential for improving upon the results.  
The fact that proteomics is beginning to have a serious impact on problems of significant 
clinical interest, providing very valuable data that can be used in the treatment of disease, 
underscores the importance of developing optimal strategies for processing and mining 
these data.  Phosphoproteomics in particular is of immense importance in the 
understanding the dynamics of diseases such as cancer.  Signaling pathways directing 
cellular growth and differentiation are almost always altered, making the elucidation of 
the components in this process critical.  The work discussed below improves upon the 
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Improved classification of mass spectrometry 






  Manual analysis of mass spectrometry data is a current bottleneck in high-
throughput proteomics.  In particular, the need to manually validate the results of mass 
spectrometry database searching algorithms can be prohibitively time-consuming.  
Development of software tools that attempt to quantify the confidence in the assignment 
of a protein or peptide identity to a mass spectrum is an area of active interest.  The goal 
of this study is to extend work in this area by investigating the potential of recent machine 
learning algorithms to improve the accuracy of these approaches, and as a flexible 
framework for accommodating new data features.  Specifically, the ability of boosting 
and random forest approaches to improve the discrimination of true hits from false 
positive identifications in the results of mass spectrometry database search engines, 
compared to thresholding and other machine learning approaches, is demonstrated.  We 
accommodate additional attributes obtainable from database search results, including a 
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 The study outlined in the chapter was originally published by Ulintz PJ, Zhu J, Qin ZS, 
Andrews PC as ―Improved classification of mass spectrometry database search results using 




factor addressing proton mobility.  Performance is evaluated using publically available 




  The proteomics field is driven by the need to develop increasingly high-
throughput methods for the identification and characterization of proteins.  Mass 
spectrometry (MS) is the primary experimental method for protein identification; tandem 
mass spectrometry (MS/MS) in particular is now the de-facto standard identification 
technology, providing the ability to rapidly characterize thousands of peptides in a 
complex mixture.  Instrument development continues to improve the sensitivity, accuracy 
and throughput of analysis.  Current instruments are capable of routinely generating 
several thousand spectra per day, detecting sub-femtomolar levels of peptide at 10 ppm 
mass accuracy or better.  Such an increase in instrument performance is limited, however, 
without effective tools for automated data analysis.  In fact, the primary bottleneck in 
high-throughput proteomics production 'pipelines' is in many cases no longer the rate at 
which the instrument can generate data, but rather it is in quality analysis and 
interpretation of the results to generate confident protein assignments. This bottleneck is 
primarily due to the fact that it is often difficult to distinguish true hits from false 
positives in the results generated by automated mass spectrometry database search 
algorithms.  All MS database search approaches produce scores describing how well a 
peptide sequence matches experimental fragmentation, yet classifying hits as ―correct‖ or 
―incorrect‖ based on a simple score threshold frequently produces unacceptable false 
positive/false negative rates.  Consequently, manual validation is often required to be 
truly confident in the assignment of a database protein to a spectrum.   
Software and heuristics for automated and accurate spectral identification (1-7) 
and discrimination of correct and incorrect hits (8-16) is thus an onging effort in the 
proteomics community, with the ultimate goal being completely automated MS data 
interpretation.  The most straightforward approach to automated analysis is to define 
specific score-based filtering thresholds as discriminators of correctness, e.g. accepting 
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SEQUEST scores of doubly-charged fully tryptic peptides with XCorr > 2.2 and delta Cn 
values at least 0.1 (17); these thresholds are typically published as the criteria for which 
correctness is defined.  Other efforts have focused on establishing statistical methods for 
inferring the likelihood that a given hit is a random event.  A well known example of this 
is the significance threshold calculated by the Mascot search algorithm, which by default 
displays a threshold indicating the predicted probability of an assignment being greater 
than 5% likely to be a false positive based on the size of the database.  Use of a reverse 
database search to provide a measure of false positive rate is another method frequently 
used (8, 18). More formally, Sadygov and Yates model the frequency of fragment ion 
matches from a peptide sequence database matching a spectrum as a hypergeometric 
distribution (12), a model also incorporated into the openly available X!Tandem 
algorithm (6, 13); while Geer et al. model this distribution as a Poisson distribution (7). 
Keller, et al. (11) were among the first to implement a generic tool for classifying 
the results of common search algorithms as either correct or incorrect.  Their 
PeptideProphet tool represents arguably the most well-known openly-available tool 
implementing a probabilistic approach to assess the validity of peptide assignments 
generated by MS database search algorithms.  Their approach contains elements of both 
supervised and unsupervised learning, achieving a much higher sensitivity than 
conventional methods based on scoring thresholds.  One concern with PeptideProphet, 
however, is the degree to which the supervised component of the model can be 
generalized to new types of data and the ease with which new potentially useful 
information can be added to the algorithm.   
This work attempts to address these difficulties by applying a set of simple ―over 
the counter‖ methods to the challenging peptide identification problem.  Anderson, et al. 
demonstrated that support vector machines could perform well on ion-trap spectra 
searched using the SEQUEST algorithm (14).  In this chapter, we demonstrate that the 
latest machine learning techniques for classification, namely, tree-based ensemble 
methods such as boosting and random forest, are more suitable for the peptide 
classification problem and provide improved classification accuracy. The rationale for the 
improvements lies in their ability to efficiently combine information from multiple easy-
to-get, but dependent and weakly discriminatory attributes.  Such work will hopefully 
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result in development of software tools that are easily installed in a production laboratory 
setting that would allow convenient filtering of false identifications with an acceptably 
high accuracy, either as new tools or as a complement to currently existing software.  The 
problem of classification of mass spectrometry-based peptide identification seems well 
suited to these algorithms and could lead to more readily-usable software for automated 
analysis of the results of mass spectrometry experiments. 
 
2.3 Experimental Procedures 
2.3.1 Overview of classification techniques 
Mixture Model Approach in PeptideProphet 
Among all the methods that have been proposed in the literature for the peptide 
identification problem, the mixture model approach implemented in the PeptideProphet 
algorithm (11) is perhaps the most well known.  In this method, a discriminant score 
function sss xcxccxxxF  ...),...,,( 11021  is defined to combine database search 
scores x1, x2,…,xS where ci‘s are weights. Based on a training dataset, a Gaussian 
distribution is chosen to model the discriminant scores corresponding to correct peptide 
assignments, and a Gamma distribution is selected to model the asymmetric discriminant 
scores corresponding to incorrect peptide assignments. All the scores are therefore 
represented by a mixture model )()1()()( 21 xfrxrfxp  , where )(1 xf  and )(2 xf  
represent the density functions of the two types of discriminant scores, and r is the 
proportion of correct peptide identifications. For each new test dataset, the EM algorithm 
(19) is used to estimate the probability that the peptide identified is correct. A decision 
can be made by comparing the probability to a pre-specified threshold. When compared 
to conventional means of filtering data based on SEQUEST scores and other criteria, the 
mixture model approach achieves much higher sensitivity.  
  A crucial part of the above approach is the choice of discriminant score function 
F. In (11), the ci‘s are derived in order to maximize the between- versus within-class 
variation under the multivariate normal assumption using training data. To make this 
method work, one has to assume that the training data and the test data are generated from 
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the same source.  When a new set of discriminant scores is generated and needs to be 
classified, one has to retrain the ci weight parameters using a new corresponding training 
set; in other words, the discriminant function F is data dependent. In an area such as 
proteomics in which there is a good amount of heterogeneity in instrumentation, protocol, 
database, and database searching software, it is fairly common to come across data which 
display significant differences.  It is unclear to what degree the results of a classification 
algorithm are sensitive to these differences, hence it is desirable to automate the 
discriminant function training step. Another potential issue is the Normal and Gamma 
distribution used to model the two types of discriminant scores. There is no theoretical 
explanation why the discriminant scores should follow these two distributions; in fact, a 
Gamma distribution rather than a Normal distribution may be appropriate for both 
positive and negative scores when using the Mascot algorithm (20). It is possible that for 
a new set of data generated by different mass spectrometers and/or different search 
algorithms, the two distributions may not fit the discriminant scores well.  Also, certain 
types of data attributes or scores may be more difficult to accommodate into such a model 
if those attributes significantly alter the shape of the discriminant score distribution.  For 
example, qualitative or discrete attributes may be more difficult to model.  As a result, 
higher classification errors may be produced using this model-based approach.   
Machine learning techniques 
  Distinguishing correct from incorrect peptide assignments can be regarded as a 
classification problem, or supervised learning, a major topic in the statistical learning 
field. Many powerful methods have been developed such as CART, SVM, random forest, 
boosting, and bagging (21). Each of these approaches has unique features that enable 
them to perform well in certain scenarios; the SVM, for example, is a good tool for small 
sample size, large feature space situations.  On the other hand, all approaches are quite 
flexible and have been applied to an array of biomedical problems. In this project, several 





  The boosting idea, first introduced by Freund and Schapire with their AdaBoost 
algorithm (22), is one of the most powerful learning techniques introduced during the past 
decade. It is a procedure that combines many ―weak‖ classifiers to achieve a final 
powerful classifier.  This section provides a concise description of boosting in the two-
class classification setting.  Suppose we have a set of training samples, where xi is a 
vector of input variables—in this case, various scores and attributes of an individual MS 
database search result produced from an algorithm such as SEQUEST— and yi is the 
output variable coded as -1 or 1, indicating whether the sample is an incorrect or correct 
assignment of a database peptide to a spectrum.  Assume we have an algorithm that can 
build a classifier T(x) using weighted training samples so that, when given a new input x, 
T(x) produces a prediction taking one of the two values {-1, 1}; the classifier T(x) is 
typically a decision tree.  Then boosting proceeds as follows: start with equal weighted 
training samples and build a classifier T1(x).  If a training sample is misclassified, e.g. an 
incorrect peptide is assigned to the spectrum, the weight of that sample is increased 
(boosted).  A second classifier T2(x) is then built with the training samples, but using the 
new weights, no longer equal.  Again, misclassified samples have their weights boosted 
and the procedure is repeated M times.  Typically, one may build hundreds or thousands 
of classifiers this way.  A final score is then assigned to any input x, defined to be a linear 
(weighted) combination of the classifiers.  A high score indicates that the sample is most 
likely a correctly assigned protein with a low score indicating that it is most likely an 
incorrect hit.  By choosing a particular value of the score as a threshold, one can select a 
desired specificity or a desired ratio of correct to incorrect assignments.   
Random Forests 
  Similar to boosting, the random forest (23) is also an ensemble method that 
combines many decision trees.  However, there are three primary differences in how the 
trees are grown: 1. Instead of assigning different weights to the training samples, the 
method randomly selects, with replacement, n samples from the original training data; 2. 
Instead of considering all input variables at each split of the decision tree, a small group 
of input variables on which to split are randomly selected; 3. Each tree is grown to the 
largest extent possible.  To classify a new sample from an input, one runs the input down 
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each of the trees in the forest.  Each tree gives a classification (vote).  The forest chooses 
the classification having the most votes over all the trees in the forest.  The random forest 
enjoys several nice features:  like boosting, it is robust with respect to input variable noise 
and overfitting, and it gives estimates of what variables are important in the classification.  
A discussion of the relative importance of the different attributes used in our analysis of 
MS search results is given in the results section.   
Support vector machines  
  The support vector machine (SVM) is another successful learning technique (24).  
It typically produces a non-linear classification boundary in the original input space by 
constructing a linear boundary in a transformed version of the original input space.  The 
dimension of the transformed space can be very large, even infinite in some cases.  This 
seemingly prohibitive computation is achieved through a positive definite reproducing 
kernel, which gives the inner product in the transformed space.  The SVM also has a nice 
geometrical interpretation in the finding of a hyperplane in the transformed space that 
separates two classes by the biggest margin in the training samples, although this is 
usually only an approximate statement due to a cost parameter. The SVM has been 
successfully applied to diverse scientific and engineering problems, including the life 
sciences (25, 26, 27). Anderson, et al. (14) introduced the SVM to MS/MS spectra 
analysis, classifying SEQUEST results as correct and incorrect peptide assignments. 
Their result indicates that the SVM yields less false positives and false negatives 
compared to other cutoff approaches. 
  However, one weakness of the SVM is that it only estimates the category of the 
classification, while the assignment probability )(xp  may be of interest itself, where 
)|1()( xXYPxp   is the posterior probability of a sample being in class 1 (i.e. a 
correctly identified peptide).  Another problem with the SVM is that it is not trivial to 
select the best tuning parameters for the kernel and the cost.  Often a grid search scheme 
has to be employed, which can be time consuming.  In comparison, boosting and the 
random forest are very robust, and the amount of tuning needed is rather modest 






2.3.2 Reference Datasets 
  Two collections of mass spectrometry data were used in this study, representing 
the two most common protein MS ionization approaches: electrospray ionization (ESI) 
and matrix-assisted laser desorption ionization (MALDI). The performance of boosting 
and random forest methods in comparison with other approaches using a known, 
published ESI dataset is benchmarked.  The performance these methods to newer in-
house generated MALDI data from an ABI-TOF/TOF (28) are then evaluated. 
ESI-SEQUEST dataset 
  The electrospray dataset was kindly provided by Andy Keller, as described in (11) 
and (29).  These data are combined MS/MS spectra generated from twenty-two different 
LC-MS/MS runs on a control sample of eighteen known (non-human) proteins mixed in 
varying concentrations.  A ThermoFinnigan ion trap mass spectrometer was used to 









Each spectrum was searched by 
SEQUEST against a human protein database with the known protein sequences appended.  
The top-scoring peptide hit was retained for each spectrum; top hits against the known 
eighteen proteins were labeled as ―correct‖, and manually verified by Keller, et al.  All 
peptide assignments corresponding to proteins other than the eighteen in the standard 
sample mixture and common contaminants were labeled as ―incorrect‖.  In all, 2757 
(7.44%) peptide assignments were determined to be correct.  The distribution of hits as 
used to train and test the methods used in this study are indicated in Table 1.  
MALDI-SpectrumMill dataset 
  One goal of the study was to evaluate performance of the algorithms on data 
generated using different instrumentation; namely, MALDI data.  Toward that end, 300 
purified recombinant human protein samples were procured from Genway Biotech Inc 
(San Diego, CA).  Aliquots of these proteins were run on 1D SDS-PAGE to confirm 
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purity and protein molecular weight. Plugs from the band on each 1D gel were subjected 
to in-gel trypsin digestion, serially diluted (in many cases) to generate potentially more 
‗realistic‘ spectra, and cleaned by C-18 ZipTip.  Resulting digestions for each protein 
were spotted in four replicates on MALDI target plates, and MS/MS spectra acquired on 
an Applied Biosystems Inc (Foster City, CA) 4700 Proteomics Analyzer (―TOF/TOF‖).  
Spectra were collected from the successive replicate spots by selecting the most abundant 
ions from each replicate and excluding previously selected peaks, until reasonably sized 
MS peaks could no longer be detected; this process resulted in up to twenty-four MS/MS 
spectra for each standard protein.  At the time of this analysis, results from 158 of these 
protein standards had been generated and were used to compose the dataset. 
  To generate testing and training datasets for this analysis, all MALDI spectra 
were searched using the Agilent (Palo Alto, CA) Spectrum Mill platform (specifying 
trypsin as the proteolytic enzyme, and accommodating oxidized methionine and Pyro-Glu 
modifications) against a version of the NCBInr-Human dataset downloaded March 10, 
2005.  The NCBInr database was modified by replacing all entries corresponding to the 
Genway protein standards with annotated entries that include the appropriate N-term 
affinity tag (either T7 or 6xHis), and appending the E. coli K12 sequences, as E. coli was 
the host organism in which the recombinants were produced.  Tolerances of 0.7 Da for 
precursor ion selection and 0.3 Da for fragment ion selection were used in the search, 
with a minimum matched peak intensity of 40%.  ―Correct/Incorrect‖ labels were 
assigned to each spectrum in a semi-automated manner by correlating the accession 
number of the search result with that of the protein digest known to be spotted at the plate 
location from which each spectrum was derived.  The dataset consists of 11764 search 
results from 4340 spectra (up to the top five ranking hits for each spectrum).  1044 are 
‗true positive‘ hits; of these, 111 are non-top-ranking hits.  The precise distribution of hits 
as used to test the algorithms are shown in Table 1.  Note, the relatively low fraction of 
true positives as per what would be expected from this instrument is primarily due to the 
fact that the top five ranking hits were selected, not just the top hits, from every search 
result.  The inclusion of non-top ranking hits was done to examine whether the machine 
learning tools could be used to distinguish correct hits among these lower-ranked results, 
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a frequent occurrence in MS/MS search data.  The lower ranked hits contain potentially 
valuable protein identifications that would be discarded using many normal approaches.   
  The complete set of annotated MALDI protein standard data (named ‗Aurum‘) is 
available for download on the ProteomeCommons website
6
.  To our knowledge, this 
represents to first publicly-available annotated MALDI dataset useful for development of 
these types of algorithms.   
 
  Training Testing 
ESI-SEQUEST    
Correct  1930 827 
Incorrect  24001 10286 
Total  25931 11113 
MALDI-SpectrumMill    
Correct  731 313 
Incorrect  7504 3216 
Total  8235 3529 
 
Table 2-1. Number of spectra examples for the ESI-SEQUEST dataset and the 
MALDI-Spectrum Mill dataset 
 
 
2.3.3 Attributes extracted from each dataset 
  Both *.out search result files from SEQUEST and *.spo result files from 
Spectrum Mill were parsed into a simple text row/column format suitable for use by 
pattern classification algorithms using custom modules written in Python (available upon 
request).  For the SEQUEST results, only the top hit for each spectrum was parsed; again, 
for the MALDI dataset, the top five ranking hits were retained.   
SEQUEST 
                                                          
6
  http://www.proteomecommons.org 
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  The attributes extracted from SEQUEST assignments are listed in Table 2.  
Attributes include typical scores generated by the SEQUEST algorithm (Sp, Sp rank, 
deltaCn, XCorr), as well as other statistics included in a SEQUEST report (total intensity, 
number of matching peaks, fragment ions ratio).  Length is included amongst the 
PeptideProphet attributes since PeptideProphet normalizes the XCorr attribute using the 
length of the peptide.  Number of tryptic termini (NTT) is a useful measure for search 
results obtained by specifying no proteolytic enzyme, and is used extensively in 
PeptideProphet (11).  Other attributes include features readily obtainable from the 
candidate peptide sequence: C-term residue (K='1', R='2', others='0'), number of prolines, 






)5.0()8.0()0.1(   
MPF attempts to provide a simple measure of the mobility of protons in a peptide, a 
theoretical measure of the ease of which a peptide may be fragmented in the gas phase 
(30, 31, 32).  A smaller value for MPF is indicative of higher protein mobility, whereas 
peptides with MPF >= 1 can be considered ‗nonmobile‘.  R, K, and H refer to the number 
of these amino acid residues present in the sequence, reflecting the overall basicity of the 
peptide.  The coefficients for these factors reflect the relative basicity of the three residues 
normalized to the dissociation constant of arginine (the pKa values of Arg, Lys and His 
being 12.0, 10.0, and 5.9, respectively).  Charge indicates the charge on the parent 
peptide, reflecting the number of free protons potentially available for charge-directed 
fragmentation.  We include MPF to demonstrate the ease of accommodation of additional 
information into the classification algorithms, amounting to simply adding an additional 
data column to the data set.   
Spectrum Mill: 
  Spectrum Mill attributes are indicated in Table 3.  Spectrum Mill is a search 
platform based initially on the Protein Prospector set of scripts (3), further developed by 
Karl Clauser and commercialized by Agilent. The primary Spectrum Mill score is non-
probabilistic, intended as an absolute measure of the information contained in an 
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assignment of a spectrum with a peptide sequence, and is database-size independent.  The 
score increases with peaks matching theoretical fragment ions types (in an instrument-
dependent way), with a penalty for unmatched peaks.  Intensity of peaks is a factor in the 
score, as is peptide length.  The scoring system accommodates all major fragmentation 
ion types and neutral losses, and the presence of internal and immonium ions.  Scored 
Peak Intensity (SPI) is the second primary Spectrum Mill scoring measure, reflecting the 
percentage of total peak intensity matching predicted fragment ion masses.  Spectrum 
Mill implements semi-automated spectrum validation and curation tools based on linear 
thresholds for primary Score and SPI.  Background Cleavage Score (BCS) indicates the 
number of cleavage events generating b- or y-ions; unused ion ratio (number of unused 
ions / number of total ions after peak thresholding) provides a measure of the amount of 
signal not accounted for in the match; and delta parent mass measures the difference 
between the observed and experimental peptide precursor masses.  Terms such as parent 
charge were avoided in the Spectrum Mill data due to the fact that the ions are produced 
























Delta MH+ (M+H)+ Parent ion mass error between observed and theoretical 
Sp Rank Rank/Sp Initial peptide rank based on preliminary score 
Delta Cn deltCn 1 – Cn: difference in normalized correlation scores 
between next-best and best hits 
XCorr XCorr Cross-correlation score between experimental and 
theoretical spectra 






Inferred from Peptide  Measures whether the peptide is fully tryptic, partially 
tryptic, or non-tryptic (2, 1, or 0, respectively)  
Additional 
(III) 
Parent Charge (+1), (+2), (+3) Charge of the parent ion 




# matched peptides Number of database peptides matching the parent peak 
mass within the specified mass tolerance 
Sp Sp Preliminary score for a peptide match 
Ion Ratio Ions Fraction of theoretical peaks matched in the preliminary 
score 
C-term Residue Inferred from Peptide Amino acid residue at the C-term of the peptide (1 = R, 2 
= 'K', 0 = 'other') 
Number of 
Prolines 
Inferred from Peptide Number of prolines in the peptide 
Number of 
Arginines 





calculated  A measure of the ratio of basic amino acids to free 
protons for a peptide (described in Experimental 
Procedures) 
 
Table 2-2. SEQUEST attribute descriptions. Attribute names in bold are treated as 








Attribute Name Attribute Description 
Delta MH+ Parent ion mass error between observed and theoretical  
Rank Rank by Score and number of unmatched ions of the peptide among 
all peptides matched for the spectrum  
Score SpectrumMill score 
Percent Scored Peak Intensity 
(SPI) 
Percentage of total peak intensity from observed peaks which match 
theoretical fragment ion masses 
Backbone Cleavage Score (BCS) Number of backbone cleavage events from which a y or a b ion is 
observed 
Unused Ions Ratio  (Number of observed peaks not matched to fragment ion masses)/ 
(Number of observed peaks matched to fragment ion masses) 
 
Table 2-3. Spectrum Mill attribute descriptions. 
 
 
2.3.4 Implementation Specifics 
 A single training and testing dataset was constructed for each of the ESI-
SEQUEST and MALDI-SpectrumMill datasets by random selection.  Random sampling 
was done separately for ―correct‖-labeled and ―incorrect‖-labeled data so that both 
training and testing data contain the same proportions.  For all results, evaluation was 
done on a test set that does not overlap the training set.  Two thirds of all data were used 
for training and one third for testing.  
  The PeptideProphet standalone application used in this analysis was downloaded 
from peptideprophet.sourceforge.net.  PeptideProphet is also available as part of the 
Trans-Proteomics Pipeline being developed at the Seattle Proteome Center 
(http://tools.proteomecenter.org/TPP.php).  All SEQUEST *.out result files 
corresponding to each test set were placed in a separate directory and processed using the 
out2summary.c script to generate the PeptideProphet html input file.  PeptideProphet was 
run by executing the runPeptideProphet script, using default parameters.  PeptideProphet 
was not run on the MALDI-SpectrumMill dataset.   
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  Contributed public packages for the R programming language were used for the 
boosting and random forest approaches, specifically the AdaBoost algorithm (22) 
implemented by Greg Ridgway
7
, and the randomForest v4.5-8 package, an R port by 
Andy Liaw and Matthew Wiener of the original Fortran algorithm developed by Leo 
Brieman and Adele Cutler.  In general, the parameters (i.e. tree size, number of trees etc.) 
of the random forest and boosting implementations were not fine tuned, for two reasons: 
classification performances of both the random forest and boosting are fairly robust to 
these parameters, and also because our ultimate goal is to provide a software tool that can 
be easily used in a production laboratory setting without a significant tuning requirement.  
For the AdaBoost analysis, a decision trees with forty leaves was used for the ‗weak‘ 
classifier, and the number of boosting iterations (M) was fixed to 1000.  For random 
forests, the default number of attributes for each tree-- one third of the total number of 
attributes-- was used, except for the five-variable case in which the number of attributes 
was fixed at two.  The default number of trees in the forest is 500, and each tree in the 
forest was grown until the leaf is either pure or has only five samples.   
  For the support vector machine, a radial kernel was chosen to classify the 
samples, as implemented in the libSVM package (version 2.7)
8
. The radial kernel is 
flexible and performed well in preliminary studies. In order to select the optimal set of 
tuning parameters for radial kernel, a grid search scheme was adopted using a modified 
version of the grid.py python script distributed with the libSVM package.  Optimal 
parameters are sensitive to specific training sets:  for the precise results presented in this 











2.4 Results and Discussion 
2.4.1 Classification Performance 
  Each of the machine learning approaches used produces an ordering of the 
collection of examples in the test dataset.  With PeptideProphet, the examples are ordered 
highest to lowest on the basis of a Bayesian posterior probability, as described in (11).  
For either boosting or random forest, the algorithm returns, in addition to a 
'correct'/'incorrect' classification, an additional 'fitness' term.  In the case of the random 
forest, the fitness term can be interpreted as a probability of the identification being 
correct.  A probability score can be generated from the boosting fitness measure as well 
using a simple transformation.  The SVM returns a classification and a measure of the 
distance to a distinguishing hyperplane in attribute space that can be considered a 
confidence measure.  When examples are ordered in this way, results can be represented 
as a Receiver Operating Characteristic (ROC) plot, which provides a way of displaying 
the ratio of true positive classifications (sensitivity) to the fraction of false positives (1 – 
specificity) as a function of a variable test threshold.  The threshold, chosen on the ranked 
ordering of results produced by the classifier, represents a trade-off between being able to 
select the true positives without selecting too many false positives.  If the scoring 
threshold is set very high, the number of false positives can be minimized or eliminated 
but at the expense of missing a number of true positives; conversely, as the scoring 
threshold is lowered, more true positives are selected but more false positives will be 
included as well.  The slope at any point in the ROC plot is a measure of the degree to 
which one group is included at the expense of the other. 
  The ESI-SEQUEST dataset allows the comparison of all four classification 
approaches: boosting, random forests, PeptideProphet, and the SVM.  ROC plots showing 
the results of classifying correct vs incorrect peptide assignments of the ESI-SEQUEST 
dataset using these methods are shown in Figure 2-1A.  All methods perform well on the 
data.  As can be seen, the boosting and random forest methods provide a slight 
performance improvement over PeptideProphet and the SVM classification using the 
same six attributes.  At a false positive rate of roughly 0.05%, the boosting and random 
forest achieves a sensitivity of 99% while PeptideProphet and SVM provide a 97-98% 
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sensitivity.  It should be noted that, although a systematic difference of 1-2% can be seen 
in these results, this corresponds to a relatively small number of total spectra.  Also 
indicated in Figure 2-1 are points corresponding to well-known attribute thresholds from 
several literature citations.  Each point shows the sensitivity and specificity that would be 
obtained on the test dataset by applying these published thresholds to the SEQUEST 
attributes Charge, Xcorr, Delta Cn, and NTT.  
  Of interest is the fact that the boosting, random forest and SVM results 
asymptotically approach 1.0 sensitivity, whereas PeptideProphet approaches a sensitivity 
of about 0.98 for most of the length of the ROC curve (the PeptideProphet results do 
achieve 1.0 sensitivity at the very end).  These results point to a set of spectra that the 
tools learn to discriminate differently; in the case of the test set described here, the 
discrepancy corresponds to fourteen spectra out of the total 11113.  Eleven of these 
spectra are results annotated as 'correct' hits that PeptideProphet assigns as 'incorrect', and 
three 'incorrect' results that PeptideProphet assigns as 'correct'.  The eleven spectra of the 
former category all represent singly charged spectra with very small SEQUEST DeltaCn 
values; PeptideProphet appears to have some difficulty with instances of +1 spectra in 
which the second-highest hit has a score very close to the top hit.  The other three spectra 
represent an interesting case.  Since the LCQ instrument on which the spectra were 
generated lacks the resolution to discriminate between doubly- and triply-charged parent 
ions, typical peaklist extraction protocols produce two identical peaklists for non-singly 
charged precursor masses, one each for the doubly- and triply-charged case.  The database 
search for only one of these two peaklists should produce a correct result under normal 
circumstances.  The cases that PeptideProphet ―misses‖ here are an exception to this rule.  
They are cases in which two peptides containing identical sequence from the same 
protein-- a larger peptide with a +3 charge and one or more missed tryptic cleavage sites, 
and a smaller peptide (a subset of the first) with a +2 charge-- have the same apparent 
mass.  For example, in one instance a parent precursor with a m/z of 1109 Da is selected, 
corresponding to a peptide from the CAH2_BOVINE protein. The CAH2_BOVINE 
peptide SSQQMLKFRTLNFNAEGEPELLMLANWR has a mass of 3324.82 Da.  This 
peptide has two missed trypsin cleavage sites, a Lys at position seven and an Arg at 
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position nine.  The peptide resulting from cleaving after position nine is 
TLNFNAEGEPELLMLANWR, with a mass of 2220 Da.  The longer peptide was hit by 
SEQUEST for the +3 peaklist, and the shorter one for the +2 peaklist: 3326/3 ~= 2219/2 
~= 1109 Da.  Following the rule that only one of the two identical peaklists generated 
from the 1109 Da precursor mass spectrum can be correct, the annotation provided with 
the ESI-SEQUEST dataset assigned the +3 spectrum as correct and the +2 spectrum as 
incorrect.  The 'incorrect' annotation to the search result of the +2 peaklists is misleading 
in these cases, however.  PeptideProphet distinguishes these cases, accurately providing a 
'correct' classification for the +2 spectra.  The other three completely supervised 
algorithms learn to classify these cases as incorrect based on similar examples in the 
training dataset.  
               
Figure 2-1.  Performance machine learning methods on the ESI-SEQUEST dataset. 
The figure shows a ROC plot of classification of the test set by PeptideProphet, SVM, 
boosting, and random forest methods using attribute groups I and II. The plot on the right 
is a blowup of the upper left region of the figure on the left. Also displayed are points 
corresponding to several sets of SEQUEST scoring statistics used as linear threshold 
values in published studies. The following criteria were applied for choosing correct hits 
(the +1, +2, and +3 numbers indicate peptide charge): a, +1: XCorr ≥1.5, NTT=2; +2, +3: 
XCorr ≥2.0, NTT=2 (36); b, ∆Cn > 0.1, +1: XCorr ≥ 1.9, NTT = 2; +2: XCorr ≥ 3 or 2.2 
≤ XCorr ≤ 3.0, NTT = 1; +3: XCorr ≥ 3.75, NTT ≥ 1 (17); c, ∆Cn ≥ 0.08, +1: XCorr ≥ 
1.8; +2: XCorr ≥ 2.5; +3: XCorr ≥ 3.5 (20); d, ∆Cn ≥ 0.1, +1: XCorr ≥ 1.9, NTT = 2; +2: 
XCorr ≥ 2.2, NTT ≥ 1; +3: XCorr ≥ 3.75, NTT ≥ 1 (16); e, ∆Cn ≥ 0.1, Sp rank ≤ 50, NTT 




  Panels 1B and 1C compare the performance of the boosting and random forest 
methods using different sets of input attributes, as shown in Table 2.  The panels contains 
the results of these algorithms using three combinations of features: 1) attribute groups I 
and II: the six attributes used by the PeptideProphet algorithm (SEQUEST XCorr, Delta 
Cn, SpRank, Delta Parent Mass, Length, and NTT);  2) attribute groups I, III, and IV (all 
attributes except NTT); and 3) attribute group I-IV (all fifteen variables shown in Table 
2).  Overall, it can be seen that both machine learning approaches provide improvement 
over the scoring thresholds described in the literature.  The best performance was 
obtained by including all fifteen variables, indicating that accommodation of additional 
information is beneficial.  The random forest appears to be slightly more sensitive to the 
presence of the NTT variable than boosting.  Of note is the fact that effective 
classification is attained by the boosting and random forest tools even in the explicit 
absence of the NTT variable, as demonstrated by feature combination 2), despite the fact 
that the ESI dataset was generated using the ‗no enzyme‘ feature of SEQUEST.  No 
enzyme specificity in the database search is often time-prohibitive in routine production 
work; it is much more common to restrict searches to tryptic peptides (or any other 
proteolytic enzyme used to digest the protein sample).  Restricting to trypsin narrows 
results to having an NTT=2, rendering the attribute non-discriminatory.  It must be noted, 
however, that in this analysis the C-term Residue attribute is not completely independent 
of NTT in that it contains residue information on one of the termini.  If trypsin-specificity 
is turned on in a search, in addition to distinguishing between Lys- and Arg-terminated 
peptides, C-term Residue will discriminate tryptic and semi-tryptic peptides, the latter 
being possible if the peptide is the C-terminal peptide of a protein.  If trypsin specificity is 
not used in the search (as in these data), although the C-term Residue variable cannot 
predict the NTT value of a peptide, it can discriminate between cases.  If the C-term of 
the peptide is tryptic, the the peptide may be either fully or partially tryptic; if it is not, it 
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b) 
Figure 2-2.  Performance of Boosting and Random Forest methods using various 
combinations of attributes for the ESI-SEQUEST dataset.  a) Results of the random 
forest method using various sets of attributes. The black line represents the result of the 
random forest using six attributes defined in Table 2-2 as groups I and II: the SEQUEST 
XCorr, Sp rank, ∆Cn, delta parent mass, length, and NTT. The red line is the result using 
14 attributes, groups I, III, and IV (no NTT). The blue line represents the result using all 
attribute groups I–IV, all 15 variables. b) ROC plot of the boosting method using attribute 
groups I and II (black); I, III, and IV (red); and I–IV (green). Points plotted on the curves 
in both full-scale figures represent published attribute threshold combinations as 




  The results of classifying the MALDI-SpectrumMill data using boosting and 
random forest are shown in Figure 2-2.  The functionality necessary to run 
PeptideProphet on SpectrumMill data would require customization of the tool, and was 
therefore not used.  The SVM on the MALDI-SpectrumMill dataset was not run since the 
superior performance of the boosting and random forest methods were already 
demonstrated on the ESI-SEQUEST dataset. Overall, the two classifiers performed 
similarly, with boosting outperforming random forests slightly when the false positive 
rate is above 15%.  Both methods show dramatic improvement over thresholding 
combinations, based on default recommended combinations of Spectrum Mill Score and 
Shared Peak Intensity (SPI) values.  Spectrum Mill documentation suggests three 
guideline threshold combinations for ―Outstanding‖, ―Good‖ and ―Modest‖ hits, indicated 
in the figure.  The ―Outstanding‖ threshold effectively discriminates results with a low 
false positive rate but discards a majority of true positives.  The learning approaches are 
able to pull a much greater number of true positives at a similar false positive rate: at a 
false positive rate of 5%, the learners classify roughly 70% of the true positives.  The 
MALDI-SpectrumMill dataset was generated by selecting the top five hits from search 
results, since 11% of the correct results were non-top ranking hits.  It does not appear to 
be the case that the machine learning algorithms were able to effectively select these 
cases out, however (data not shown).  Note that the Spectrum Mill tool is intended to 
facilitate manual curation, and as such these threshold levels are only guidelines and are 





Figure 2-3. Performance of boosting and random forest methods on the MALDI-
Spectrum Mill dataset. The variables used are: rank, Spectrum Mill score, SPI, delta 
parent mass (∆M+H), BCS, and unused ion ratio. Points corresponding to standard 
guideline scoring threshold values from the Spectrum Mill documentation are displayed: 
a, Spectrum Mill score >15, SPI > 70% (outstanding); b, Spectrum Mill score >10, SPI > 
70% (good); c, Spectrum Mill score >5, SPI > 70% (modest). 
 
 
2.4.2 The impact of individual attributes on the final prediction 
accuracy  
 
  It is interesting to examine the relative importance of the various attributes used 
by the boosting and random forest algorithms to classify search results.  The relative 
importance of each attribute is determined by noting nodes in the ensemble of trees in 
which the individual attribute appears, and summing the relative information content or 
loss of entropy that each node containing the attribute provides.  Attributes which provide 
the greatest combined discrimination amongst all the nodes in which it appears thus have 
a higher importance.   
  Figure 2-4 displays the relative importance each attribute from SEQUEST and 
SpectrumMill search results using the boosting and random forest methods.  Results for 
classification of the ESI-SEQUEST dataset incorporating the six attributes used by 
PeptideProphet are shown in Panel 2-4a.  All six attributes show a contribution to the 
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discrimination, with the most important contribution from the NTT variable.  
PeptideProphet incorporates only the first five attributes in the calculation of the 
discriminant function, introducing NTT distributions using a separate joint probability 
calculation.  The coefficients for their discriminant score weight XCorr highest, followed 
by Delta Cn, with much lower contributions due to Delta M+H and Sp Rank.  Again, 
Length is used by PeptideProphet to correct for the well-known peptide length 
dependence of the XCorr variable.  Our results indicate a roughly equivalent contribution 
from Delta Cn and XCorr, with a significant contribution from Sp Rank.  Delta M+H and 
Length showed a much more moderate contribution.  The six attributes display a high 
importance when used in conjunction with the other nine attributes from groups III and 
IV, as indicated in Panel 2-4b.  Of these additional nine, Sp score shows a surprising 
contribution, as this scoring measure is rarely used for discrimination in popular usage.  
Also significant is the PeakMatchRatio measure and the MPF.  For those attributes that 
are in common, these results are in agreement with Fisher's discriminant scores calculated 
by Anderson, et al. (14), with the exception of Delta M+H which showed very little 
contribution using their SVM approach.  The number of Arginine and Proline measures, 
as well as Parent Charge, Length, and Number of Matched Peptides, appear to provide 
very little discriminative value. 
  The NTT variable provides by far the most important contribution, particularly for 
the boosting approach, but is informative only for the non-enzyme-specific searches.  The 
results above indicate, however, that the machine learning approaches perform quite well 
even in the absence of this variable.  The relative importances of the other measures in the 
absence of this variable are shown in Panel 2-4c.  In this scenario, the Delta Cn measure 
provides the most importance contribution.  A comparison of Figs 2-4b and 2-4c suggests 
that in the absence of NTT, the C-term Residue variable contributes much more 
significantly to the discrimination.  As discussed above, although not as discriminatory as 
NTT, C-term Reside does contain some of the same information, and may be useful as a 
partial replacement for NTT in situations in which NTT is prohibitively time-consuming 
to obtain.   
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  The relative importance of different attributes for the SpectrumMill data are 
shown in Figure 2-5.  Not surprisingly, Rank and Score features are very important for 
discrimination.  It is interesting, however, that Rank and Score do not duplicate each 
other, since the ranking of results is primarily based on Score.  One surprising feature is 
the importance of Delta MH+ in the final discrimination.  This attribute is relatively 
unimportant in the ESI-SEQUEST results;  this may demonstrate a difference between the 
SpectrumMill and SEQUEST scoring schemes, but can more likely be explained by the 
greater mass accuracy of the TOF/TOF instrument compared to the LCQ.  The percent 
scored peak intensity (SPI) attribute is analogous to the ‗fraction matched MSMS TIC‘ 
variable published by Anderson, et al., and is one of the primary criteria used for judging 
the correctness of a hit in the SpectrumMill package.  Its low importance measure in the 
context of the other attributes is of interest.  The Backbone Cleavage Score and Unused 
Ion Ratio attributes calculated by SpectrumMill appears relatively less important in this 
context as well.  Note, NTT was not calculated for the MALDI-SpectrumMill dataset due 
to difficulties in performing a no-enzyme specificity search against the NCBInr-human 















Figure. 2-4. Relative importance of SEQUEST data attributes used for classification 
by boosting and random forest methods. a) Relative importance using attribute groups 
I and II. b) Attribute importance using all attributes in random forest and boosting 
methods. c) Attribute importance using attribute groups I, III, and IV.  Atribute 
abbreviations: TotInt, Total Intensity; NumMatchPeps, Number of Matching Peptides; 









Figure 2-5. Relative importance of Spectrum Mill data attributes used for 
classification by boosting and random forest methods.  Abbreviations: SPI, Scored 
Peak Intensity; BCS, Backbone Cleavage Score; UIR, Unused Ion Ratio. 
 
 
2.4.3 Unsupervised Learning and Generalization/Comparison to 
PeptideProphet  
 In general, machine learning defines two primary types of models to address the 
classification problem, generative approaches and discriminative approaches. Algorithms 
such as the boosting and random forests methods discussed in this chapter are 
discriminative, non-parametric approaches in that they do not rely on an explicit 
distribution of the data, and model the posterior probability p(y|x) directly (see 24 for a 
general description). A generative method assumes a model for the distributions of the 
attributes given the class label and learns the distribution p(x|y), then uses Bayes rule to 
infer the posterior probability and the classification rule. In effect, these models 
incorporate assumed prior information in the form of probability distributions for each of 
the classes being modeled, and use these distributions to calculate the probability that a 
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data point belongs to each class.  PeptideProphet is a generative, parametric method, 
modeling correct identifications as a Gaussian distribution and incorrect identifications as 
a Gamma distribution. If this model fits the observed data well, i.e. the distributions 
describing the different classes in the problem accurately reflect the physical processes by 
which the data are generated, the generative approach works well even for a small 
amount of training data.  On the other hand, if the data diverge from the modeled 
distributions in a significant way, classification errors proportional to the degree of 
divergence result.  Therefore, although straightforward, the performance of the 
parametric-based generative approaches tends to be sensitive to the assumed model.  For 
the peptide classification problem discussed in this manuscript, there is little scientific 
evidence that supports a particular distribution assumption, one has to rely on past 
experience to make the decision. Discriminative approaches, on the other hand, are a less 
risky option in that they do not rely on knowledge of the distributions of classes of the 
data.  They become increasingly safe, approaching optimality, as data size increases. 
Keller, et al. demonstrate that, for their data, the distributions described in their mixture 
model fit the data well.  Whether these distributions are appropriate for all types of 
instruments and MS search engines, and whether they are optimal, is a research question.  
It may be the case that the addition of new attributes, which alter the discriminant score 
and thus the shape of the score distribution, may be problematic for a generative tool.  
Due to their flexibility, our approaches are expected to generalize well to other type of 
data obtained from various instruments, search engines and experimental conditions.  I 
believe this is a particularly attractive feature.  
 The boosting/random forest methods are supervised approaches, relying on 
training data for their functionality.  PeptideProphet implments both supervised and 
unsupervised learning components.  PeptideProphet uses training data to learn 
coefficients in the calculation of the discriminate score; it subsequently uses these scores 
to establish the basic shape of the probability distributions modeling correct and incorrect 
search hits as a function of parent peptide charge.  For each unique dataset, when 
additional test data arrives, the distribution parameters are refined using an EM 
algorithm, such that a refined classification procedure can be performed.  This 
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unsupervised component can function to compensate for a less-than-optimal fit of 
observed data to the model distributions.  How to combine the unsupervised learning 
techniques such as clustering with out-of-the-box classification tools such as the 
ensemble tree methods discussed here is a challenge that needs to be addressed.  Our 
approach provides a framework for performing the supervised aspect of the problem in a 
more general way, using established out-of-the-box functionality. This approach can be 
coupled with an unsupervised component to provide more flexible functionality, 
assuming appropriate training datasets are available that match the input data.  I have 
described one such dataset here, potentially useful as a distributed resource for training 
purposes. The degree to which an individual training dataset provides adequate 
parameterization for a particular test set is an open question. Certainly, training sets will 
need to be search algorithm specific, and it is the intention of myself and my 
collaborators to extend this work to other algorithms such as Mascot and X!Tandem in 
future studies; whether instrument-specific datasets are necessary is an area of 
investigation.    
 Having a tool which generates a truly accurate probability of correctness is an 
attractive feature of all algorithms in this domain.  The fitness scores generated by the 
random forest method are probability estimates, and the boosting fitness scores can be 
directly converted into probability estimates via a logit transformation.  True probability 
estimation is a difficult problem, however.  It must be clearly noted that, as with other 
tools in this domain, these estimates must be considered approximate.  Various methods 
have been developed for converting these types of scores into accurate probability 
estimates (33, 34).  These methods are referred to as probability calibration methods in 
the literature.  On the other hand, accurate classification of results does not require 
accurate probability estimates.  For example, in a simple two-class classification setting 
such as ours, one may only need to know whether the probability is bigger or smaller 
than some selected value in order to achieve an accurate classification rule. 
 As a final note, the work described here addresses the problem of generating 
rankings and confidence measures for identification of peptides using mass spectrometry 
database search algorithms.  This step is typically not the end-goal of data analysis:  the 
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peptide measures can be combined to generate confidence measures for the presence of a 
protein in a sample.  This problem of combining peptide results to generate accurate 
protein identifications has been addressed in other algorithms, such as ProteinProphet 
(35).  Improvement in peptide identification will increase the sensitivity and specificity of 
downstream protein identifications, and the results from the algorithms described in this 




 In a production proteomics lab, researchers are often faced with the challenge of 
curating large lists of protein identifications based on various confidence statistics 
generated by the search engines.  The common methodology for selecting true hits from 
false positives is based on thresholding.  These approaches can lead to a large number of 
false positives (using a more promiscuous threshold), or a large number of false negatives 
(using a relatively stringent threshold).  Machine learning approaches such as boosting 
and random forest methods provide a more accurate method for classification of the 
results of MS/MS search engines as either correct or incorrect.  Additionally, newer 
scoring criteria continue to be published which could improve the ability of automated 
tools to better discriminate true search results, and can complement the standard scoring 
measures generated by popular search engines.  Flexible methods that allow for 
accommodation of these new scoring measures are necessary to allow them to be easily 
incorporated into production use.  Modern machine learning approaches such as the 
ensemble methods described here can perform very well out-of-the box with very little 
tuning.  Improved results could very likely be obtained by tuning these tools to particular 
data sets, i.e. by making use of class prior probabilities to accommodate the imbalanced 
sizes of the correct and incorrect datasets.  These approaches can additionally be used to 
generate measures of relative importance of scoring variables, and may be useful in the 
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 matching statistics: a 
model for coupling consecutive stage mass 






3.1 Summary  
  
Improvements in ion trap instrumentation have made n-dimensional mass 
spectrometry more practical.  The overall goal of the study is to describe a model for 




 information in mass spectrometry experiments.  A statistical 
model is presented for adjusting peptide identification probabilities based on the 





 spectra.  Using two data sets, a mixture of known proteins and a complex 
phosphopeptide-enriched sample, I demonstrate an increase in discriminating power of 




 data only.  This work 
                                                          
9
 The study outlined in the chapter was originally published by Ulintz PJ, Bodenmiller B, 
Andrews PC, Aebersold R, Nesvizhskii AI. as ―Investigating MS2/MS3 matching statistics: a 
model for coupling consecutive stage mass spectrometry data for increased peptide identification 
confidence.‖ Mol Cell Proteomics. 2008 Jan;7(1):71-87. 
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also addresses the overall value of generating MS
3
 data as compared to an MS
2
-only 




Advances in mass spectrometer design continue to propel proteomics research.  
One of the most widely used mass analyzers for protein work has historically been the 
ion trap, and a large proportion of the data from current mass spectrometry-based 
proteomics experiments are generated on such instruments.  This trend continues with 
current generation ‗linear trap‘ instruments that are characterized by increased ion 
capacity and thus improved resolution and sensitivity (1,2).  Standard proteomics 
approaches are based on the predictable fragmentation of peptides in the collision cell of 
the mass spectrometer and the subsequent interpretation of the resulting spectra to infer 
amino acid sequence, referred to as tandem mass spectrometry (MS/MS or MS
2
) (3-7). In 
practice, however, acquired MS/MS spectra are often noisy, contain only a small number 
of fragment ions due to incomplete peptide fragmentation, or reflect unanticipated 
instrumental or chemical artifacts. As a result, in a typical analysis of MS/MS spectra 
generated in a large scale experiment, a small fraction (frequently as low as 15%) of the 
spectra can be successfully interpreted and assigned a peptide sequence with high 
confidence (8,9).  
 Newer instrumentation supports alternative techniques for data generation that 
have the potential to improve peptide and protein identification.  One such technique is 3-
stage mass spectrometry (MS
3
), in which peptide ions in an ion trap or ICR mass 
spectrometer are subjected to an additional stage of isolation and fragmentation.  The 
faster acquisition times of newer linear trap instruments such as the LTQ provide the 
option of collecting MS
3
 spectra of abundant MS
2
 peaks with overall cycle times similar 
to those of normal MS/MS
2
 cycles on older 3D trap instruments.  As a result, a number of 
researchers are choosing to routinely collect MS
3
 spectra during LC-MS/MS runs which 
have the potential to provide additional information useful for peptide identification and 
characterization.  This is deemed particularly important in the case of proteins identified 
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by single peptides (10, 11) and for the analysis of phosphopeptides, the spectra of which 
are frequently dominated by a major fragment ion representing neutral loss of the 
phosphate group from the precursor peptide.  Therefore, phosphopeptides have been 
analyzed by automated data-dependent triggering of MS
3
 acquisition whenever the 
dominant neutral loss ion of the appropriate mass is detected in an MS
2
 spectrum (12-14).  
Fragmentation of the neutral loss ion typically provides significantly increased structural 
information via increased peptide bond cleavage.  Similar approaches may be applied to 
other major neutral loss ions (e.g. loss of 64 Da from peptides containing methionine 
sulfoxide) and to excessive prolyl- or aspartyl-directed fragmentation.  MS
3
 spectra have 
proven to be useful in top-down analysis as well, both for protein identification and for 
characterization of specific sites of post-translational modification. (15, 16) 










 spectra directly at the spectrum level, generating an 
―intersection spectrum‖ that contains only one type of ion, thus allowing simplified de 
novo sequencing of the peptide. This approach has been described by Zhang and 
McElvain, who demonstrated the technique‘s usefulness in protein sequencing (17).  
Olsen and Mann describe a custom scoring algorithm for MS
3
 spectra: their final score 
for a peptide is the product of the Mascot-generated MS
2
 and the custom MS
3
 score (11).   




 provide complementary 
structural information on a glycopeptide: information on the structure of side-chain 
carbohydrate moieties is generally obtained from the MS
2
 spectrum, while amino acid 
sequence information is more readily obtained in the MS
3
 (18).  In the top-down 
technique described by Zabrouskov et al (16), sequence tags are extracted from MS
3
 
spectra using a de novo algorithm and used to complement correlated MS
2
 spectral data 
in a ―hybrid‖ database search strategy, implemented in the ProSight PTM search engine 
(19).  




 spectrum integration, de novo sequencing-
based algorithms have been described for combining pairs of spectra corresponding to 
unmodified and modified versions of the same peptide, or pairs of spectra corresponding 
to the same peptide tagged with a light or heavy version of a labeling reagent (20-23). 
63 
 
However, while de novo sequencing approaches are promising, no computational tools 
are currently available that can be robustly applied in a high throughput environment.  As 




 data is still largely carried out with a conventional 
database search approach using commercially available programs such as SEQUEST, 
MASCOT, SpectrumMill, Phenyx, Paragon, or open source programs X! Tandem, 
OMMSA, Inspect, or ProbID (24-29).     





 spectra, automated analysis of those different types of spectra may not be 




 spectra be separated for 
processing.  The main reason for this is that the measured precursor mass associated with 
MS
3
 spectra will not always correspond to the mass of an appropriate database peptide 
calculated using the same conventional rules that are applied in the case of MS
2
 spectra.  
For example, in phosphopeptide analyses variable modifications of -18 Da due to loss of 
phosphoric acid from S or T residues need to be specified for MS
3
, while the normal +80 
Da phosphorylation modification on S, T, and Y are used for MS
2
.  It is computationally 
inefficient, and an unnecessary source of false positive identifications, to perform a 
combined search which permits both the -18 Da loss for MS
2
 spectra and the +80 Da 
addition for MS
3
 spectra.  
 Searching MS
3
 spectra separately from their parent MS
2
 spectra essentially 





results in matching peptide sequences, there is an increased confidence in both 
identifications. The work described here attempts to provide a general, statistically sound 





spectra from the same peptide. In contrast to aforementioned work, a workflow is 




 spectra are searched independently using a common 
search engine (namely, SEQUEST in this work) and are independently statistically 




 scans are then re-
coupled and the peptide probabilities initially computed by PeptideProphet are adjusted 




 information. A model is described that 





 spectra generated using a control protein mixture, that such a 
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correction can be used to better discriminate between correct and incorrect database 




 probabilities to compute a 
single confidence measure for their corresponding unique peptide are also investigated. 
The utility of the method is then further demonstrated using a phosphopeptide-enriched 
data set generated from D. melanogaster samples on an LTQ linear ion trap instrument. 




 spectra are generated with an MS
2
-only method 
are compared to address the overall benefit of generating MS
3
 data.  
 
3.3 Experimental Procedures 
3.3.1 Sample Preparation and Mass Spectrometry 
Two experimental data sets of MS/MS spectra were used in this work to evaluate 
the statistical model and to investigate its utility in the analysis of phosphopeptide-
enriched samples. All spectra were acquired using an electrospray ionization (ESI) linear 
ion trap tandem mass spectrometer (Thermo Electron‘s LTQ). 
(1)  Nine-Protein Mix (―9-Mix‖) sample. A mixture of nine commercially available 
protein standards-- P68082, myoglobin of Equus caballus (horse); P00698 Lysozyme C 
precursor of Gallus gallus (Chicken); Q29443 Serotransferrin precursor (Transferrin) of 
Bos Taurus; P18915 Carbonic anhydrase 6 precursor of Bos taurus (Bovine); P12763, 
Alpha-2-HS-glycoprotein precursor (Fetuin-A) of Bos taurus (Bovine); P02754 Beta-
lactoglobulin precursor (Beta-LG) of Bos taurus (Bovine); P62894 Cytochrome C of Bos 
taurus (Bovine); P02666 Beta-casein precursor of Bos taurus (Bovine); P02769 Serum 
albumin precursor (BSA) of Bos taurus (Bovine)-- was digested using trypsin and the 
resulting peptide mixtures were purified using reverse phase chromatography prior to 
mass spectrometric analysis. For the analysis of the peptides using mass spectrometry see 
―Mass spectrometry‖.  The final data set consisted of three LC-MS/MS runs, with 58081 
MS/MS spectra in total.  
(2) ―Phosphopeptide sample‖. This sample is a trypsin-digested, IMAC-enriched D. 
melanogaster whole cell lysate. The preparation of the phosphopeptide samples is 
described in detail in Bodenmiller et al. (30). Several mass spectrometry analyses of this 
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sample were conducted, both for analysis of performance of the probability model and to 




An LTQ quadrupole linear ion trap mass spectrometer (ThermoElectron, San 
Jose, CA) was used with a HP 1100 solvent delivery system (Agilent, Polo Alto, CA) for 
the analysis of the D. melanogaster Kc167 cells cytosolic phosphoproteome. Peptides 
were loaded on a capillary (BGB Analytik, Böckten, Switzerland) reverse-phase C18 
column (75 μm i.d. and 11 cm of bed length with Magic C18 AQ 5 μm 200Å resin 
(Michrom BioResources, Auburn, CA, USA)), and then eluted from the capillary column 
at a flow rate of 200-300 nl/min to the mass spectrometer through an integrated 
electrospray emitter tip. Peptides were eluted
 
for each analysis from 12% to 33% 
acetonitrile in which the ions were
 
detected, isolated, and fragmented in a completely 
automated
 
fashion.  The exact settings for MS
n
 acquisition were as follows: 
9 protein mix  
In the first scan event, all peptides eluting from the column were recorded in MS 
mode. The most intense ion was selected for product ion spectrum (MS
2
) in the second 
event. An MS
3
 spectrum of the most intense peak in the MS
2
 spectrum was automatically 
selected in the third scan event. The second and third events are then repeated two more 
times in the cycle, for the second and third most abundant MS
1
 ions, for a total cycle of 
seven events. A threshold of 5,000 ion counts was used for triggering an MS
2 
attempt. 




 scan events; MS
2
 isolation width 
was set to 2.0 m/z and MS
3
 isolation width was set to 4 m/z. For triggering an MS
3
 event 
the most intense ion had to be above 50 ion counts. No further restrictions were made for 
the selection of the MS
3
 precursor.   
Phosphopeptide sample 
All peptides eluting from the column were recorded in MS mode in the first scan 
event. The most intense ion was selected for product ion spectrum (MS
2
) in the second 
event. An MS
3
 spectrum of the most intense peak in the MS
2
 spectrum, which for the 
phosphopeptide containing sample is in most cases the neutral loss peak (of 98 Da) from 
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a serine/threonine phosphopeptide, was automatically selected in the third scan event. 
These three events form one complete cycle.  A threshold of 20,000 ion counts was used 
for triggering an MS
2 







 isolation width was set to 2 m/z and MS
3
 isolation width was set to 3 
m/z. For triggering an MS
3
 event the most intense ion had to be above 500 ion counts. No 
further restrictions were made for the selection of the MS
3
 precursor. 












 data set the data-dependent MS
n
 spectra were acquired as 
follows: in the first scan event, all peptides eluting from the column were recorded in MS 
mode, and then the most intense ion was selected for product ion spectrum (MS
2
) in the 
second event. In the third event a MS
3
 spectrum was triggered specifically in the event of 
a phosphate neutral loss (-98 Da for singly, -49 Da for doubly and -32.66 Da for triply 
charged peptides) in the MS
2
 event. The second and third events are then repeated two 
more times in the cycle, for the second and third most abundant MS
1
 ions, for a total 
cycle of seven events. For the MS
2
-only data set the data-dependent MS
n
 spectra were 
acquired as follows: in the first scan event, all peptides eluting from the column were 
recorded in MS mode, and then the three most intense ions were consecutively selected 
for product ion spectrum (MS
2
) for a total cycle of four events. Further settings for these 




 scan events, MS
2
 
isolation width was set to 2 m/z and MS
3
 isolation width was set to 4 m/z. For triggering 
an MS
3




 data set the most intense ion had to be above 50 ion counts. 
No further restrictions were made for the selection of the MS
3
 precursor.   
 
3.3.2 Database Searching and Results Analysis 
 MzXML files were generated from ThermoFinnigan *.raw files using the ReAdW 




 peaklist files in *.dta format 





.  For the 9-Mix data set, a custom fasta sequence file was constructed 
consisting of sequences corresponding to the proteins in the mixture and common 
contaminants appended to a reversed version of the IPI Human data set.  Resulting *.dta 
files for the 9-Mix data set were searched with SEQUEST using the following 
parameters:  peptide tolerance of 3.0 Da; b- and y-ion series; partial trypsin digestion, 
allowing for one missed cleavage site; a fixed modification of 57.02 was specified for 
Cysteine and a variable post-translational modification (PTM) of 16.0 to Methionine.  
MS
3
 data sets were searched using identical parameters.  Note, partial trypsin specificity 
is required for searching MS
3
 spectra corresponding to the fragmentation of a selected y- 
or b-ion from the MS
2
 spectrum.  If sufficient computational resources are available, 
searching MS
2
 spectra allowing for partially tryptic peptides can often be beneficial and 
result in additional identifications. However, doing so requires that the results are 
properly analyzed with a tool that accommodates tryptic termini information in the 
statistical model, such as PeptideProphet.  In addition, a subset of MS
3
 spectra from this 
data set was also searched allowing for the C-terminus variable modification of -18.0 Da 
to accommodate the possibility that the MS
3
 precursor is a b-ion (11). The results 
indicated that including this modification does not significantly alter the overall 
performance; in fact, accommodating the variable modification decreases the number of 
identifications slightly (due to loss of a number of true peptide assignments because of 
increases in search space). Based on this, the C-terminal modification was not used in the 
final analysis of data presented in this chapter. The resulting data set contained 76873 
peptide assignments, counting 2+/3+ duplicates: 48921 MS
2
 (554 singly charged, 24233 
doubly charged, and 24134 triply charged), and 27952 MS
3
 (4582, 11700, and 11670 
singly, doubly, and triply charged, respectively).  Note that because of the charge state 
ambiguity (in the case of low mass accuracy data such as the data sets used in this work, 
the charge state of a multiple charged peptide ion cannot be reliable determined), most of 
the multiply charged spectra were searched twice, assuming 2+ or 3+ charge state.  
Furthermore, due to a relatively small number of singly charged MS
2
 spectra, all such 
spectra were left out of the subsequent analysis.  





 The database for the phosphopeptide-enriched samples consisted of all 
Drosophila melanogaster sequences exported from the UniProt database (34), 26311 
entries total, to which the reversed set of sequences was appended. Parameters for the 
MS
2
 search were: peptide tolerance of 3.0 Da; partial trypsin digestion, one possible 
missed cleavage; fixed modification of 57.02 for Cysteine; variable modifications of 80 
Da were specified for S, T, and Y; a maximum 4 PTMs per peptide. The MS
3
 spectra 
were searched with the same set of parameters except that variable modifications of -18 
Da on S and T (instead of +80 Da) were specified to accommodate loss of phosphoric 
acid leading to a dehydroalanine or dehydrobuyric acid, respectively. SEQUEST database 







comparisons) resulted in 28865 peptide assignments, counting 2+/3+ duplicates: 16647 
MS
2
 (143 singly charged, 8483 doubly charged, and 8021 triply charged), and 12218 MS
3
 
(547, 5895, and 5776 singly, doubly, and triply charged, respectively).  







-only methodologies consisted of the following number of peptide 
assignments following SEQUEST database searching-  Run 1 (A07_5205): 4915 MS
2
 
assignments (95 singly charged, and 2410 each of doubly and charged), and 1897 MS
3
 
assignments (31 singly and 933 each doubly and triply charged); Run2 (A07_5206): 6450 
MS
2
 assignments (126 singly, 3162 doubly and triply charged); Run 3 (A07_5207): 4883 
MS
2
 assignments (103 singly charged, and 2390 each of doubly and charged), and 1879 
MS
3
 assignments (43 singly and 918 doubly and triply charged); and Run 4 (A07_5208): 
6403 MS
2
 assignments (159 singly, 3122 doubly and triply charged). 
 




 search results  
 Search results for each LC-MS/MS run were generated by first producing an html 
results file using the out2summary tool, exporting one result file for each MS level, for 
each run:  a total of six files for the 9-Mix data set and two files for the phospho data set.  
Html results were then converted into pepXML format (31) using Sequest2XML. 
PeptideProphet (32) was run on each result set, generating probability scores for each 
search result that are added to the pepXML documents.. For the phospho data sets, 
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PeptideProphet was run with the “-l” option, which results in alternate processing of 
DeltaCn scores marked with „*‟, results for which the top and second-highest ranked 
peptide assignment to a spectrum have homologous sequences (>70% sequence identity).  
With this option on, PeptideProphet will use the Xcorr score of the first non-homologous 
lower scoring peptide match when computing DeltaCn score of the best scoring peptide. 
This option is beneficial in the event that the search returns several identical results that 
differ only by modification site for a sequence, as often occurs in phoshorylated peptide 
identifications.
11
  Resulting files were parsed and processed to generate all matching 
statistics using a custom set of scripts implemented in Python. Certain subsets of data 
were also exported into a local Mysql database instance to facilitate generation of specific 






 scans and search results 
 The spectra in these experiments were generated in an interlaced manner, i.e. the 





















, with the MS
2
 scans triggered in a data dependent manner 
from the MS
1
, and the MS
3
 scans triggered from the preceding MS
2





 scans were generated based on consecutive scan numbers. In the 
resulting data set, MS
2
 scans with no consecutive MS
3
 were retained and designated as 




 scans without preceding MS
2
 scans 
should not occur physically, but do in these data for several reasons: namely, the 
corresponding MS
2
 peaklists that produced no database search result are typically not 
reported.  Also, some spectra containing only a few peaks may be filtered out by the data 
conversion software. The small number of instances in which these ―orphaned‖ MS
3
 
scans are generated invariably result in incorrect peptide identifications and are 
eliminated from subsequent analysis.   
 Due to uncertainty with the charge state each multiply charged scan was searched 
twice (in both 2+ and 3+ charge state), resulting in multiple search results for each scan. 
                                                          
11
 The default option in PeptideProphet is to set SEQUEST DeltaCn score to zero to reduce the probability 
that the best scoring peptide assignment to a spectrum is correct when the second best scoring peptide 
has high sequence homology.   
70 
 




 search results 
for any pair of scan numbers. A +1 MS
2
 search result may only be linked to an MS
3
 
search result that is +1, and a +2 MS
2
 scan may produce a link to a search result with 
either a +1 or +2 charge state.  The double- and triple-charged SEQUEST search 
duplication, however, creates a situation in which a +3 MS
2
 search result may produce 
two possible links to +2 and +3 MS
3
 search results for any pair of scan numbers. After 
generating all possible links, one pair of search results amongst all possible pairs for any 
two scan numbers (designated as the ―unique pair‖) is selected based on whether the 
sequences of the two peptide identifications composing a pair are matching.  Matching is 
defined here as whether or not the sequences are equal, or whether one contains a 
subsequence of the other.  For non-matching pairs, and scan sets with more than one pair 
with matching sequences, the match pair with the highest summed PeptideProphet 
probability is designated as the unique pair.  A schematic of all matching possibilities and 
selection of a unique pair is shown in Figure 3-1. 
 
 




 charge state linking possibilities and unique pair 
selection. Panel a) indicates all possible linked pair possibilities. Solid lines indicate 
physically possible link pairs, dashed lines between charge states indicate transitions that 
should not occur. The redundant +2 and +3 search results generated for an individual 
spectrum to accommodate charge ambiguity are schematically represented. b) An 
example set of three linked pairs for two consecutive scan numbers. The top-scoring 
sequences and the corresponding PeptideProphet probabilities are shown. c) The unique 




3.4 Results and Discussion 
3.4.1 Overview of the probability adjustment method 
 The overall methodology for the approach is outlined in Figure 3-2.  Data 
generated by the mass spectrometer are processed via the Trans-Proteomic Pipeline 
(TPP) following normal procedures and using SEQUEST, Mascot, or X! Tandem 
database search tools for peptide identification (the tools currently supported by the TPP), 
up through generation of peptide probabilities from PeptideProphet (32).  Analyses in this 




 data.  To calculate an 
adjusted probability for all assignments, successive scans must be linked as described in 
the Methods section.  The multiple potential matches resulting from the charge state 
ambiguity are reduced in the processing, retaining only the most probable matching pair 









 spectra are extracted from the 
raw data and the spectra are assigned peptides using sequence database searching 
(SEQUEST or similar programs). The resulting peptide assignments are statistically 
validated using PeptideProphet, which calculates for each assignment in the data set a 






 and MS3 
scan results are correlated based on scan number, in which an MS
3
 spectrum is linked to 
an MS
2
 if its scan number is consecutive.  Based on the overall matched data set, a 










scan results are combined and a final probability calculated for each scan number as 
representative of the peptide identification. 
 
 
 Based on the sequence of the highest scoring peptide produced by the database 




 pairs may then be classified as to 
whether or not they match the same peptide sequence.  This classification forms the basis 
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for the adjusted probability score (see below), which functions to reward assignments 
with matching sequences.  Only the top-ranked peptide sequence for each spectrum is 
used in this analysis; accommodation of lower ranking results, while potentially useful, is 
not considered for simplicity. The result of the probability correction procedure is a data 










 data: a case study of the 9-Mix data set 
 This analysis is carried out using a mixture of purified proteins (9-protein mix 
data set), in which it is possible to confidently label peptide identifications as „correct‟ or 
„incorrect‟. Because this data set was searched against a database consisting of the 
sequences of the mixture proteins appended with a much larger reversed human protein 
sequence database, each spectrum could be assigned a correctness label based on whether 
the top SEQUEST hit for the spectrum was to one of the known protein entries.  The 
method used was simply to label as incorrect any assignment of a peptide from a known 
incorrect database entry (reversed human protein sequence entries in this case), whereas 
all assignments of peptides to one of the sample proteins can be considered correct (32).  




 scans using their scan 
numbers. Overall, there were 48921 MS
2
 spectra and 27952 MS
3
 spectra generated for 
the 9-Mix dataset.  Due to the uncertainty in the precursor charge state for LTQ spectra, 




 scan numbers, there 
may be one or two SEQUEST search results generated for each MS level, as described in 
Experimental Procedures. Consequently, an MS
2
 search result may be linked to more 
than one MS
3
 search result.  For the 9-Mix data set, there are 16140 unique linked pairs 
in which the MS
3




 charge states of 
+1/+1, eight of which match “correct” protein sequences in the database (either one or 
both of the sequences match).  For doubly-charged MS
2
 pairs, 3761 are +2/+2 and 4043 
are +2/+1, of which 878 and 2020 are correct, respectively.  For triply-charged MS
2
, 
+3/+3: 4020 pairs, 631 correct; +3/+2: 3777 pairs, 1177 correct; and +3/+1: 450 pairs, 
111 of which are correct.  In all, linked pairs in which the MS
3





 are more likely to be correct.  However, linked pairs for which the MS
3
 is the 
same charge state as MS
2
 account for 36% of the correct identifications.   
 Neutral loss of amino acids from the N- and C-termini is a common phenomenon 





 sequences are labeled correct and of the same charge state (+1/+1, +2/+2, and 
+3/+3) allows us to identify examples of amino acid neutral loss.  Our data confirms the 
conventional rules for amino acid neutral loss described in the literature.  Virtually all 
examples correspond to N-terminal loss of 1-4 amino acid residues, most frequently N-
terminal to a proline.  276 out of 323 of the occurrences are doubly-charged, three are 
singly-charged, and the remaining forty-four triply-charged.  Most examples occur 
multiple times:  in all there are one, thirty-four, and nine unique neutral loss sequence 
examples for the singly-, doubly-, and triply-charged cases, respectively.  These 
examples are provided in Supplementary Table S1.  
  After linking consecutive scans and selecting a unique linked pair, the peptide 
assignments are binned into sequence match categories dependent on whether a 
consecutive scan exists, and if so, whether the top-scoring SEQUEST sequence result of 
the successive scans match (Table 3-1).  Sequence match categories (referred to as Match 
categories, or simply „Match‟ later in the text) are defined as follows: 0) no consecutive 




 sequences do not match; 2) consecutive 
scans, MS
3
 sequence is a subset of the MS
2
 sequence; 3) consecutive scans, MS
3
 
sequence identical to the MS
2
 sequence; and 4) consecutive scans, MS
2
 sequence a subset 
of MS
3
 sequence. In the data set of unique pairs, 69% of all MS
2
 spectra produced 
consecutive MS
3
 spectra (16140).  Out of those consecutive pairs, 1458 (9%) had 
matching sequences in which the MS
3
 sequence was a subset of the MS
2
 sequence.  116 
MS
3
 spectra were orphaned because they did not have a preceding MS
2
 scan, and were 





 top-scoring hits in the 9-Mix data set, as may occur for neutral-ion events 
in which only a side-chain moiety is lost from the otherwise intact peptide backbone (e.g. 
a phosphate).  These losses are observed in other similar data sets, however, and do occur 











 scan pairs for the 9-Mix data set 
into sequence match categories.  Counts indicate the number of unique pairs as 
described in the text.  Seq, Sequence. 
 
 For a small number of linked pairs, the top-scoring MS
3
 sequence appears to be a 
superset of the MS
2
 sequence, binned as sequence match category 4.  Clearly such pairs 
are not physically possible. Detailed analysis indicated that that most of those cases can 





 scan. For example, in some of these instances, the sequence corresponding 
to the +2 MS
2
 is a subsequence of both the +3 MS
2
 sequence and the +2 MS
3
 sequence, 




 pair selected as the unique pair. In those cases, the peptide 
assignment to the +3 MS
3
 peaklist (with +3 being the true charge state of the peptide ion) 
scored lower than the assignment of a shorter peptide (a subsequence of the true peptide) 
to the +2 MS
3
 peaklist. Other examples involved cases of a high scoring assignment of a 
longer partially tryptic peptide sequence when the true peptide was a post-translationally 
modified tryptic peptide missed due to the restricted nature of the database search. 
Similarly, several cases were observed where an MS
3
 scan acquired on a doubly charged 
b-ion fragment from the parent MS
2
 spectrum resulted in a match of a longer sequence to 
the +3 MS
3
 peaklist, and no match in the case of the correct +2 charge state.  In any 
event, as can be seen from Table 3-1, match category 4 represents a small number of 
special case instances.  For simplicity of articulation, this category is dropped from 
subsequent analysis. 
 Using the labeling of the data, the accuracies and sensitivities of the probability 
calculations could be determined.  Towards this end, each linked pair of spectra can also 





 scans.  The truth category is a label indicating whether neither, both, or 
76 
 
which one of the matching scans has a „correct‟ label.  The total numbers of scans in each 
truth category are shown in Table 3-2.  The number of unique pairs of search results in 
which both sequences were correctly assigned is 1509, corresponding to 6.4% of the total 
number of unique pairs of scans.  A greater number of linked pairs (3316 total, 14.2%) 
have either the MS
2
 only assigned correctly (2029), or only the MS
3 
(1287).    
 
 




 scan pairs for the 9-Mix dataset 
into truth categories. A “+” in the truth category column descriptors indicate a correct 







 When comparing the counts in the sequence match category bins (Table 3-1) with 
the truth category bins (Table 3-2), there appear to be several (thirty four) more +/+ truth 
matches than expected from the number of entries in the sequence match bin categories 2 
and 4.  These entries are the result of sequence match category 1 entries contributing to 





sequences both match one of the sample mix proteins, but the proteins are different or the 
match is to different peptides from the same protein.  Most of the instances are examples 
of the latter case:  a homologous sequence in the protein TRFE_BOVIN results in two 
different peptides (CLMEGAGDVAFVK and KGDVAFVK) being identified in the 
joined pairs. One of the commercially obtained proteins in the mixture, TRFE_BOVIN, 
was also contaminated with the homologous TRFL_BOVIN, which exhibits 59% 
sequence identity.  As a result, homologous but not identical peptide sequences between 





 identifications in the pair are labeled correct in that individually their 
sequences match one of the sample proteins, there is no similarity between the matching 
sequences.  These can be considered as chance matches to one of the sample mix proteins 
incorrectly labeled as correct (the observed number of such chance matches is consistent 
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with the expected number given the relative sizes of the 9-Mix and the reversed Human 
protein sequence database).  In all of such cases, either the MS
2
 or the MS
3
 was a high-
probability result with the other joined probability very low.  
 
3.4.3 Probability adjustment calculation  
 In automated analysis of mass spectrometry data, one of the most important tasks 
is the calculation of accurate and discriminative confidence measures for each peptide 
assignment to a spectrum produced by a database search tool. Towards that end, we seek 
to calculate a correction to the probability score that accommodates the increase in 









 spectra are more likely to be correct forms the basis for 
adjusting the probabilities of these spectra. 





 data, represents the starting point in this analysis.  
PeptideProphet computes a probability for a peptide, designated here as p(+|D), by using 
the mixture model EM algorithm to model the distributions of various discriminant 
spectrum-level parameters, collectively represented here as D. The spectrum-level 
information D typically includes the discriminant database search score (a linear 
combination of the renormalized search scores reported by the database search tool used), 
the number of termini consistent with the specificity of the enzyme used to digest 
proteins, the number of missed internal cleavage sites, and the difference between the 
measured and the calculated precursor ion mass. In certain cases, additional parameters 
are included in the model such as the peptide pI value (37), or the presence of certain 
residues or sequence motifs in the sequence of the assigned peptide (e.g., the presence of 
a cysteine in the case of ICAT experiments, or NxS/T motif in the case of experiments 
employing glycopeptide-enrichment strategies).  PeptideProphet probabilities are 




 spectra.  A plot displaying probability 










identifications for the 9-Mix dat set.  MS
2
 results are shown as a solid line and MS
3
 as 
dashed.  A perfect model would produce a 45° line, plotted as a dotted line. The amount 
of deviation of the calculated probability score from the true probability is indicated by 
deviation from 45°.  To generate this figure, all peptide assignments were first sorted 
based on the calculated probability.  A sliding window with a size of fifty was then 
applied to the ranked list, calculating the fraction of correct assignments within the 
window.  The PeptideProphet probabilities of spectra within the window were also 
summed and averaged. 
 
 The approach used to accommodate the additional sequence matching information 
is similar to the method described in (33) for adjusting probabilities to account for 





 sequence match information is not available at the initial data analysis step, but 










data. Given the sequence match category (Match) assignments for all linked spectra, the 
adjusted probability of a linked peptide assignment from a certain sequence match 
category, p(+|D, Match), may be calculated as: 









          (1) 
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where p(Match|+) and p(Match|-) represent the empirically derived probabilities of 





and incorrect peptide assignments in the data set, respectively.  Note that this calculation 
assumes that the information derived from linking consecutive scans is independent of 
the identification information generated by a search engine. This is largely true. 
Normalized PeptideProphet SEQUEST discriminant score distributions for correct and 
incorrect peptide assignments to MS
2
 spectra of doubly charged precursor ions, plotted 
separately for peptide assignments to MS
2
 spectra belonging to different Match 
categories, are shown in Figure 3-4; score distributions are similar for all values of Match 
parameter, justifying the assumption of the independence between the discriminant 
database search score and Match parameter. 
 The probability distribution p(Match|+)  may be calculated for each match 
category k as follows: 

















  (2) 




) peptide assignments in the data set, and 
the sum is over all peptides i  in each Match category. The term p(Match|-) is calculated 
in a similar way. The overall proportion p(+) of correct assignment in the data set may be 
calculated as:  








    (3) 
 The probabilities in Eq. 1, and the Match parameter distributions in Eq. 2, can be 
determined by starting with the initial PeptideProphet probability for each assignments, 
p(+|Di) and the overall proportion, p(+). The probabilities and Match distributions can 
then be updated in an iterative manner.  However, a single iteration was deemed to be 










 match parameters. Normalized discriminant score distribution among correct 
and incorrect peptide assignments to 2+ charged MS
2
 spectra from the 9-Mix data set are 
plotted separately for peptides in Match category 0, 1, and 2. 
 
3.4.4 Application of the probability adjustment method to the 9-Mix 
data set 
 Table 3-3 lists p(Match|+) and p(Match|-) distributions calculated using Eq. 2 for 




 scans.  It can be seen that, in the case of MS
2
 
spectra, a larger fraction of incorrect assignments have no consecutive matching scan.  
For all instances, the most likely sequence match category is category 1, corresponding to 
the case in which consecutive scans occur but with no matching sequence.  This is 





 will produce an identifiable sequence, but not both.  The most obvious 
discriminating measure is the fact that for 30% of the correctly assigned MS
2
 spectra (the 
top row in the table), the linked MS
3
 spectrum was assigned a peptide sequence that is a 
subset of the MS
2





identifications.  If sequence matches are observed, identifications are thus much more 
likely to be correct; the same argument applies for MS
3
 scans preceded by MS
2
 scans.  
Also noteworthy is the fact that for match category 1 pairs, the probability of a correct 
identification is less than the probability of an incorrect identification.  This will result in 
a probability penalty for consecutively linked scans without matching sequences.  The 
penalty is small in this case, much smaller than the boost due to a consecutive matching 
scan, but is nevertheless an effect of the model. 
 
 
Table 3-3.  Posterior probabilities of observing a correctly (+) or incorrectly (-) 




 scan. Shown are results for the four most frequently 
observed sequence match categories in the 9-Mix data set: 0, no consecutive scan; 1, 
consecutive scan, no matching sequence; 2, consecutive scan, MS
3
 sequence is a subset 
of MS
2
 sequence; 3, consecutive scan, MS
3




 It should be noted that in addition to classifying peptide match pairs into bins as a 
function of sequence matching, they can also be classified into various precursor charge 
state pairs. Significant differences exist between the precursor charge state distributions 
of correct and incorrect matches. An expansion of the sequence match category 
probabilities into charge category bins is provided in Figure 3-5 (Panels b-e) for each of 
the four posterior Match probability distributions of Table 3-3, as well as total counts of 
the number of matches falling into each bin for the 9-Mix data set (Panel a). The charge 
state information would likely provide additional discriminative power. However, further 
sub-classification of the data into charge state pairs requires larger amount of data and 
complicates the model. Thus, the charge state information has not been utilized in the 





Figure 3-5.  Total bin counts and posterior match probability distributions of 
unique matching pairs for the 9-Mix data set.  Charge categories a labeled based on 
the charge of both parent ions; e.g the charge category “2_1” indicates a +2 MS
2 
and a +1 
MS
3
.  The “0” in the “3_0”, “2_0” and “1_0” categories denotes that there is no 
consecutive MS
3
 scan for the spectrum.  Please see the main text for a description of the 
five sequence match categories.  Panel a) shows total match pair counts for each 
charge/seq match bin for the 9-Mix data set.  Panels b)-e) plot joint posterior probability 
values for each of the respective charge/seq match bins.  Each of the four distributions-
MS
2
 correct (+), MS
2
 incorrect (-), MS
3
 correct, and MS
3






 An example of the probability adjustment procedure described above is illustrated 
in Figure 3-6 using a pair of matching scans from the 9-Mix data set.  MS
2
 spectrum 
A06_7233_c.18651.18651 is first paired to MS
3
 spectrum A06_7233_c_18652.18652 by 
consecutive scan number. MS
2
 assigned peptide sequence 
TLNFNAEGEPELLMLANWRPAQPLK is then compared to MS
3
 sequence 
GEPELLMLANWRPAQPLK.  Since the MS
3
 sequence represents a fragment of the MS
2
 
sequence, the linked pair is assigned to sequence match category 2.  The adjusted 
probabilities are then calculated for each spectrum using Eq 1. In this instance, the initial 
PeptideProphet probability of 0.712 is adjusted to 0.995 for the MS
2
 spectrum, and 0.832 
to 0.989 for the MS
3
.  A combined probability may then optionally be calculated for the 
linked pair as a new discriminating measure, as discussed later in the text.   
 
 




 linked pairs and the probability correction 
procedure.  MS
2
 (left) and the matching consecutive MS
3
 peaklist (right) are shown.  
The MS
2
 spectrum is triply-charged and the MS
3
 spectrum doubly-charged.  The 
sequence matches categorize the pair into Sequence Match Category 2, allowing for a 










 Indicated in Figure 3-7 are examples of fragmentation patterns from other charge 
state pairs.  These examples are provided here to illustrate both differences in the relative 
extent of fragmentation that can occur as a function of charge and also the presence of 




 spectra.  Panels 3-7a – 3-7c contain 
examples from the phospho data set, specific features of which will be discussed in more 












 linked pairs with different charge states. MS
2
 
(left) and the matching consecutive MS
3
 peaklist (right) are shown.  a) A +2/+1 match 
pair for a phosphopeptide identification in which the y12 ion is selected for MS
3
. b) A 
+3/+1 phosphopeptide identification; the y8 ion is selected for MS
3
.  c) An example of a 
+2/+2 loss of the phosphate moiety in which the most abundant MS
2
 peak selected for 
MS
3




 In the development of the model, several (match category 2) cases were observed 
where both paired spectra had a low initial probability of being correct, but their 
probabilities became intermediate or even high values after adjustment. For example, the 
initial probabilities for peptide assignments to linked scans A06_7232_c.4362.4362.3 
(MS
2
 scan), and A06_7231_c.4363.4363.2 (MS
3 
scan) of 0.077 and 0.319 would get 
boosted to 0.827 and 0.830, respectively, if the probabilities were adjusted using the 
Match parameter distributions shown in Table 3-2. Boosting such low probability 
assignments may be undesirable regardless of their match category. To address this, 
several approaches were investigated, including introduction of probability-dependent 
match categories. A very simple constraint that worked well in the case of the 9-Mix data 





 probabilities were below a specified threshold, 0.5 in the case of these data.  
This was an optional feature that was investigated using the 9-Mix data set but not 
utilized for the phosphopeptide data sets, as it was deemed a minor adjustment that did 
not significantly affect the overall results; specifically, the number of entries in the 9-mix 
data set that were affected by this exception was only 24 out of a total 23367 unique 
matches  
 The improved discriminatory power of the adjusted probabilities, calculated using 
the p(Match|+) and p(Match|-) distributions shown in Table 3-3 (after the empirical 
correction described above), is indicated in Figure 3-8, which shows Receiver-Operator 





 spectra. The false positive error rate is plotted as a function of the 
sensitivity attainable by selecting a variable probability threshold.  Sensitivity in this case 
is defined as the ratio of the number of correct peptide assignments to MS
2
 (Figure 3-8a) 
or MS
3
 scans (Figure 3-8b) with a probability greater than or equal to a specific 
probability threshold and the total number of correct assignments to MS
2
 (4870) or MS
3
 
(1256) spectra, respectively.  Similarly, the false positive error rate is calculated as the 
fraction of incorrect matches in the total number of spectra above each probability 




 peptide assignments, 



















 b) scores are shown as a function of sensitivity for initial (dashed) 
and adjusted (solid) probabilities.  Inserted panels are zoomed areas of the plots for the 0 
- 10% error rate range 
 




 scans, the adjusted probability provides a better 
performance profile, achieving greater sensitivity at an equivalent error rate as compared 
to the initial data.  For example, at a 0.9 probability threshold, the initial MS
2
 probability 
results in the selection of 4072 correct peptide assignments at the expense of 67 incorrect 
ones. Using the adjusted probabilities, selecting the same number of correct 
identifications results in only 38 incorrect peptide assignments. The improvement in MS
3
 
discrimination is even more pronounced, especially in the optimal region of the curve. 
Using initial probabilities, 1350 correct and 19 incorrect assignments to MS
3
 spectra pass 
the 0.9 threshold. Using the adjusted probabilities, it becomes possible to select the same 







 The result of the probability adjustment procedure described above is now two 





Possibilities for best utilizing both of these scores in selection of correct and incorrect 
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identifications are now explored.  Ideally, a combined scoring approach would provide a 
greater discriminatory power for selecting correct and incorrect identifications than a 




 taken individually.  Two 
possibilities for utilizing both scores are examined:   
                   )1)(1(1 32 MSMScomb ppP                 (4a) 
                   32 ,maxmax MSMS ppP                              (4b) 





respectively, for the same linked pair.  The first option is appropriate when the two 
probabilities can be considered independent, and has been utilized (in a different context, 
i.e., for combining the evidence from different peptides) for the protein identification 
problem (33, 38).  Pcomb reflects the probability that at least one of the two peptide 
assignments, either to the MS
2
 or to the MS
3





 spectra, and therefore the probability scores pMS2 and pMS3  of those 
spectra, are not fully independent measurements of a peptide in that identical ions will be 
measured in both spectra.  An alternative approach is to select the assignment with the 
highest probability, Pmax, thus reducing the likelihood of possible overestimation of the 
final probability.  Pmax has been used in other similar situations, e.g. in selecting amongst 
several alternative equivalent peptides (assignments of the same peptide to multiple 
MS/MS spectra) in the ProteinProphet protein probability score (33), and in Mascot 
protein-level scoring (24).   
 Figures 3-9a and 3-9b show the results of counting the number of correct peptide 
assignments above specified probability thresholds, utilizing all possible scores 









, Pmax, and Pcomb.  Displayed are the results on the set of all 





again demonstrates an increase in the number of selectable correct peptide 
assignments at any probability threshold as a result of the probability adjustment.  Both 
Pmax and Pcomb scores perform similarly, and provide improved discrimination as 
compared to the individual measures.  Obviously, the primary reason for the performance 





 or the MS
3
 for any linked pair, thus permitting a pair to be selected as correct if 





, Pmax and Pcomb probabilities correspond to 3141, 1050, 3775, 
and 3807 correct peptide identifications, respectively.  Figure 3-9c provides a measure of 
the rate of false-positives on these data for the most interesting thresholds.  The same 
performance trends are evident:  including roughly 40 false positives, specifically 40, 41, 




, Pmax, and Pcomb measures, respectively, results 
in selection of 1806, 4139, 4594, and 4762 correct identifications.  In all, Pcomb provides 
the most discriminative measure. 
 In addition to analyzing the discriminative power of computed probabilities, one 
must also assess their accuracy.  Probability accuracy plots for the adjusted and combined 
measures are shown in Fig 3-9d.  The adjusted probability scores still provide an accurate 
representation of true probabilities and fit the 45° line well.  The Pcomb and Pmax measures 
perform similarly well.  Interestingly, Pcomb does not overestimate probabilities as one 




 level spectra on this data set.  






Figure 3-9.  Discriminating power and accuracy of computed probabilities.  a) Total 





 spectra alone, both initial and adjusted, and both Pmax and 
Pcomb scores.  b) Same as a), zoomed in the region of minimum probability threshold 0.9 
to 1.0.  c) Number of correct peptide assignments as a function of the number of incorrect 
assignments, plotted separately for MS
2
 (green) and MS
3
 (blue) initial (dashed) and 
adjusted (solid) probabilities, as well as the combined Pmax (red) and Pcomb (purple).  d) 




, Pmax and Pcomb probabilities. 
 
 
3.4.6 Phosphopeptide data set results 




 data is to increase the 
confidence levels and the total number of phosphopeptide identifications. The 
identification of phosphopeptides from MS
2
 spectra is challenging because spectra 
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recorded using an ion trap mass spectrometer often exhibit one or more dominant neutral 
loss peaks of 98 Da, whereas the occurrence and intensity of the other fragment ions 
(containing peptide sequence information) may be impaired. To investigate potential 
improvement in discrimination as a result of the probability adjustment on a 
phosphopeptide-enriched data set, a data set of MS spectra from a single LTQ injection 
of an IMAC-enriched D. melanogaster sample was selected for detailed analysis in this 
work. The data were acquired in a data-dependent mode, with MS
3
 scans triggered for the 
most abundant peak of the MS
2
 spectra which in the case of this sample mostly 
corresponds to the neutral loss peaks: -98.00 (-116.00), -49.00 (-58.00), -32.60 (-36.66) 
Da from the precursor, as explained in the Experimental Procedures section.  Since the 
sample in this case is a complex protein mixture, a precise labeling of peptide 
identifications as ‗correct‘ or ‗incorrect‘ is not possible.  Instead, only the composite false 
discovery rates (FDR) (a single measure for each filtering threshold) can be estimated by 
counting the number of matches to reversed sequences. 
 The methodology for generating adjusted probability scores for this data set is 




 SEQUEST peptide 
assignments are linked based on consecutive scan numbers, and the top-scoring pair for 
consecutive scans is selected. Note that if MS
3
 spectra are triggered based on neutral loss 
peaks, charge state ambiguity between matching pairs can potentially be reduced.  This 
fact is not exploited in the analysis; rather, I maintain the same procedure for allowing all 
possible charge pairs in a match. The match pairs are then classified into sequence match 
categories as described above. The same four sequence match categories are used: 0, no 
consecutive match; 1, consecutive match but no matching sequence; 2, matching 
sequences with MS
3
 sequence a subset of MS
2
 sequence; and 3, matching sequences with 
MS
3
 sequence identical to MS
2
.  In this data set, there were only two instances of scans 
that would correspond to the sequence match category 4: matching sequences with MS
2
 
sequence a subset of MS
3
 sequence.  Again, this category was eliminated for simplicity.  
We note that the additional constraints imposed by the data-dependent triggering of these 
data and the resultant database searching provisions would allow us to generate additional 
useful sequence match categories, corresponding to whether the site of modification of a 
match is identical between the two sequences.  We observed a number of instances in 
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these data where the sequences matched but the sites of modification of the match did 
not, indicating ambiguity in the localization of the modified residues.  A larger data set 
would allow a more rigorous analysis of these types of results (39, 40).      





 data sets, respectively, corresponding to 7547 unique matching pairs of 
searched results.  Of these, 6270 had non-null MS
3
 assignments.  Counts for the four 
sequence match categories are shown in Table 3-4.  Most significant is the fact that the 
sequence match category corresponding to neutral loss-only pairs (match category three) 
is no longer null; rather it is the more abundant category amongst the two representing 
matching sequences with 313 unique matches.   
 
 
Table 3-4.  Match probabilities and sequence match category counts for the 
phosphopeptide-enriched data set 
 
 Corresponding posterior probabilities were calculated for the sequence match 
categories, and then used to calculate the final adjusted probability for each unique pair.  
These numbers are also shown in Table 3-4.  The frequencies of observing a correct or 
incorrect assignment to an MS
2
 scan with no matching MS
3
 sequence (match category 
one) are relatively close; only a small probability correction occurs for these instances.  
MS
3
 category one probabilities are penalized, as are MS
2
 instances that lack a 
corresponding MS
3
 result.  A probability boost is received for pairs in categories two and 
three, with a greater correction given to the latter.  
 Although a true sensitivity measure for these data is impossible, it is possible to 
evaluate the relative performance of the various probability measures by examining the 
number of reversed database matches.  The decoy database method is increasingly being 
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used as an effective means of estimating false positive rates in database searching when 
other methods of error rates estimation cannot be readily performed (41, 42). At any 
given probability threshold, the number of matches to reversed sequences can be 
calculated and compared to the total number of peptide assignments above that threshold 
to derive an estimate of the FDR (42). A measure of the performance of the various 
model probabilities on these data is shown in Figure 3-10. 
 
Figure 3-10.  Performance of probability scores on the phosphopeptide data set.  The 
number of correct identifications estimated using the decoy database method is plotted as 
a function of FDR estimated using the decoy database search method. 
 
 
 The figure plots the estimated number of correct identifications as a function of 
FDR. These data are generated by ranking all peptide assignments in order of decreasing 
probability.  The number of assignments of peptides from the forward database (nf) 
having a probability equal or greater than the probability of the n
th
 top-ranking reverse 
entry (nr) is counted, and the estimated false discovery rate is determined as nr/nf.  The 
estimated number of correct assignments is similarly measured as nf – nr. This analysis is 





initial and adjusted, as well as the combined probability measures Pcomb and Pmax.  A 
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version of these data in table form is provided in Table 3-5, which presents estimated 
false positive percentages and number of forward match counts for inclusion of one, two, 
five, ten, fifty, and one hundred reversed matches, as well as the number of those forward 




























































































































































































































































































































































































 As can be seen from Figure 3-10 and Table 3-5, at equivalent false discovery 




 data provide a small but 
distinguishable improvement in the number of correct entries that can be selected, 
particularly for MS
3
. The bigger benefit of course comes with the combined Pcomb and 





 probabilities.. For example, by filtering the data using Pmax instead 
of the initial MS
2
 probability it becomes possible to extract 203 more forward matching 
identifications without allowing any reverse database matches (1703 peptide 
identifications vs. 1499). At a roughly 5% FDR, the initial MS
2
 probability estimates 
1893 correct peptides whereas the Pmax measure selects 2093.  It is interesting that Pcomb 
is much more discriminative than the Pmax probability measure on these data, selecting 
2328 correct peptides at the 5% FDR. Overall, the acquisition of MS
3
 spectra does appear 
to increase the total number of phosphopeptide identifications by 10-25% in this data set, 
depending on the specific combined probability score used for comparison.  
 The results discussed above for this sample have focused on the total number of 
identifications, the majority of which are phosphopeptides. An equivalent plot of the 
results, but including only ranked non-phosphorylated identifications from the 
phosphopeptide data set, is shown in Figure 3-11.  In general, the same trends can be 





Figure 3-11.  Performance of probability scores on the non-phosphorylated peptides 






 spectra from the phosphopeptide data set 
 In order to understand the underlying reasons for improved identification 
confidence, it is informative to briefly revisit the example shown in Figure 3-7.  These 




 phospopeptide spectra of 
various precursor charge states. Several spectral features are of interest. Figure 3-7a 
shows an example of a +2/+1 match pair. The threonine in position three of the sequence 
matching the MS
2
 spectrum is phosphorylated.  The large y12 peak corresponding to a 
fragmentation n-terminal to a double proline was selected by the instrument for MS
3
.  
This is a general characteristic of the singly charge spectra corresponding to correct 
identifications in these data: the majority are proline-directed, with a Pro identified in the 
first position. Although the fragmentation is reasonable in this MS
3
 spectrum, a large 
fraction of singly-charged spectra exhibit poor fragmentation with one or two major 
peaks corresponding to Pro, Asp or occasionally Glu cleavage dominating.  This is not 
surprising due to the relatively low energy imparted to singly-charged ions via collision-
induced dissociation (CID) in a trap instrument;  typically the most facile fragments are 
the most readily observable. As can be seen, many of the same ions occur in both spectra.  





simplify the spectrum and increases confidence in the identification. Figure 3-7b shows a 
+3/+1 phosphopeptide example.  +3/+1 instances are rarer than the +2/+1 (see 
Supplementary Figure 3), and the same trends occur.  The MS
3
 spectrum shown is a 
proline-directed fragmentation event, with Asp-directed fragmentation peaks dominating 
the spectrum.   
 Figure 2d is an example of a +2/+2 phosphopeptide ion. The peak selected for 
MS
3
 corresponds to the doubly-charged y13 peak with a -98 Da loss of the phosphate 
moiety.  Although many identical ions are identified in both spectra, there is a significant 
difference in the fragmentation pattern, with several ions observable in MS
3
 which are 




3.4.8 Data set dependence of probability adjustment 
 Since the two primary data sets used in this work differ significantly in terms of 





 matching statistics and the degree to which the initial peptide probabilities 
are adjusted to account for the sequence match information. The Match parameter 
distributions p(Match|+) and p(Match|-) vary between the data sets, reflecting the 
differences in the sample complexity and data set size. This is illustrated in Figure 3-12, 
which plots the logarithm of the ratio p(Match|+)/p(Match|–) for each match category k 
for both data sets. A ratio greater than 1 (log ratio greater than 0) indicates the region 
where the probabilities are boosted after adjustment for Match information, whereas a 
ratio less than 1 (log ratio below 0) indicates that the Match adjustment reduces the 
probability that a peptide assignment is correct.  While the overall trend is similar for 
both data sets, significant differences exist in the amount of adjustment. For example, the 
penalty applied to a peptide assignment to a MS
2
 spectrum with no subsequent MS
3
 
spectrum (match category 0) is approximately twice as high in the case of the 
phosphopeptide enriched data set than in the 9-Mix data set.  On the other hand, the 
amount of probability boost for peptide assignments in the Match=2 category is higher in 







 linking statistics for a larger data set. However, it is clear that the amount of 
probability adjustment in each sequence match category is data set-dependent.  Thus, it is 




-level data that can 
learn the appropriate amount of probability adjustment from the data itself, such as the 
method presented in this work.    
 
 
Figure 3-12.  Degree of probability score adjustment by sequence match category 
for the 9-Mix and phosphopeptide data sets.  
 
3.4.9 Comments on the overall merit of generating MS
3
 data 




 information for cases 
in which such data has been generated.  A fundamental question arises, however, as to 
whether or not the benefits of generating MS
3
 justifies the additional cycle time on the 
instrument, or whether the additional MS
2
 spectra that would be generating in that time 
would offset the potential advantage. It has recently been suggested (e.g. Ref 43) that the 
overall benefit of generating MS
3
 information for phopsphopeptide experiments may be 
limited. Although a comprehensive analysis of the merits of MS3 data generation is 
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beyond the scope of this work, the situation is explored here by comparing sets of mass 





discussed above, and an MS
2
-only method.  
 LC-MS/MS analysis was performed on two additional IMAC-enriched whole-cell 
D. melanogaster tryptic digests using a Thermo LTQ, as described in Experimental 
Procedures. Each sample was separated into two equal fractions which were run 











peaklists were extracted from the raw data file and searched separately using SEQUEST. 
Final SEQUEST reports were then combined into two final result sets for each pair of 




, and one for the MS
2
-only data.  These four result 
sets were then analyzed using Peptide/ProteinProphet. 
 To compare results at both the peptide and protein levels, individual 
identifications for each of the two final result sets were grouped based either on unique 







-only runs were calculated. The results are displayed as 
Venn diagrams in Figure 3-13 for both pairs of experiments. Given that there was 
significant variation between the number of peptide and protein identifications of the 
same run method, the two pairs of experiments were not combined to reduce the effect of 
instrument sampling rate variability in peptide identification, providing a more fair 
assessment of differences between the two methods. The top pair of Venn diagrams 
indicate the number of unique proteins identified by each method. Proteins were included 
in a set if they participated in an identified protein group (see Ref 33) with a group 
probability of at least 0.95. Proteins from the same group (indistinguishable proteins 
given the sequences of identified peptides) were counted as a single entry. The lower set 
of Venn diagrams shows unique peptide identifications. Peptides were included in these 
sets if their modified sequences were unique, i.e. two peptides with any modification or 
sequence differences were considered two unique peptides for the main figure. 
PeptideProphet probability scores of 0.95 or above were required for inclusion.  Peptide 
uniqueness can be defined by a number of standards, however, and the number of 
identifications listed in each area of the Venn diagram may be overestimated depending 
on the definition.  The break-out boxes for each of the peptide sets indicate the number 
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for each region of the Venn diagram under four alternative definitions of peptide 





 scans that differ only by the loss of one or more phosphate groups on one of the 
residues (i.e., MS
3
 was triggered on the neutral loss) were considered identical and 
counted as one. Under the Type 2 definition, peptides which differ at the N- or C-
terminus by one or more amino acid residues (e.g., due to a missed cleavage) were 




where S+80 indicates a phosphorylated Ser residue. Under the Type 3 definition, 
peptides were counted as identical if they had the same sequence but the modification site 
was ambiguous (residues identified as being phosphorylated are within three amino acid 
sequences of each other), e.g.  
 KES+80NSEDELEYDPSLYPQR 
 KESNS+80EDELEYDPSLYPQR 





 KKESNS-18 EDELEYDPSLYPQR 
were considered identical sequences.  While these four definitions do not include all 
possible types and permutations that occur, using them to count peptides allows a more 











-only experimental runs. Two 





 (left) and MS
2
-only (right) data sets based on unique identifications at 
the peptide and protein levels. All identifications are based on a 95% probability 
threshold. The top diagrams display protein identifications based on unique Uniprot entry 
name.  The numbers represent the number of ProteinProphet protein groups that have a 
protein group probabilities equal or greater than 0.95. The lower diagrams show the same 
for peptide identifications based on peptide sequence, using initial PeptideProphet 
probability scores.  Peptide identifications with the least stringent, most inclusive 
uniqueness criteria are shown in the main figure.  Counts for each region of the diagram 
utilizing more stringent uniqueness criteria are shown in the boxes, labeled as ―- Type‖. 
 
 
 The results indicate that for these data there are potential advantages to both 
techniques. At the protein level, the majority of proteins were identified by both methods. 
However, in one pair of runs the MS
2














 method was able to identify more phosphorylated peptide forms in both sets 
of runs under most of the criteria in which modifications were considered unique (Types 
1-3). In terms of the number of unique peptides identified by sequence-alone (Type 4), 
not taking into account modification state, the MS
2
-only set identifies more peptides in 
one of the runs.  This suggests that, at least for certain conditions, sequence coverage may 
be better with the MS
2
-only method.  
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Overall, these results indicate that generation of MS
3
 data may result in a decrease in the 
number unique peptide and protein identifications. However, several additional 
comments are necessary for more objective evaluation of the benefits of acquiring MS
3
 
data. First, the probabilities used in the comparison presented above (Figure 7) were the 
original probabilities generated by the PeptideProphet and ProteinProphet tools. The 
probability correction procedure described in this work should permit the selection of a 
greater number of peptides (and therefore proteins) at a fixed FDR, which would 
potentially mitigate the loss of sequence coverage. Furthermore if the goal of the study is 
to identify as many unique modification states as possible, MS
3
 data may improve the 
results. It should also be mentioned that the phosphopeptide data sets used in this work 
were of high quality (high degree of phosphopeptide enrichment), resulting in sufficiently 
strong intensity MS signal of phosphopeptide ions and relatively good MS2 
fragmentation. On the other hand, it is possible that in other data sets (e.g., no or poor 
phosphopeptide enrichment), the relatively low abundance of phosphorylated peptides 
would lead to less intense MS signal and less interpretable MS
2
 spectra, thus making 
benefits of acquiring MS
3
 data more apparent.   
 
3.5 Concluding Remarks 
 
 The generation of MS
3
 information is common in directed areas of proteomics 
such as phosphopeptide identification.  Whether generation of MS
3
 information is the 
best strategy or not is partially dependant on the overall goals of the experiment. Data 
generated from a complex phosphopeptide-enriched sample suggest that generation of 
MS
3
 spectra can potentially result in an increased number of unique phosphorylation site 
identifications.  On the other hand, the cycle time spent on generation of MS
3
 data does 
appear to detract from the overall number of unique peptides (by sequence only) and 
proteins identified in such an experiment. Also, although MS
2
 spectra in which neutral 
loss peaks are dominant are still observed in current generation trap instruments, these 
spectra appear to frequently contain better backbone fragmentation than older equivalents 









 matching information from the entire experiment can be 
used to adjust the probabilities of the individual peptide assignments, which has the effect 
of compensating for the reduced number of MS
2
 spectra.  
 In cases in which a very high certainty in a mapped phosphorylation site is 
needed, MS
3
 experiments are highly valuable as exemplified in the mapping of 
phosphorylation sites for which biological follow-up experiments are performed. Also, in 
cases in which neither measurement time nor the amount of phosphopeptide samples are 
limiting factors, the measurement of MS
3
 spectra is advantageous. In fact, in an 
experimental setup which aims to maximize the number of identified phosphorylation 
sites from a complex sample, one efficient strategy is to first perform MS
2
 experiments 





measurements (44, 45). 
 Generally speaking, much of proteomics data analysis relies on the scores and 
probabilities produced by automated search algorithms. It is thus important that any 
probability measure is accurate, and makes use of all available information, particularly 
in situations where the targeted peptide identifications are rare, e.g. for phosphopeptides 
and/or when proteins are identified by a reduced number of peptides (such as an analysis 
in which N-terminal peptides are enriched).  Here I have described methods for 





 spectra into a combined probability score, improving the ability to 
discriminate between true positive and false positive identifications.  I have demonstrated 
an increase in sensitivity and a corresponding decrease in the error rate of selecting 
correct identifications as a result of the adjusted probability using a mixture of known 
standard proteins, and applied the method to a complex phosphopeptide-enriched data 
set, demonstrating an improved discrimination between correct and incorrect peptide 
assignments for that sample.  
 The goal of this study was to describe a relatively simple but valid mechanism for 
adjusting probabilities of peptide identifications in scenarios in which standard database 




 data sets. An alternative computational 
strategy for accommodating MS
3




 spectra into a 
single spectrum prior to database searching.  Full investigation of the relative merits of 
104 
 
pre-database search, spectral merging approaches versus a post-database search 
probability adjustment procedure such as the one discussed here is beyond the scope of 
this work, but is the subject of current investigation.  Other methodologies, such as 
merging spectra from differently charged precursors of the same peptide, could likely be 
utilized to improve peptide identification as well. 
 As instrumentation continues to improve the speed and accuracy of tandem MS 
measurements, the ability to generate complementary information such as MS
3
 spectra 
for any given ion will become increasingly practical.  Methods for accommodating this 
information are consequently useful, and can significantly improve the quality of the 
results generated by automated processing of mass spectrometry data.     
 
  3.6 Data and Code Availability 
 
 MzXML and RAW datafiles, and processed unique linked pair data, for both the 
9-Mix and phospho samples are available online via the Tranche system 
(http://tranche.proteomecommons.org).  The software used in this work was developed in 
Python.  Python modules were implemented making use of the code library available 
with the InsPecT software package by the UCSD Computational Mass Spectrometry 
Research Group (28).  All code modules developed by myself for this project are 
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 Current mass spectrometers provide a number of alternatives for producing 
spectra specifically for phosphopeptide analysis.  In particular, generation of MS
3
 spectra 
in a data-dependent manner upon detection of the phosphoric acid neutral loss is a 
popular technique for circumventing the problem of poor phosphopeptide backbone 
fragmentation. The newer Multistage Activation method provides another option for 
generating phosphopeptide spectra.  Generation of these types of spectra require 
additional cycle time on the instrument, however, and reduce the number of MS
2
 spectra 
that can be measured in the same amount of time.  Additional informatics is often 
required to make most efficient use of the additional information provided by the spectra 
produced using these methodologies as well.  Here I present a comparison of several 
mass spectrometry methods commonly used for the study of phosphopeptide-enriched 
samples: an MS
2





dependent neutral loss method.  Several strategies for dealing effectively with the 
resulting MS
3 
data in the latter approach are presented and compared.  The overall goal is 






Phosphorylation is one of the most highly studied and ubiquitous protein post-
translational modifications (PTMs), playing a key role in cell cycle regulation, cell 
growth and death, metabolism, transcription, morphology and motility, and 
differentiation due to its prominence in signaling mechanisms and protein complex 
formation (1, 2).  The fact that there are over 500 protein kinases in mammals (3, 4), a 
number that is likely doubled in plants (5), and that an estimated 30% or more of proteins 
are phosphorylated at some point during their life cycle (2), underscores the biological 
importance of this modification.  Alterations in normal phosphorylation patterns have 
been implicated in a number of diseases, including cancer (6-8) and Alzheimer‘s (9).  The 
identification of phosphoproteins, and understanding the dynamics of this modification in 
response to cellular and environmental factors, is thus critical for elucidating the systems 
biology of complex disease mechanisms and global regulatory networks.  Consequently, 
development of methods for detecting and characterizing phosphorylated proteins has 
been an active area of research in the proteomics community. In particular, high 
throughput analysis of phosphorylation using directed enrichment methods followed by 
mass spectrometry has become a standard approach for phosphoprotein detection (10-18). 
There are several aspects of phosphoproteomics that make it a challenging 
endeavor.  The primary difficulty is one of stoichiometry:  phosphoproteins are often 
expressed in relatively low amounts in a cell, and relatively few of these proteins exist in 
a phosphorylated form at any one time.  Also, enrichment strategies, while improving, are 
sub-optimal.  Thirdly, phopshopeptides can exhibit poor fragmentation in a mass 
spectrometer.  Lastly, informatics approaches for processing the results of 
phosphopeptide mass spectrometry data are not yet routine. 
The third issue mentioned, the poor fragmentation of phosphopeptides, is due to 
the fact that the phosphate moiety is often the most labile element on the peptide.  In the 
case of collision-induced dissociation (CID), much of the fragmentation energy used to 
produce a tandem (MS/MS or MS
2
) mass spectrum often is absorbed in the dissociation 
of the phosphate group.  The resulting spectrum is often dominated by one or several 
peaks corresponding to the neutral loss of phosphoric acid, with little other fragmentation 
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information useful for identification of the peptide sequence (19).  This issue has been 
addressed using data-dependent MS
3
 methodologies for generating mass spectra, 
typically on ion-trap instruments.   Subjecting neutral-loss fragment masses to a further 
cycle of fragmentation often produces a spectrum with much more useful structural 
information on the peptide (20).  Therefore, phosphopeptides have often been analyzed 
by automated data-dependent triggering of MS
3
 acquisition whenever the neutral loss ion 
of the appropriate mass is detected in an MS
2
 spectrum as a dominant peak (16, 21- 27). 
Despite the apparent advantages, researchers are beginning to question the merits 
of generating MS
3
 data for phosphopeptide studies that are conducted on the most current 
instruments.  An argument given is that, due to increased trap capacity, spectra generated 
on current instruments often contain sufficient fragmentation information in their MS
2
 
spectra to uniquely identify the peptide.  Although the dominant peak is most often still 
due to the neutral loss of the phosphate, sufficient information is contained in the smaller 
peaks to derive amino acid sequence information (28).  Moreover, it is argued that the 
cycle time spent on generating MS
3
 information detracts from the overall number of MS
2
 
spectra that can be produced, potentially reducing the number of unique identifications.  
Addressing this concern, an alternative strategy for fragmentation of phosphopeptides has 
been proposed and made available on current instrumentation, referred to as Multistage 
Activation (MSA) or ―Pseudo MS
n
‖ (29).  With MSA, the neutral loss fragment ions in 
an MS
2
 spectrum are activated without a separate isolation/activation cycle on the 
instrument for neutral loss fragments; the net result is a composite spectrum containing 
fragmentation ions from both the original MS
2
 fragmentation as well as the fragmentation 
resulting from activation of the neutral loss ions.   It has been demonstrated that the 
search scores generated by automated search algorithms such as Mascot (30) are 
improved over their conventional MS
2
 equivalents, ideally translating into the ability to 
select more peptide identifications at any given scoring threshold (29). 
A consequence of the MS
3
 methodologies discussed above is that the downstream 
informatics of processing MS
3
 spectra requires additional consideration, and is often not 
equivalent to those used for processing MS
2





 spectra are ideally derived from the same peptide, and may 
generate matches to identical peptides using database searching tools.  The resulting 
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matches must be integrated in some manner in final reports.  Another issue is that the 
measured precursor masses associated with MS
3
 spectra will not always correspond to the 
masses of appropriate database peptides calculated using the same rules that are applied 
in the case of MS
2
 spectra.  For example, in phosphopeptide analyses variable 
modifications of -18 Da due to loss of phosphoric acid from S or T residues need to be 
specified for MS
3
 spectra, while the normal +80 Da phosphorylation modification on S, 
T, and Y are used for MS
2
.  It is computationally inefficient, and an unnecessary source 
of false positive identifications, to perform a combined search which permits both the -18 
Da loss for MS
2
 spectra and the +80 Da addition for MS
3
 spectra.  Moreover, any MS
3
 
spectrum generated from a peptide in which amino acids are lost in addition to the 
phosphate moiety, an event that does occur, requires the searches to be conducted in a 
semi-tryptic manner, preferably allowing for internal ion masses.  This is beyond the 
capabilities of some of the popular database search platforms.    
Such considerations have led several investigators to develop their own 
algorithms for handling MS
3
 scans.  Olsen and Mann describe a custom scoring algorithm 
for MS
3
 spectra: their final score for a peptide is the product of the Mascot-generated 
MS
2
 probability and the custom MS
3
 score, implemented in a modified version of their 
MSQUANT software
1 
(20).  Hoffert et al. developed a framework called PhosphoPIC 
that processes SEQUEST results of phosphoepeptide-enriched samples to allow more 
effective filtering and post-search compilation of the data (24). In addition to standard 
database searching, methods for computing a score associated with the specific site of 
phosphorylation on the peptide have been published.   Beausoleil et al. describe an 
extension of the score developed by Olsen and Mann that calculates a value indicative of 
whether the specific site of phosphorylation can be localized to a particular residue (31). 





processing methodology, I performed an initial assessment of the merits of generating 
MS
3
 spectra by comparing an MS
2
-only methodology to an approach generating MS
3
 
spectra on a phosphopeptide-enriched sample.  Initial results indicated that generating 
MS
3
 spectra could indeed result in fewer unique peptide identifications.  However, there 
was evidence that the number of unique sites of phosphorylation increased as a result of 
MS
3
.  The goal of this chapter is to address this issue more precisely.  Overall, I seek to 
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provide evidence as to whether a particular methodology for analyzing phosphopeptide 
data performs better than another, both in terms of the number and quality of 
identifications as well as in simplicity of implementation.  In as equivalent a manner as 
possible, I compare three approaches: an MS
2





methodology, and an MSA methodology.   The primary criterion for comparing 
methodologies is the number of unique peptide identifications.  I also examine the effect 
of the method on the determination of the site of modification as well as whether there is 




 data, I also compare 
several different informatics methods for interpretation of the resulting spectra. 
4.3 Experimental Procedures 
4.3.1 Sample Preparation and Mass Spectrometry 
 
The sample used in this study is a trypsin-digested, IMAC-enriched cytosolic 
protein extract from Drosophila melanogaster Kc167 cells, identical to the 
―Phosphopeptide Sample‖ described in Chapter 3. The preparation of the phosphopeptide 
samples is described in detail in Bodenmiller et al. (32). A total peptide amount of ~12 g 
was divided into six equal samples, with duplicate samples run on the instrument for each 
of the three mass spectrometry methods described next.     
Mass spectrometry: Mass spectrometry and chromatographic separation of 
phosphopeptides was basically identical as described in Bodenmiller et al. (32) and 
Chapter 3, except that an LTQ-FT (ThermoFischer Scientific, Bremen, Germany) and a 
gradient from 2 % to 25% acetonitrile in 90 minutes was used. 
Three mass spectrometry methodologies are explored in this study:  a standard 
MS
2
-only methodology (abbreviated as ―MS2‖ in this document), a MultiStage 
Activation (MSA, also called ―Pseudo MS
n
‖) methodology, and a method which 
generates both MS
2
 and data-dependent MS3 spectra (abbreviated ―MS3‖).  For the MS2 
methodology, all peptides eluting from the column were recorded in MS mode in the first 
scan event using the Fourier transform (FT) analyzer. The most intense ion was selected 
for a product ion spectrum (MS
2
) in the second event on the linear trap analyzer of the 
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instrument.   This MS
2
 event is repeated up to six times for subsequently less intense 
peaks exceeding a threshold of 500 ion counts, for a total possible cycle of seven events.  
For the MSA methodology, all peptides eluting from the column were recorded in MS 
mode in the first scan event using the FT analyzer. The most intense ion was selected for 
a product ion spectrum (MSA) in the second event on the linear trap analyzer of the 
instrument. During fragmentation, the neutral loss species at 98, 49, 32.66 and 24.5 m/z 
below the precursor ion mass were additionally activated as described in (29). This MSA 
event is repeated up to five times for subsequently less intense peaks exceeding a 





 method, first and second method events were analogous to the MS2 method.  
However, in the third event an MS
3
 spectrum was triggered specifically in the event of a 
phosphate neutral loss (-98 Da for singly, -49 Da for doubly and -32.66 Da for triply and 
-24.5 Da for quadruply charged peptides). The second and third events are then repeated 
two more times in the cycle, for the second and third most abundant MS
1
 ions, for a total 
cycle of seven events. A threshold of 200 ion counts was used for triggering an MS
2 




 scan events. MS
2
 
isolation width was set to 2 m/z and MS
3
 isolation width was set to 4 m/z. For triggering 
an MS
3
 event the most intense ion had to be above 50 ion counts. No further restrictions 
were made for the selection of the MS
3
 precursor.  
A profile of spectral counts for each of the six instrument runs is shown in Table 
4.1.  Charge state could be determined to a high degree of accuracy due to the high mass 
accuracy of the FT.  Singly-charged peaklists were excluded from further analysis in the 
extraction phase because of their high false positive likelihood and are not shown in the 









Table 4-1.  Spectra counts for the MS2, MSA, and MS3 datasets.  The final term in 
the filename specifies the type of run: MS2 for MS
2
-only, MSA for Multistage 




 runs.  Columns indicating the number of spectra of 





 spectra of that charge state.  Singly-charged peaklists were 
eliminated from the analysis. 
 
 
4.3.2 Database Searching and Results Analysis 
 MzXML files were generated from binary ThermoFinnigan *.raw files using the 
ReAdW tool available in the Trans-Proteomic Pipeline (TPP) suite of programs (33-35).  





 runs, the -level option
12





separately. The database for the phosphopeptide-enriched samples consisted of all D. 
melanogaster sequences exported from the UniProt database (36), 26311 entries total, to 
which the reversed set of sequences was appended. Results were searched using Mascot 
with parameters for the MS
2




 (described below) spectra as 
follows: peptide tolerance of 25ppm, fragment ion tolerance of 0.8 Da; full trypsin 
digestion, two possible missed cleavages; fixed carbamidomethyl modification of 57.02 
for Cysteine; variable modifications of +80 Da for Ser, Thr, and Tyr, and +16 Da for 
Met.  The instrument type was set to ESI-TRAP, this is significant in that it determines 
the types of ions that Mascot scores.  The ESI-TRAP setting does not calculate internal 





ions.  A comparison of the performance of this instrument setting with a setting that 
utilizes internal ions showed that the latter significantly degraded the quality of search 
results (data not shown).  The MS
3
 spectra were searched with the same set of parameters 
except that variable modifications of -18 Da on Ser and Thr (instead of +80 Da) were 
specified to accommodate loss of phosphoric acid leading to a dehydroalanine or 
dehydrobuyric acid, respectively.   
Search results generated by Mascot in the *.dat format were converted to pepxml 
format using the TPP mascot2xml program.  The results were then analyzed using 
PeptideProphet (34), resulting in a probability score for each spectrum.  PeptideProphet 
was run with the “-l” option, which results in alternate processing of DeltaCn scores 
marked with „*‟, representing cases in which the top and second-highest ranked peptide 
assignment to a spectrum have homologous sequences (>70% sequence identity) as often 
occurs for phophopeptides when the specific site of phosphorylation is ambiguous.  
ProteinProphet (35) was also run on the pepxml result files from PeptideProphet for each 
of the MS2, MSA, and MS3 cases, combining results of the two replicate experiments for 
each method type for a total of three final result sets at the protein level.     
 
4.3.3 MS2/MS3 spectra data processing 
MSA spectra are composite spectra containing MS
2
 fragment ions as well as ions 
generated by activating several neutral loss product ions generated by the initial MS
2
 
event.  These spectra require no special processing to search using standard tools.  
However, it has been noted (29) that current search engines may not consider all 
combinations of fragment ions that may be simultaneously present in MSA spectra (e.g. 
simultaneously scoring a corresponding bn and a bn-H3PO4 ion). 




 methodology can be processed in several ways.  





spectra can be paired after database searching, providing an ability to adjust the 
probability scores of both spectra based on whether the sequence assignments of these 







 spectra may then be used individually, or the two scores may be 





 spectra are searched separately, to avoid the need for 
specifying multiple variable modifications (+80 Da for MS
2
 and -18 Da for MS
3
) on the 
same residue.  The specification of the -18 Da neutral loss for MS
3
 is required to allow a 
standard search engine to select peptides of the correct precursor mass in a database.  
This requirement can be eliminated, however, by simply replacing the precursor mass of 
MS
3
 spectra with the precursor mass of their parent MS
2
 scan prior to searching.  
Although the replaced MS
3
 precursor mass in a peaklist or MzXML file no longer reflects 
the actual mass selected for fragmentation in the MS
3





 spectra separately.  This ―trick‖ is implemented by default in current 
BioWorks software distributed with a ThermoFinnigan instrument (and, to this author‘s 
knowledge, is undocumented). 
 There is yet another method for utilizing MS
3
 spectra that can be performed prior 





spectra into a single spectrum.  The advantage of this technique is that it has the potential 
to both increase the signal-to-noise ratio of common ions in both spectra as well as 
provide more extensive fragmentation information in a single spectrum. Such spectra are 
referred to as ―summation spectra‖, or just ―sum spectra‖ in the remainder of this 





peaklists separately from a raw datafile into separate folders.  The scan numbers of the 




 pairs, as described in 
Chapter 3 and (25).  Consecutive spectra are then merged as follows:  First, the intensities 
of peaks in the two spectra are normalized by comparing the base peak intensity of each 
spectrum, adjusting the MS
3
 peak intensities to match MS
2
 levels.  Then a new peaklist is 





 spectra are within a specified tolerance (0.4 Da for all data presented here), 
the peaks are combined by adding the intensities.  A single m/z value—the value from the 
most intense of the two peaks— is used in the sum spectrum for the peak.   
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 will be used when referring generally to spectra of these types, and MS2 and MS3 
when referring to specific datasets discussed in this thesis. 
 
4.3.4 Calculating a score for phosphopeptide site localization: a custom 
Ascore 
 In a recent publication (31), Beausoleil et. al. describe an algorithm that computes 
a probability of phosphorylation being localized to a specific site on a peptide, called an 
Ascore
13
. A custom version of this algorithm was implemented in the Python 
programming language for this project. There are several differences between my 
implementation and the published version.  Most importantly for this work, my 
implementation allows me to calculate a score for MS
3
 spectra, a feature not supported in 
the online version of the Ascore algorithm provided by the Gygi lab.  Also, the published 
implementation calculates multiple scores for multiply-phosphorylated peptides.  My 
algorithm functions by searching through all possible permutations of phosphorylated 
forms given the identified number of phosphates modifying the peptide.  It then selects 
the two highest scoring forms to use in a more refined localization score calculation, 
generating a single score for the peptide indicating the likelihood that the given modified 
peptide is the correct form.  Thirdly, my version of the algorithm produces slightly 
different scores than the published version, likely due to differences in the assignment of 
labels to ions in the spectrum.  Given that the use of my custom implementation is for 
comparative purposes, specifically to determine if the MS methodologies differ in their 
ability to localize sites of modification, I believe it is a valid and useful representation of 
the algorithm.  However, in that it is not an identical measure, the score produced by my 
algorithm is called a ‗localization score‘ rather than an ‗Ascore‘ in this document. 
 





4.4 Results and Discussion 
4.4.1 Comparison of the number of identifications 
A general belief regarding the merits of generating MS
3
 data is that doing so 
reduces the number of unique peptide identifications, simply by lowering the number of 
MS
2
 scan events in a run.  This appears to be the case in some situations, and was 
confirmed in earlier data presented in the previous chapter.  For the more extensive 
datasets examined in this study, however, this result was not found to be the case. Figure 
4-1 shows the number of unique peptide identifications for each of the six instrument 
runs.  Unique matches here are defined by primary peptide sequence; no accounting of 
modification state of the peptide assignments is taken into account.  Peptides were 
selected at a 0.95 probability threshold as reported by PeptideProphet; a similar number 
of identifications were obtained by utilizing the Mascot significance threshold for each 
peptide of (ionscore – identityscore) >= 0.0 (data not shown).  Overall, the method 
performance between all six runs was comparable.  However, the MSA methodologies 
produced more hits than the other two methodologies, 8% more than the MS2 







Figure 4-1.  Number of unique peptide identified in each dataset.  The run method is 





methodology.  Peptides selected at a 0.95% confidence threshold as reported by 
PeptideProphet.   
 
 
4.4.2 Optimizing the data for MS
3
 spectra 
 The identifications listed in Figure 4-1 for the two MS3 run methods were 
calculated based on raw, ‗unadjusted‘ probabilities.  As described in Experimental 
Procedures (section 4.3.3), several computational methods exist for further refining the 
identifications from MS
3
 spectra to make efficient use of the information.  Results on 





 probability scores based on the methods discussed in (25) for all 
identifications in the dataset (notated ―MS3-ADJ‖); 2. Combining the adjusted 
probability scores for consecutive matching pairs into a single score using the heuristic: 










for consecutive matching pairs (―MS3-sum‖). 
 Figure 4-2 shows the comparison of number of unique peptide identifications 
produced for the two MS3 runs using each of these methodologies with the raw MS3 
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scores.  The two replicate runs 10192 and 10193 are shown in the same color for each 
method.  The spectra generated for the 10193-MS3 run on the instrument obviously yield 
fewer identifications.  Overall, the three refinement methods produce a modest 
performance increase over the raw equivalents, resulting in significantly more 
identifications.  The MS3-sum spectra result in roughly the same number of unique 




 peptide probabilities individually, 




 spectra can provide a simple method for utilizing 
MS
3
 spectra.  Although the MS3-1-p method requires an additional computation step, it is 
the most successful MS3 technique for identifying unique peptide identifications on these 
data.   
 An expanded summary of counts of peptides identified by all of the 
methods is shown in Table 4-2, including counts for the number of phosphorylated 
peptides identified.  The total number of spectra generated by each method is shown as 
well as the number of total and unique peptide identifications identified at a 
PeptideProphet probability threshold of 0.95.  A new statistic is calculated, the ratio of 
Unique peptides identified to Total spectra generated: a U/T or ―Utility‖ ratio.  This ratio 
can be considered a simple measure of spectra quality.  It is interesting that the MSA 
spectra produce the highest scores for this statistic, a reflection of the increase in 
information resulting from a combination of activation events.  An increase is not evident 
in the summation spectra, however, pointing out a difference in these two techniques. 
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Figure 4-2: Comparison of MS3 data processing methodologies.  Data are shown for 
the two replicate runs for which MS
3
 spectra were generated (run IDs 10192 and 10193).  
Results from three alternative refinements, summation spectra (labeled ―-sum‖), 
probability adjustment (―-ADJ‖) and the combined 1-(1-PMS2)(1-PMS3) score (―-1-p‖) are 
compared with the unprocessed results.  
 
 
The number of unique peptides that the search engine identifies as phosphorylated 
is shown.  I also calculate a localization score for every phosphopeptide.  I use the score 
of 19 as the threshold above which a phosphopeptide can be considered localized with 
high confidence, a value suggested in the original AScore publication.  To be considered 
as a truly uniquely identified form for the Unique Peptides column of Table 4-2, a 
phosphopeptide must have a localization score above this threshold; otherwise, only the 
primary amino acid sequence for the peptide is considered.  However, the modified 
sequences of phosphopeptides meeting these criteria are considered unique for the 





Table 4-2. Summary of peptide identification counts for all methods.  The total 
number of spectra generated for each experiment are shown, as well as total and unique 
peptides identified at >= 0.95 PeptideProphet probability.  The Utility measure provides 
the ratio of unique peptide identifications to total spectra.  The Phospho Peptides column 
lists the number of unique peptides above threshold that are phosphopeptides.  Localized 
Phosphos list the number of the phosphopeptides identified as having an Ascore >= 19.0. 
 
The ratio of phosphopeptides to total unique peptides in Table 4-2 indicates a high 
degree of enrichment, confirming the results for the method described in (32).  
Surprisingly, the MS2-only methodology produces the fewest number of unique peptide 
identifications.  The MS3-1-p methodology and the MSA methodology produce the 
highest number of unique identifications, 10% more than the MS2 method.  The number 
of localized sites of modification is elevated in the MSA results, even though the MS3-1-
p results produce an equivalent number of unique peptide identifications and even more 
total unique phosphopeptide identifications than MSA.  The result is not terribly 
surprising given that an MSA spectrum can theoretically contain fragment ions from 
multiple neutral loss ions whereas the MS3 methods contain fragmentation data from at 




 events.  The results suggest a net increase in overall spectral 
quality as a result, confirmed by the Utility measure.  Amongst the four MS3 
methodologies shown, although MS3-1-p produces the higher number of unique peptide 
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identifications and the most overall phosphopeptide identifications, MS3-sum spectra 
produced the most number of confidently localized phosphopeptide identifications.  
 
4.4.3 Unique protein and peptide identifications for combined datasets 
Comparisons were made between the methods‘ performance in identifying 
proteins as well.  One of the difficulties associated with enriched phosphopeptide samples 
is that, due to the simplified nature of the mixture, often only one peptide is identified per 
protein (so-called ―one hit wonders‖).  As a result, a modified selection criteria was used 
for allowing peptide identifications in the data set.  The ProteinProphet tool clusters 
protein identifications into protein groups based on the underlying peptide identifications, 
generating a probability for each protein group.  All identified groups for a given 
methodology were ranked by probability score.  Since data were searched against a 
reverse-appended database, a false discovery rate (FDR) could then be calculated for any 
probability threshold (37, 38).  All protein identifications meeting or exceeding the 0.05 
FDR probability threshold were thus selected.  Based on the information obtained in this 
clustering, ProteinProphet then produces an adjusted probability score for peptides 
associated with these protein groups, called the NSPAdjusted probability, which reflects 
the increase in confidence in peptides that have other ―siblings‖ contributing to a protein 
identification (35).   
 Figure 4-3 displays Venn diagrams outlining the number of protein and peptide 
identifications obtained by the various methods, and their relationships.  For these 
figures, the results from the two replicate runs for each method are combined into a single 
result.  Peptides were included in these figures if their NSPAdjusted probability exceeded 
0.50, the decrease in confidence from the 0.95 threshold utilized earlier justified by the 
fact that the proteins to which they are assigned are known to be correct with high 
confidence.  Only peptides participating in the assignment of proteins which exceed the 
0.05 FDR threshold are included. Again, modified forms of phosphospeptides were 
considered as unique if their localization scores passed the 19.0 significance threshold.     
The figures show a large degree of overlap in identifications between the three 
methods, with greater than half of the identifications for any single method corresponding 
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with both other methods.  There are, however, a significant number of identifications 
identified by one method alone at the peptide, and thus the protein, level.  This difference 
can largely be attributed to sampling rate on the instrument.  The MS2 and MSA methods 
produce a total of 478 and 519 unique protein identifications, respectively, which include 
638 and 716 unique peptides.  Of the MS3 methods, MS3-sum outperformed the MS3-1-
p method in terms of the number of total identifications. 
 
 
Figure 4-3: Comparison of protein and peptide identifications for combined 
datasets.  Venn diagrams of the three primary run methodologies are compared using 
two MS3 processing methods: MS3-sum spectra (Panels a and b, top) and the MS3-1-p 
method (Panels c and d, bottom).  The figures compare unique protein assignments (left) 
and peptide assignments (right).  Total counts for all areas corresponding to each dataset 
are shown in parentheses. Proteins are selected based on an estimated FDR of 0.05 using 
the decoy database strategy.  Peptides are included for all significant proteins if their 





4.4.4 Effect of methodology on phosphorylation site localization 
In addition to the total number of identifications, the methodologies are compared 
to see if there is a difference in their ability to localize a site of modification.  Such a 
difference might be reflected in a shift in the localization score between the methods.  To 
investigate this, binned localization score values were plotted for the combined results of 
each individual method.  The results are plotted in figure 4-4.   
 
 
Figure 4-4.  Localization score histograms for individual run methods.  Each bin 
value represents the total percent of all peptide identifications in that bin range for the 
corresponding method.  The distributions in a) are calculated using only unique 
phosphopeptides identified by all three methodologies, whereas the distributions in b) are 




To generate the figure, counts between methods were normalized to 1 to display 
relative bin size.  The MS3-sum method produced the largest fraction of peptides in the 
19+ bin amongst the MS3 methods, and was thus chosen for comparison to MS2 and 
MSA, and MS3-1-p.  The overall results are similar in all methods, with MSA producing 
a higher fraction of significant (19+) localization scores.  Also, the MS3-1-p shows a 
skew towards lower localization score values.  An interesting variation arises in a manner 
that is dependent on the subset of peptides used in the comparison.  The top panel of the 
figure is restricted to a comparison of peptides identified by all three methods, whereas 
the bottom panel utilizes the localization scores for all peptides meeting or exceeding a 
probability threshold of 0.95, thus allowing peptides to be included that are identified 
uniquely by one or two methods.  The bottom panel indicates a more pronounced 
increase in the ratio of peptides achieving a significant localization score using the MSA 
method than the top panel.   
It should be noted that the localization calculations did not utilize the ion 
assignments used by Mascot for generating a score for a peptide assignment.  Our 
localization score calculation takes as input a peaklist and the corresponding peptide 
sequence assigned by Mascot.  The algorithm calculates theoretical fragmentation masses 
based on the peptide.  Fragment masses are assigned to a peak in the spectrum if a 
calculated fragment mass is within a user-defined threshold of that peak (the fragment 
mass tolerance use in the Mascot search, 0.8 Da, was used for these data). The theoretical 
fragmentation calculations are done using custom Python modules which are themselves 




 Table 4-3 shows statistics for the various ion types assigned to all high-scoring 
(>=0.95 probability) peptides for each method.  Although an optimal peak depth is used 
in the calculation of the localization score as described in (31), the peak depth was fixed 
at four to generate the results given in the table (peak depth indicates the number of top 
peaks selected per 100 Da window for the purposes of scoring).  Ions were assigned to 





peaks in a ranked order based on their likelihood, such that a peak identified by a more 
likely ion type would not be replaced by a less likely one.  Note that even though all these 
ion types were annotated, not all were utilized in the calculation of the localization score.  
The table indicates that all methods are roughly similar in the types of ions generated, 
with no significant bias.  Any performance improvement found by MSA in localizing a 
site of modification does not appear to be a function of selection of a particular set of 
ions.  The ion percentages in the table were calculated for peptides identified by all 
methods, corresponding to Panel 4-4a; the identical percentages calculated using all ions 
for a given method (Panel 4-4b) shows very little variation (data not shown).  Overall, the 
number of peaks identified per spectrum was very consistent across all methods as well, 




































M-P 1.33 1.13 0.14 0.12 1.08 1.06 
a 0.72 0.93 0.86 0.95 1 0.94 
a-h2o 0.81 1 0.87 0.94 0.83 1.05 
a-nh3 0.98 0.65 0.95 0.57 0.85 0.95 
b 18.73 18.72 17.1 17.76 15.54 15.36 
b-h2o 2.8 2.71 2.45 2.3 2.3 2.34 
b-h2o-h2o 0.05 0.03 0.03 0.03 0.04 0.02 
b-h2o-nh3 0.05 0.07 0.03 0.03 0.05 0.04 
b-nh3 2.58 2.44 2.36 2.23 2.12 2.12 
b-p 10.09 9.69 11.87 12.72 11.85 12.74 
b-p' 0.96 1.03 1.3 1.24 1.53 1.62 
b2 6.39 7.61 6.83 6.34 5.59 5.8 
b2-h2o 0.02 0.02 0 0 0 0 
b2-nh3 0.08 0.2 0.18 0.09 0.06 0.11 
b2-nh3-h2o 0.03 0.05 0.03 0 0.06 0.01 
b2-p 1.43 1.46 1.55 1.39 1.86 1.68 
b2-p' 1.13 1.23 1.12 1.26 1.37 1.04 
b3 0.86 1.05 0.86 0.98 1.07 1.1 
y 26.6 27.81 27.65 27.24 27.39 27.37 
y-h2o 2.92 3.13 3.36 3.02 3.13 3.59 
y-nh3 1.42 0.95 1.28 1.42 1.24 1.19 
y-p 2.95 2.33 3.41 3.34 4.37 3.78 
y-p' 0.35 0.43 0.33 0.44 0.38 0.27 
y2 9.34 8.96 8.14 8.46 8.12 8.15 
y2-h2o 0 0.02 0 0.01 0.01 0.01 
y2-nh3 0.06 0.17 0.12 0.07 0.05 0.12 
y2-nh3-h2o 0.03 0.07 0.07 0.04 0.01 0.02 
y2-p 4.98 3.66 4.94 5.05 5.5 5.25 
y2-p' 0.9 0.88 0.78 0.89 1 0.92 
y3 1.42 1.55 1.3 1.07 1.58 1.28 
 
Table 4-3.  Ion statistics for confident peptide identifications by methodology.  Rows 
indicate ion types.  The numbers indicate the percentage of total assigned peaks for each 
method that were labeled as the given type.  Ion types are sorted alphabetically.  A 2 or a 
3 after an ion type indicates the charge of the ion; -p indicates a 98 Da neutral loss and –
p‘. loss of 80 Da.  M-P is a label given to the precursor neutral loss peak.  Percentages for 
the MS3 methods were generated from the unadjusted probability results. Peptides with 




4.4.5 Effect of method on instrument mass accuracy 
As a last comparative measure, peptide assignments were queried to detect any 
difference in mass accuracy that may occur between the different methods.  To perform 
this comparison, 120 high-scoring peptides identified by all three of MS2, MSA, and 
MS3 methodologies were examined.  The root mean square (RMS) error as reported by 
Mascot for each peptide assignment was manually recorded (this number is available in 
the Peptide View page of an individual result) and plotted, shown in Figure 4-5.  This 
number represents the overall RMS error for all theoretical assignments to peaks in the 
experimental spectrum.  As noted earlier, database searches were performed both with 
and without internal ions; the inclusion of internal ions resulted in a significant increase 
in the average RMS error rate, not unexpected given the high rate of false peak 
assignments for these ions.  All results reported in this figure do not include internal ion 
masses in the mass error calculation.   
The RMS error results are matched vertically by instrument method for each of 
the individual unique peptide sequences and sorted by peptide length along the x-axis.  
For instance, for Peptide ID #1, the blue circle (MS2), red square (MSA) and green 
triangle (MS3) for the seven-mer sequenced peptide ADSLIYK is shown clustered 
together around 200 ppm RMS.  This peptide had a calculated RMS mass error of 188, 
192 and 199 ppm for each of the methods, respectively.  The last data points along the x-
axis represent a peptide of length thirty-nine, which produced a calculated RMS mass 
error of 505, 549 and 410 ppm for MS2, MSA, and MS3 instrument methods, 
respectively.   
While these two examples show MS2 as having better mass accuracy than MSA, 
linear regression curves indicate that MSA spectra have an overall better mass accuracy 
than the other two methods.  As can be seen from the figure, MSA identifications are 
roughly 30 ppm better than MS2 and 50 ppm better than MS3 spectra over much of the 
range of these different peptide lengths.  As the overall length of the peptide increases, 
the RMS error for the three methods approaches a similar value.  A normalization effect 
occurs as the length, and thus the number of identified ions, increases. This overall trend 
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of MSA having better mass accuracy than the other methods is interesting: one might 
expect MSA to have a higher mass error due to space charge effects within the ion trap.  
During MSA analysis, relative to MS2 and MS3, the ion trap is left open longer without 
interludes of evacuation.  Therefore, the greater number of ions collected in the MSA 
method compared with MS2 and MS3 would increase space charge effects and thus 




Figure 4-5.  Mass accuracy of fragment ion assignments from MS2, MSA, and MS3 
methodologies.  Results for individual peptides are sorted on the horizontal axis by 
decreasing mass error.  The vertical axis shows the RMS mass error in ppm of theoretical 
fragment ion matches to the experimental spectra produced by MS2 (blue circles), MSA 
(red squares), and MS3 spectra (green triangles).  Linear regression curves are fit to the 








 In the methodologies described, a complex phosphopeptide-enriched sample was 
analyzed in replicate using several different run methods on an FT-LTQ mass 
spectrometer.  At one level, the methods generated a similar number of identifications: 
the difference in the number of unique peptide assignments between the best- and worst- 
performing algorithms is 8%.  The resulting MS2 datasets contained the largest number 
of MS
2





combined.  However, given that the net intensity of MS
3
 spectra is significantly lower 
than MS
2
, one might expect the net result to be a higher number of peptide identifications 
from MS
2
 spectra even for phosphopeptide-enriched samples.  The fact that current 
instrumentation often generates sufficient fragmentation information to uniquely identify 
a phosphopeptide despite the dominance of the neutral loss peak supports this notion.  On 
these data, however, this was not the case.  Out of the three methodologies discussed, 
MS2 produced the fewest number of unique peptide identifications.  The most overall 
(phosphorylated + unmodified) modifications were found by the MSA methodology and 
the MS3 methodology that utilized post-search probability correction and the 1-(1-
PMS2)(1-PMS3) score: the MS3-1-p method.  More total phosphorylated peptides were 
identified by the MS3 methods, specifically the probability-corrected (MS3-ADJ and 
MS3-1-p) approaches.  Although these two approaches produced the most overall 
phosphopeptide identifications, the MS3-sum method resulted in a higher number of 
localized phosphorylation sites than the other MS3 methods.  The overall highest number 
of significantly localized sites of phosphorylation, however, was found by the MSA 
method.  MSA produced the fewest number of spectra but generated the largest fraction 
of successfully identified spectra.  MSA spectra appeared to have a slight advantage in 
localizing the site of modification as demonstrated by a minor positive skew in the 
overall Ascore distribution, and also exhibited a detectably lower overall mass error. 
 The overall result of the above analysis confirms that MSA is a convenient and 
effective overall approach.  Given the fact that MSA spectra are simple to utilize in that 





approaches and bookkeeping, they appear to be an optimal methodology, at least for the 
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automated processing pipeline I describe here.  A different biological sample, perhaps 
one generated by a different phosphopeptide enrichment strategy that produces different 
ratios of multiply-phosphorylated forms, or a less complex sample, may produce different 
results.   Other instrument conditions will likely have an effect on the utility of MS
3
 data 
as well.  The fact that both the MSA and the MS3 methodologies performed better than 
the MS2 methodology suggest that there is additional useful information contained in 
MS
3
-type data that can be utilized by a standard automated search engine in a high-
throughput approach.  A manual curation strategy, or more directed algorithms focused 
specifically on identifications of phosphorylated peptides, could produce a different set of 
outcomes on these data.       




1. Hunter, T. (2000) Signaling--2000 and beyond. Cell 100:113-27. 
2.  Cohen, P. (2000) The regulation of protein function by multisite phosphorylation– 
a 25 year update. Trends Biochem. Sci. 25: 596–601. 
3.  Manning, G., Whyte, D. B., Martinez, R., Hunter, T., Sudarsanam, S.  (2002) The 
protein kinase complement of the human genome. Science 298, 1912-34. 
4.  Caenepeel, S., Charydczak, G., Sudarsanam, S., Hunter, T., Manning, G.  (2004) 
The mouse kinome: discovery and comparative genomics of all mouse protein kinases. 
Proc Natl Acad Sci U S A. 101, 11707-12.  
5. Kersten, B., Agrawal, G. K., Iwahashi, H., Rakwal, R. (2006) Plant 
phosphoproteomics: a long road ahead. Proteomics 6: 5517-28.  
6. Mackay, H. J., Twelves, C. J. (2007) Targeting the protein kinase C family: are 
we there yet? Nat Rev Cancer 7: 554-62. 
7. Rikova, K., et al. (2007) Global survey of phosphotyrosine signaling identifies 
oncogenic kinases in lung cancer. Cell 131: 1190-203. 
8. Guo, A., et al. (2008) Signaling networks assembled by oncogenic EGFR and c-
Met. Proc Natl Acad Sci U S A. 105: 692-7. 
9.  Mazanetz, M. P., Fischer PM. (2007) Untangling tau hyperphosphorylation in 
drug design for neurodegenerative diseases. Nat Rev Drug Discov. 6: 464-79. 
10. Hoffert, J. D., Knepper, M.A. (2008) Taking aim at shotgun phosphoproteomics. 
Anal Biochem. Nov 22: [Epub ahead of print] 
11. Witze, E. S., Old, W. M., Resing, K. A., Ahn, N. G. (2007) Mapping protein post-
translational modifications with mass spectrometry. Nat Methods. 4: 798-806.  
12.  Ptacek, J., Snyder, M. (2006) Charging it up: global analysis of protein 
phosphorylation. Trends Genet. 22: 545-54. 
13. Pflieger, D., Jünger, M., Müller, M., Rinner, O., Lee, H., Gehrig, P., Gstaiger, M., 
Aebersold R. (2007) Quantitative proteomic analysis of protein complexes: Concurrent 
identification of interactors and their state of phosphorylation.  Mol Cell Proteomics. Oct 
23 [Epub ahead of print]  
135 
 
14. Bodenmiller, B., Mueller, L. N., Pedrioli, P. G. A., Pflieger, D., Jünger, M. A., 
Eng, J., Aebersold, R., and Tao, W. A. (2007) An integrated chemical, mass 
spectrometric and computational strategy for (quantitative) phosphoproteomics: 
Application to Drosophila melanogaster Kc167 Cells. Molecular BioSystems, 3, 275-286. 
15. Villén, J., Beausoleil, S. A., Gerber, S. A., Gygi, S. P. (2007) Large-scale 
phosphorylation analysis of mouse liver.  Proc Natl Acad Sci U S A. 104: 1488-93. 
16. Gruhler, A., Olsen, J. V., Mohammed, S., Mortensen, P., Faergeman, N. J., Mann, 
M., and Jensen, O. N. (2005) Quantitative phosphoproteomics applied to the yeast 
pheromone signaling pathway. Mol Cell Proteomics 4, 310-327. 
17.   Ballif, B. A. Villén, J., Beausoleil, S. A., Schwartz, D., Gygi, S. P. (2004) 
Phosphoproteomic analysis of the developing mouse brain. Mol. Cell. Proteomics 3: 
1093–1101.  
18.  Ficarro, S. B., McCleland, M. L., Stukenberg, P. T., Burke, D. J., Ross, M. M., 
Shabanowitz, J., Hunt, D. F., White, F. M. (2002) Phosphoproteome analysis by mass 
spectrometry and its application to Saccharomyces cerevisae. Nat. Biotech. 20, 301–305 
19.  Tholey, A., Reed, J., Lehmann, W. D. (1999) Electrospray tandem mass 
spectrometric studies of phosphopeptides and phosphopeptide analogues. J Mass 
Spectrom. 34: 117-23. 
20. Olsen, J. V., and Mann, M. (2004) Improved peptide identification in proteomics 
by two consecutive stages of mass spectrometric fragmentation. Proc Natl Acad Sci U S 
A 101, 13417-13422 
21. Beausoleil, S. A., Jedrychowski, M., Schwartz, D., Elias, J. E., Villen, J., Li, J., 
Cohn, M. A., Cantley, L. C., and Gygi, S. P. (2004) Large-scale characterization of HeLa 
cell nuclear phosphoproteins. Proc Natl Acad Sci U S A 101, 12130-12135 
22.  Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., Mann, 
M. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling 
networks. Cell. 127: 635-48. 
23. Macek, B., Mijakovic, I., Olsen, J.V., Gnad, F., Kumar, C., Jensen, P. R., Mann, 
M. (2007) The serine/threonine/tyrosine phosphoproteome of the model bacterium 
Bacillus subtilis. Mol Cell Proteomics 6: 697-707. 
24. Hoffert, J. D., Wang, G., Pisitkun, T., Shen, R.F., Knepper, M. A. (2007) An 
automated platform for analysis of phosphoproteomic datasets: application to kidney 
collecting duct phosphoproteins. J Proteome Res. 6: 3501-8. 
136 
 





 matching statistics: A model for coupling consecutive 
stage mass spectrometry data for increased peptide identification confidence.  Mol Cell 
Proteomics 7, 71-87. 
26. Wu, J., Shakey, Q., Liu, W., Schuller, A., Follettie, M. T. (2007) Global profiling 
of phosphopeptides by titania affinity enrichment. J Proteome Res. 6: 4684-9. 
27. Palumbo, A. M., Tepe, J. J., Reid, G. E. (2008) Mechanistic Insights into the 
Multistage Gas-Phase Fragmentation Behavior of Phosphoserine- and Phosphothreonine-
Containing Peptides. J Proteome Res. Jan 9; [Epub ahead of print] 
28.  Li, X., Gerber, S. A., Rudner, A. D., Beausoleil, S. A., Haas, W., Villén, J., Elias, 
J. E., Gygi, S.P. (2007) Large-scale phosphorylation analysis of alpha-factor-arrested 
Saccharomyces cerevisiae. J Proteome Res. 6, 1190-7.  
29.  Schroeder, M. J., Shabanowitz, J., Schwartz, J. C., Hunt, D. F., Coon, J. J. (2004) 
A neutral loss activation method for improved phosphopeptide sequence analysis by 
quadrupole ion trap mass spectrometry. Anal Chem. 76: 3590-8.  
30. Perkins, D. N., Pappin, D. J., Creasy, D. M., Cottrell, J. S. (1999) Probability-
based protein identification by searching sequence databases using mass spectrometry 
data. Electrophoresis. 20: 3551-67. 
31. Beausoleil, S. A., Villén, J., Gerber, S. A., Rush, J., Gygi, S. P. (2006) A 
probability-based approach for high-throughput protein phosphorylation analysis and site 
localization. Nat Biotechnol. 24: 1285-92. 
32.  Bodenmiller, B., Mueller, L. N., Mueller, M., Domon, B., and Aebersold, R. 
(2007) Reproducible isolation of distinct, overlapping segments of the phosphoproteome. 
Nature methods 4, 231-237. 
33. Keller, A., Eng, J., Zhang, N., Li, X. J., and Aebersold, R. (2005) A uniform 
proteomics MS/MS analysis platform utilizing open XML file formats. Mol Syst Biol 1, 
2005.0017. 
34. Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002) Empirical 
statistical model to estimate the accuracy of peptide identifications made by MS/MS and 
database search. Anal Chem 74, 5383-5392. 
35. Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical 
model for identifying proteins by tandem mass spectrometry. Anal Chem 75, 4646-4658 
137 
 
36. Bairoch, A., et al. (2005) The Universal Protein Resource (UniProt). Nucleic 
Acids Res. 33:D154-159. 
37. Elias, J. E., Gygi, S. P. (2007) Target-decoy search strategy for increased 
confidence in large-scale protein identifications by mass spectrometry. Nat Methods. Mar 
4: 207-14. 
38.  Käll, L., Storey, J. D., Maccoss, M. J., Noble, W. S. (2008) Assigning 
significance to peptides identified by tandem mass spectrometry using decoy databases. J 
Proteome Res. 7: 29-34. 
39.  Tanner, S., Shu, H., Frank, A., Wang, L., Zandi, E., Mumby, M., Pevzner, P. A., 
Bafna, V.  (2005) InsPecT: Fast and accurate identification of post-translationally 







Differential expression of a dengue infected 







 One of the results often observed in large-scale proteomics studies is the degree to 
which different analyses of a similar or identical biological sample produce different 
peptide identifications.  The funding of large, multi-group projects such as the HUPO 
Plasma Proteome Project (PPP) (1), and the recent availability of public repositories of 
protein mass spectrometry data, provides an opportunity for large inter-group data 
comparisons that explore this observation.  In a current publication, Klie et al. present 
results in which they use natural language processing techniques to look for latent 
semantic patterns in large datasets (2). The analysis produces measures of similarity 
between experiments based on the number of proteins identified between them, and 
permits a view of overall similarity patterns across all the data.  The results demonstrate a 
dramatic lack of reproducibility between experiments.  Not a single protein is identified 
in all of the submitted datasets of the HUPO plasma sample, 95 experiments total.  Out of 
the 7884 proteins identified, only 40 are identified in more than half the experiments, and 
70% of the reported protein identifications are found in only one or two experiments.  
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The results can be partially attributed to the variety of experimental approaches and 
instrumentation utilized, and also to the well-known under-sampling issue common to 
LC-MS/MS experiments.  The study confirms the latter finding, indicating a much higher 
degree of similarity between 2D gel-based experimental methodologies than LC-based 
shotgun methodologies. 
 Other researchers have systematically looked at the degree to which replicate 
analyses yield new unique identifications.  In examining the data submitted to the 
PeptideAtlas database (3), the Aebersold group observes that the rate at which new 
unique peptides are identified can begin to saturate due to overlapping identifications 
from similar experiments.  The saturation occurs well below the threshold of the total 
number of predicted peptides for a genome, and appears to be more of a function of 
experimental methodology and instrument.  In yeast, although still below a complete 
saturation, they identified a total of 36133 unique peptide identifications with 
PeptideProphet scores > 0.9 from 4.9 million MS
2
 spectra (the number included in 
PeptideAtlas at the time of publication of the manuscript) (4).  The calculated number of 
detectable (mass range 500 to 4000 Da) tryptic peptides in yeast, by contrast, is 436,445.  
All methodologies combined were thus only identifying less than 10% of the theoretical 
tryptic peptides in the genome. 
 These results have obvious implications for experimental design.  The study in (2) 
suggests that if the goal of an experiment is to produce a broad coverage of all proteins in 
a sample, a shotgun methodology might be more appropriate; whereas for a quantitative 
study of a simpler protein mixture reproducibility might be a priority, suggesting a gel-
based methodology.  The PeptideAtlas evaluation suggests that introduction of different 
experimental methodologies can introduce new peptide identifications at a faster rate.  
Also, different computational processing strategies applied to the same dataset can 
produce different and complementary results as well.  Using multiple search engines, for 
example, has been demonstrated to be quite useful in selecting more peptide 
identifications (5).   
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 Over the course of several years, an analysis of differential expression of proteins 
as a result of viral infection has been generated by our group.  The overall goal of the 
study was to examine the differential expression of proteins in a human cell line as a 
result of infection with the dengue virus.  The sample is a challenging one in that the 
virus is somewhat subversive:  it hijacks the transcriptional machinery of the cell in a 
subtle manner and does not outright kill the cell in a short period of time.  Infected cells 
are harvested 48 hours after infection, at which point there is enough time for a 
significant viral titer to accumulate in the cell, but not a sufficient amount to destroy it.  
To be able to detect significant expression changes, a more involved proteomics strategy 
that permits a deeper view into the proteome of the human cell was thus necessary.  
Overall, differences in the relative expression of several significant proteins were found 
in the course of the study.  These biological findings will be presented elsewhere.  The 
goal of this portion of the thesis is to use the datasets generated in this study for 
computational analysis. 
 The data generated in the course of this project are illustrative for examining 
issues of depth and breadth of proteomics experiments, and the degree to which various 
experimental approaches are ‗orthogonal‘—yield unique identifications— and 
complementary.  There are several bases for method differentiation that may be examined 
in these data: intact vs peptide-level iTRAQ labeling; four methods of fractionation: 
strong cation exchange (SCX), peptide isoelectric focusing (IEF), polyacrylamide gel 
(SDS-PAGE), and size-exclusion chromatography; and different search engine analyses.  
What follows is a comparison of these methodologies, focusing on the degree to which 
different methods produce orthogonal results and, in essence, justify variation in method 




5.2 Experimental Methodology 
Sample Preparation:  The samples utilized for the study consisted of 1·10
8
 U937 human 
monocytic cells.  Two full samples were utilized, one a control and one infected with 
Dengue 2 New Guinea C strain for 48 hours.  Samples were washed and lysed 
enzymatically with the Sigma CelLytic-M Lysis solution with added mammalian protease 
and phosphatase inhibitor cocktails and 200 mM Tris-2-carboxyethyl phosphine (TCEP) 
in 1.5M Tris-HCl, pH 8.8.   
iTRAQ labeling: Samples were labeled with the iTRAQ reagent in two ways: at the 
peptide level following digestion and intact, at the protein level.  At the peptide level, 
after an acetone precipitation, the protein precipitate was resuspended, reduced, and 
alkylated with the reagents contained in the iTRAQ kit exactly as described in the 
manufactures instructions (Applied Biosystems, Foster City, CA).  Proteins were then 
digested overnight with trypsin and labled following the standard iTRAQ protocol.  The 
intact labeling protocol is almost identical, except there was no trypsin digestion:  the 
iTRAQ labeling reagent was added directly to the protein solution and the mixture was 
incubated at room temperature for 2 hours.   
1
st
 dimension fractionation: Peptide iTRAQ labeled samples were separated via two 
means of fractionation: strong cation exchange (SCX) and isoelectric focusing (IEF).  For 
SCX, peptides were loaded onto polysulfoethyl-A spin columns (SEM HIL-SCX, 
PolyLC, The Nest Group. Southboro, MA).  The bound peptides were washed then eluted 
in a stepwise gradient of increasing salt concentration (50, 80, 115, 155, 180, 205, 350, 
and 500 mM of KCl) in equilibration buffer.  For IEF, the OFFGEL in-solution IEF 
fractionation device was utilized (Agilent Technologies, Santa Clara, CA).  24 cm pH4-7 
IPG strips were used in the device to fractionate samples into 24 fractions.  Resulting 
fractions were cleaned on a C18 column (Sep-Pak Vac 1cc, Waters).  Collected fractions 
from both methods—eight for SCX and 24 for IEF—were dried in a vacuum centrifuge 
and reconstituted with 43 µl of 0.1% TFA in water for reverse phase chromatography.   
 Protein-level iTRAQ samples were separated using two different means as well:  
SDS-PAGE and size-exclusion chromatography (SEC). For SDS-PAGE separation, the 
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dry, labeled protein samples were reconstituted in gel loading buffer and separated with a 
1 mm 4-20 % Nu-PAGE Bis-Tris gradient gel (Invitrogen, Carlsbad, CA).  The gel was 
cut into 11 sections and the excised gel bands were digested overnight with with trypsin.  
For SEC, the iTRAQ labeled protein sample was placed on a Zorbax GF 250 4 µm (4.6 x 
250) column (Agilent Technologies, Santa Clara, CA). One minute fractions were 
collected across the elution profile (750 μL/min flow rate) for a total of eight fractions. 
These fractions were concentrated in a speed vacuum centrifuge, resuspended, and 
subjected to trypsin digestion.  Following digestion, eluted peptides were dried in a 
vacuum centrifuge and reconstituted in 0.1% TFA for reverse phase chromatography. 
Mass spectrometry: 1
st
 dimension fractions from all four methods were reverse phase 
(RP) separated by C18 nano LC and spotted onto a stainless steel Opti-TOF MALDI 
Plate System with a spotting robot. Samples were spotted at 10-second intervals, 384 
spots per plate.  The spotted fractions were analyzed in the ABI 4800 TOF/TOF mass 
spectrometer.  First stage MS analysis was completed in positive ion, reflector mode 
acquiring precursor ions in a mass range of 950-4000 m/z for protein level labeling and 
800 – 3500 m/z for peptide level labeling.  Tandem MS analysis was completed in a data 
dependent manner in which the most abundant 15 and 8 peaks were selected per spot, 
with a minimum S/N 40 and 100, for protein level labeling and peptide level labeling, 
respectively.  Fragmentation of all peptides was induced by the use of atmosphere as a 
collision gas with collision energy of 1kV.  
Database Searching: Searches were conducted using four algorithms: SEQUEST 
(version 27, rev. 12) (6), Mascot (version 2.1.0) (7), X!Tandem (version 2006.09.15.1) 
(8), and Protein Pilot with the Paragon algorithm (version 2.0) (9).  The database utilized 
by all search algorithms was generated by concatenating the reversed protein sequences 
to the forward sequences of the entire human IPI database (version 3.29, updated May 
2007).  Where indicated and specified, database searches consisted of using trypsin 
enzyme specificity, a mass tolerance of 0.7 Da on parent ions and 0.3 Da on fragment 
ions, a maximum of two missed cleavages.  Variable modifications included 
methylmethane thiosulfonate (MMTS) and iodoacetamide on cysteine, iTRAQ reagent on 
lysine, tyrosine, and the peptide N-terminus, deamidation of asparagine and glutamine, 
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and oxidation of methionine.  Paragon does not utilize these database search parameters, 
but uses an unrestrained search algorithm that is detailed in (9).  Proteins in ProteinPilot 
were accepted as confident identifications if the probability > 95% probability as 
calculated by Paragon.  Scaffold (version 01_06_03)
15
 was used to visualize MS/MS 
based peptide and protein identifications from SEQUEST, Mascot and X!Tandem.  
Identifications were accepted if they exceeded the 95% protein probability and a 90% 
peptide probability calculated by the Scaffold implementation of the Prophet algorithms 
(5, 10, 11)  Proteins that contained similar peptides and could not be differentiated based 
on MS/MS analysis alone were grouped to satisfy the principles of parsimony.  
 
5.3 Search Engine Comparison 
 Processing the results for all four methodologies provided an opportunity to 
assess the performance of the various mass spectrometry database search engines, and to 
evaluate a new, promising search engine: ProteinPilot/Paragon (6).  Paragon relaxes 
normally specified constraints on the mass tolerance of identifications and automatically 
searches a large number of possible PTMs.  It has been known for some time that search 
engines produce different results on identical datasets: after all, their scoring algorithms 
are not identical and function to reward attributes in the data in different ways.  Typically 
the differences in identification tend to be ―borderline‖ cases, with the most obvious 
examples of both correct and incorrect assignments assigned correctly by all tools.  The 
size of this ―grey area‖ differs between search engine comparisons, however, so it is 
instructive when using a new algorithm to evaluate the relative overlap between its 
results and the results of other algorithms.  
 An excellent tool for integrating the results of the ―Big Three‖ most commonly-
used search engines—SEQUEST, Mascot, and X!Tandem—has been developed: the 
Scaffold tool by Proteome Software.  This tool takes as input results from these three 
engines and calculates new probability scores for each peptide and protein assignment 





using a customized implementation of the Peptide and ProteinProphet tools.  A new 
―agreement score‖ method is also implemented based on evidence from all algorithms for 
a match.  Overall, the software boosts the probabilities for peptides identified by multiple 
engines, and effectively permits an increase in sensitivity as a result (5).   
 Scaffold was used to integrate the results from the Big Three search engines as a 
basis for comparison with ProteinPilot.  The results from all four searches are indicated in 
Figure 5-1.  The results indicate several interesting observations.  Overall, Paragon 
identifies many more proteins than any of the other methods.  Many of the proteins that 
Paragon identifies are also identified by one or more of the other search tools, but there 
are 444 unique proteins found by Paragon alone.  The identifications from the other three 
search engines produce relatively similar results in that the number of identifications 
common to all three is the largest area.   
 
Figure 5-1.  Comparison of the number of protein assignments between search 
engines.  Numbers represent total unique protein identifications meeting the 0.95 
probability threshold as defined by the search engine; searches marked with ‗*‘ were 
thesholded via Scaffold data integration software.  Results represent data from all four 
fractionation methodologies. The Venn diagram is not area-proportional. 
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 These results suggest an orthogonality in the way Paragon scores that the other 
engines do not share.  We know this to be true theoretically in that Paragon implements a 
somewhat ―blind‖, unrestricted search for a large number of PTMs, and also permits the 
inclusion of peptides with significantly more broad delta mass errors under defined 
circumstances (9). The results, however, require a justification if the results from Paragon 
are to be believed:  it is a new algorithm producing results that have not had the benefit of 
years of validation on the behalf of pundits in the community. Since Scaffold provides a 
mechanism to integrate the results of the three other, more established algorithms, it may 
be used as a basis of comparison with Paragon.  Toward that end, the integrated results 
from Scaffold were compared with the Paragon algorithm at both the protein and peptide 
levels (Figure 5-2). 
 
 
Figure 5-2.  Comparison of Scaffold and Paragon results at the protein and peptide 
levels.  Areas show unique identifications; protein identifications are based on unique 
gene name, peptide identifications based on unique sequence.  To be included in the 
results, protein probabilities must meet the 95% confidence threshold and include two or 
more unique peptide identifications. 
 
 Figure 5.2a presents similar data as the previous figure, but with the results from 
the Big Three engines integrated.  As can be seen from Figure 5-2b, 43% of the total 
peptide identifications are identified by Paragon alone, compared to 9% with the other 
engines.  If such results can be confirmed, these data indicate a significant enhancement 
in performance by Paragon above the other search algorithms.  Nevertheless, there is 
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merit in running the others in that a significant number of identifications were made by 
them that were not found in Paragon. 
 Based on an examination of the unique Paragon identifications, the majority of 
these results are explainable as being based on features not accommodated by the other 
search tools.  The numbers of unique Paragon IDs having specific features are listed in 
Table 5-1.  Note that the percentages are not cumulative; an individual peptide 
identification can have more than one of these features.  62% of the unique Paragon 
identifications corresponded to non-standard tryptic cleavage.  The extensive number of 
additional modifications calculated by Paragon that are not accommodated by standard 
search approaches accounted for at least 12%.  A number of other less common 
modifications were found in a smaller number of peptides, not shown in the table.  A 
large portion of identifications, 5%, could be attributed to iTRAQ labeling of non-
standard amino acids Ser and His.  Surprisingly, only 2% of the unique identifications 
were found to have precursor mass errors > 0.7 Da.  Given the range of the timed ion 
selector (TIS) on the 4800, a larger number was expected.  A significant number of 
identifications with > 2 missed cleavages were identified as well. 
 Several of these results have been confirmed using other search engines.  
Promiscuous iTRAQ labeling, for example, is a known event.  Confirmation searches in 
which the Mascot search engine was specifically programmed to find abnormal labeling 
of Ser and His produced positive results.  Loosening the search constraints of the 
standard tools to accommodate partially tryptic search would pick up a number of these 
identifications in the standard tools, at the expense, however of an order of magnitude 
larger search time and an increase in the false positive rate.  A number of abnormal 
modifications have been examined by expert curators as well and have been found to be 
believable.  Taken together, these results are an indication that the additional Paragon 
peptide assignments are largely valid.  Based on this premise, the bulk of the work in the 





Non-standard feature  Percent of unique Paragon 
identifications 
Atypical (non-tryptic) cleavage: N-term 45 
Atypical (non-tryptic) cleavage: C-term 17 
Atypical iTRAQ labeling (S, H residues) 5 
More than 2 missed cleavages 4 
Acetaldehyde modification 3 
Atypical Oxidation (P, H residues) 3 
Delta mass > 0.7 Da 2 
Formyl/Carbamyl@N-term 1 
 
Table 5-1: Frequency of non-standard features amongst unique Paragon 
identifications.  Feature percentages are not exclusive; a peptide might be counted in the 
total of more than one feature.  
 
5.4 Comparison of Fractionation Methodologies 
 The identifications from the various fractionation methods are now compared.  
The results presented here represent a comparison of four different methods of 1
st
 
dimension separation, two using digests of intact iTRAQ-labeled peptides and two using 
standard peptide-level iTRAQ-labeled peptides:  All experiments consisted of two 
experimental replicates each of uninfected control and viral infected sample.  The 
uninfected samples were labeled with the 114 and 115 iTRAQ labels and the infected the 
116 and 117 labels, and the four samples mixed.  The two protein-level fractions are: 
 Protein-level size-exclusion (Protein-SE) fractionation: 100 μg each 
sample, 400 μg total loading. 
 Protein-level SDS-PAGE (Protein-Gel): 25 μg each sample, 100 μg total 
loading. 
 Peptide-level isoelectric focusing (Peptide-IEF): 100 μg each sample, 400 
μg total loading. 
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 Peptide-level strong cation exchange (Peptide-SCX): 50 μg each sample, 
200 μg total loading.  
Fractions from each 1
st
 dimension separation were further fractionated by reverse phase 
chromatography for analysis as described in the methods section.  All results were 
processed using the Protein Pilot/Paragon software and compared.  The number of unique 




Figure 5-3.  Comparison of unique peptide and protein identifications between four 
fractionation methodologies as identified by the Paragon algorithm.  Results 
including if P > = 0.95; protein identifications required a minimum of 2 unique peptides.  
 
 Results at the peptide level (Figure 5-3b) indicate a surprisingly small overlap 
between the identifications by the various fractionation methods.  In all, 80% of the 
peptide identifications were seen by only one method.  In contrast, only 79 
peptides,1.2%, were identified by all four methodologies.  A small overlap size could be 
expected between the intact vs peptide-level iTRAQ, in that the protein level labeling 
would prevent tryptic digestion at lysines.  However, a quite significant disparity exists 
between the methods at the same levels of iTRAQ labeling; between the protein-labeled 
levels, for example, the vast majority of the identifications were of different peptides. 
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 The methods do vary quite largely in the number of identifications returned.  The 
largest number of identifications results from the Peptide-IEF method, followed by the 
Protein-Gel method.  The variance can be attributed to both sample loading and number 
of 1
st
 dimension fractions to some degree, although not completely so.  Peptide-IEF and 
Protein-SE both had the highest loadings at 400 μg, whereas the Peptide-SCX and 
Protein-Gel had 200 μg and 100 μg total loading, respectively.  Peptide-SCX and Protein-
SE both had only eight fractions, whereas Protein-Gel had 11 and Peptide-IEF had 24.  It 
is therefore not terribly surprising that the most successful experiment, Peptide-IEF, had 
both the highest loading and the largest number of fractions.  Its notable that the Protein-
SE experiment had by far the lowest overall total number of significant identifications 
(designated ‗seqs‘ in the figure), but had more unique identifications than the Peptide-
SCX method.  This can likely also be attributed to the intact labeling, yielding overall 
longer peptides with more information content. 
 At the protein identification level (Fig 5-3a), the same pattern is observed, 
however there is a degree of convergence in the identifications: 9% of the proteins are 
identified by all four methods and only 55% are identified uniquely by one method.  This 
still represents a significant lack of overlap, however.  Protein-SE generates the fewest 
number of unique protein identifications, with Peptide-IEF generating the most at the 
protein level.  Overall, the intuitive expectation might be that the same proteins should be 
identified by all methods, indicating that any one method is effectively sampling the 
protein complement of the sample.  These results provide a different picture, however, 
and suggest that different fractionation approaches are indeed complementary and 
orthogonal, and each contributes uniquely to the final result. 
5.5 Cumulative Fraction Orthogonality 
 When processing total results, each fraction from any methodology was spotted 
separately onto MALDI target plates and analyzed in the mass spectrometer.  These 
results were extracted individually, and provide another instructive dimension of analysis. 
In the case of the Peptide-SCX experiment, fractions were spotted multiple times to 
examine the effect of sampling rate and saturation on identical samples.  Also, in that the 
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SCX methodology was done using spin columns, flow-through fractions were spotted and 
analyzed to identify peptides that failed to bind to the column.  The net result of this 
methodology was a set of individual data sets that could be examined individually for 
uniqueness. 
 Figure 5-4 presents the cumulative number of unique peptide identifications as a 
function of number of ―quality‖ spectra acquired, these being defined as spectra 
producing a hit to a sequence with a probability P >= 0.95.  Peptide identifications were 
counted in a cumulative manner, adding to the total if a unique new peptide is identified.  
The largest number of fractions that were analyzed in the mass spectrometer was from the 
Peptide-SCX experiment.  The number of unique identifications produced by this method 
appears to saturate, likely due to replicate spottings of identical fractions.  This method 
also produced the least number of significant identifications, overall suggesting that 
increasing the number of salt elutions in this experiment might not be the most productive 
endeavor. 
 The other methods show a more distinctly linear gain; the number of unique 
identifications by fraction appears to be consistent, with minor variation by fraction.  An 
exception is the Protein-SEC experiment, which shows several fractions stacking near 
each other on the plot.  This result is a function of the specifics of the way the samples 
were spotted on the plate; the number of spots was much fewer in several of the fractions.  
In all, the non Peptide-SCX fractions seem far from saturation, and increasing fraction 
number or repetition of these experiments would likely result in a number of new 





Figure 5-4.  Cumulative number of MS/MS spectra versus number of unique 
peptide identifications by fraction.  Fractions are ordered by method, with peptide-level 
iTRAQ methods to the left and protein-level on the right.  Peptides included with P >= 
0.95, and spectra included if they produce a significant peptide. 
 
5.6 Conclusions 
 The results of this analysis show a surprisingly small amount of overlap between 
unique peptides identified by the four different experimental methodologies.  The 
methods are thus quite complementary to one another in terms of providing a significant 
number of identifications per number of spectra.  The one experiment that was replicated 
twice, the SCX method, did not seem to see a significant benefit from the repetition.  It 
was, in fact, the only method that showed saturation in the cumulative curve.  This may 
be partially due to the experimental fidelity of the method: SCX spin columns may 
simply not provide the best overall fractionation.  It might also suggest, however, that 
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rather than choosing to replicate a particular experiment using the same methodology, a 
different methodology might provide a better breadth of identifications.  The other 
fractionation methods generated a somewhat linear increase in the number of unique 
identifications per fraction, perhaps suggesting that the physical properties of peptides 
being exploited by the fractionation technique are more discriminating, providing a better 
resolving power.  Overall, such conclusions will require much larger datasets.  The 
establishment of public repositories of mass spectrometry should facilitate this type of 
analysis. 
 The database search engines were also demonstrated to produce complementary 
results.  This is a well-known property of these tools, and forms the basis of the Scaffold 
program.  The Paragon algorithm was demonstrated to produce a large amount of unique 
peptides not identified by the standard Big Three search engines, largely due to its novel 
approach to searching and its consequent ability to loosen constraints on enzyme 
specificity, post-translational modification, and mass accuracy that aren‘t currently 
possible in the standard tools. 
 This research demonstrates that MS/MS spectra from several different 
experimental methodologies can be jointly processed and combined to create a large 
dataset containing more identifications than likely would have been available from any 
one experimental method alone.  As many more large-scale datasets become publically 
available in common formats that are amenable to integration, overall properties of the 
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 As a discipline, the field of Proteomics is showing concrete signs of maturing.  
The subfield of Proteome Informatics has now arguably reached the critical mass of 
research which permits it to be distinguished as a discipline of its own right.  Aspects of 
Proteome Informatics itself are maturing as well:  the most fundamental contributions of 
the field, the mass spectrometry database search platforms such as SEQUEST, have been 
in development for fifteen years.  Yet despite ongoing effort, these platforms have not yet 
had the success necessary to allow them to be used in a completely automated manner.  
Many, if not most, of the spectra generated to this day go un-interpreted by a standard 
search engine.  Many more require manual interpretation.  The assignment of a post-
translational modification to a peptide, for example, is still tenuous enough to require a 
fully-annotated spectrum to be supplied to be accepted in the major journals (1).  
 The focus of this research has been to extend current approaches for proteome 
analysis, developing a greater penetration into the proteome by increasing the number of 
identifications attainable in particular instances.  New machine learning algorithms were 
explored which provided insight into the types of information that is most useful for 
discrimination of correct peptide identifications.  Also, in the context of 
phosphoproteomics, new methods were introduced for transforming additional 




 data into a probability score.  
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Data mining strategies, and the implementation of a localization score for 
phosphopeptides, allowed an in-depth examination of mass spectrometry methodologies 
themselves for phosphoproteomics, addressing the question of which strategy is the most 
optimal.  Also, an assessment of the orthogonality of various fractionation methodologies 
was described, demonstrating that greater proteome coverage could be achieved by 
utilizing multiple fractionation approaches and search engines.  
 In general, the methods discussed are complementary to, and indeed extend upon, 
now standard methods in the field which were developed to efficiently utilize additional 
information that may be available in a proteomics study.  These algorithms, exemplified 
by the Prophet tools and the Scaffold software
16
, can be thought of as extendable 
frameworks for accommodating this often easily obtainable and under-utilized additional 
data.  In the discussion that follows, additional examples of using these types of 
approaches are discussed.  The main results from the primary body of work in this thesis 
are also reviewed, with an eye towards their potential biological impact 
6.2 A comment on isoelectric point and the use of pI for 
phosphopeptide enrichment 
 
 An excellent example of the type of information that might be additionally 
available in a proteomics study (and which may function as a potential discriminator) is 
the isoelectric point (pI) of a peptide or protein.  pI is defined as the pH at which the 
amino acid sequence has a net charge of zero, and it can be calculated from the primary 
sequence of a peptide.  The ability to separate peptides based on pI and to also accurately 
predict a peptide pI thus provides a powerful tool for shotgun proteomics; this 
information can provide an extra filter for false positive rate calculations in that truly 
random false positive matches would be expected to produce correspondingly random pI 
measurements.  One might use this information to select peptide results that fall below 
normal score thresholds in the results of mass spectrometry database search algorithms, 





resulting in more peptide identifications, or increased confidence in ―borderline‖ 
matches.   
 PeptideProphet can accommodate pI information into a probability score for 
peptide identification.  When the pI feature is turned on in this software, the tool assumes 
that the input sample consists of a focused set of peptides.  The software calculates the 
average pI of all peptides, and refines the probability score for each peptide based on how 
close or far the calcuated pI of the peptide is from the average (2).   
 A significant amount of work has been performed in our group surrounding the 
isoelectric focusing of peptides.  One major endeavor has been the goal of utilizing pI to 
enrich for phosphopeptides.  The following theoretical experiment illustrates the idea.  
The pIs of a set of 1060 yeast phosphopeptide sequences identified in published studies 
(3,4) were calculated and binned in 0.5 pI-unit intervals.  The result are shown in figure 
6-1a.  Phosphorylation typically shifts the pI value of a peptide to a lower value due to 
the negative charge of the moiety.  As can be seen, there are regions of pI space to which 
a phosphorylated peptide might be more apt to focus, a fact that was utilized by Yates‘ 
group in a study of the tumor necrosis factor pathway (5).  It must be remembered, 
however, that the stoichiometric ratio of a phosphopeptide to its unmodified equivalent is 
at least 1/100, and perhaps as low as 1/1000 for the case of phosphotyrosine.  Even a 100-
fold enrichment would still result in an overabundance of non-phosphorylated peptide in 
almost all regions of pI space, limiting the use of pI as an enrichment strategy in this 
manner. 
 If the other negatively charged groups on a peptide that are not phospho-specific 
are eliminated, however, the differential between the phosphorylated and non-
phosphorylated forms of a peptide may be expected to be much larger.  
Methylesterification, for example, is a reaction that neutralizes the acidic groups of a 
peptide, and is commonly utilized in the IMAC enrichment strategy.  Figure 6-1b shows 
the distribution of theoretical pI values for the same group of peptides assuming that the 
peptides are fully methylesterified.  As can be seen, all pI values are shifted to higher pI 
values.  But the pI values of the non-phosphorylated forms of the peptides are shifted 
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much higher, resulting in almost all phosphopeptides located below a pI of 8.5 or 9.0.  
Isolating the lower pI fractions of isoelectrically focused methylesterified samples should 
provide a significant enrichment for phoshopeptides.  Studies are ongoing to confirm the 
feasibility of this type of enrichment strategy.  The difficulty in the experiment is getting 




Figure 6-1.  Illustration of a phosphopeptide enrichment strategy via isoelectric 
focusing.  a) Distribution of calculated pI values for 1060 yeast peptides in their 
phosphorylated forms (blue) and non-phosphorylated forms (red).  b) Distribution of the 




6.3 Machine Learning 
 
 In Chapter Two of this thesis, several machine learning algorithms were 
introduced that address the problem, ―can a peptide identification generated by a database 
search engine be classified as being correct or incorrect in an automated way with a high 
degree of confidence?‖  The answer, in short, was ‗yes‘.  The pattern classification 
algorithms, given simply a table of data, were able to achieve a sensitivity and specificity 
matching PeptideProphet and perform significantly better than published linear 
thresholding methods.  The caveat of those results was that the tools required a good set 
of training data: the algorithms are supervised approaches.  Fully labeled training data are 
not trivial to acquire, however, and such data would likely be specific to a particular 
instrument type and run methodology. The PeptideProphet algorithm on the other hand is 
an example of an unsupervised approach: it can be run on a new dataset without the need 
to provide a set of training data.  The algorithm is thus amenable to more routine use in a 
typical lab environment. 
 PeptideProphet, however, does rely on prior information.  It is an example of a 
generative model in that it fits distributions to the data and calculates probabilities based 
on those distributions.  The model works well insofar as the distributions model the data 
sufficiently accurately.  It turns out that this is a good assumption in most situations, as 
PeptideProphet has been shown to successfully model many mass spectrometry data sets.  
The boosting and random forest machine learning algorithms, on the other hand, are 
examples of discriminative models:  they make no assumptions about the underlying 
distribution of data.  It is an opinion in machine learning that a discriminative approach is 
more general and less-risky when handling new types of data, exemplified by the 
statement by Vapnik (6) that ―one should solve the [classification] problem directly, and 
never solve a more general problem as an intermediate step‖, the general problem 
discussed being the calculation of a p(x|y) empirical distribution, such as the ‗correct‘ and 
‗incorrect‘ distributions of PeptideProphet.   
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 Of course, the PeptideProphet approach is one that is easily implemented in an 
unsupervised manner such as the expectation maximization (EM) method implemented 
by the tool.  This is a less-straightforward problem using the discriminative approach, and 
the requirement for a global solution of this problem to be unsupervised trumps any 
performance degradation that may result from a less-than-optimal fit of the underlying 
model distributions.  However, perhaps some of the difficulties associated with using the 
PeptideProphet algorithm that occur can be addressed by introducing some aspects of 
discriminative models into the framework.  Moreover, if a discriminative model 
implementation such as logistic regression, boosting, etc. could be formulated with a 
sufficient unsupervised component to make it easily adaptable to various data sets and 
search engine outputs, a more optimal solution to the mass spectrometry database search 
result classification problem could be achieved.   
6.4 Application of a mixture model classification strategy:  
predicting zymogen granule membrane topology 
 
 The mixture model approach (as used in PeptideProphet) is an example of a 
general classification strategy that can be useful in a variety of situations.  An application 
of this methodology is now discussed in the context of a different problem: classifying a 
peptide as belonging to one of two distinct categories based on an abundance measure.  
This project is an illustrative example of a situation in which a simple thresholding 
strategy was insufficient, and an adequate solution required a more flexible and precise 
strategy for calculating a probability score and assigning a peptide to a state.   
 The overall goal of the research project is to develop an architectural model for 
zymogen granule membrane (ZGM) proteins.  Zymogen granules (ZGs) are specialized 
organelles in pancreatic cells for digestive enzyme storage and regulated secretion, and 
are classic models for studying secretory granule function.  The topological organization 
of a ZGM protein relative to the lipid bilayer dictates its accessibility to interacting 
partners and modifying enzymes. Therefore, an accurate topology model describing the 
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number of transmembrane spans and the orientation of a ZGM protein with respect to the 
membrane is essential for understanding its correct function. 
 The experimental methodology used for studying protein topology was a global 
protease protection analysis coupled with iTRAQ labeling.  Two groups of isolated ZG 
membrane-bound proteins were compared:  one group was treated with protease K and 
the other left untreated.  The protein samples were digested with trypsin and the resulting 
peptides labeled with separate iTRAQ reagents.  The peptides were then mixed and 
analyzed by 2D LC-MALDI-MS/MS.  The hypothesis of the experiment was that the 
population of peptides from the cytoplasmic-oriented side of the ZG membrane would be 
exposed to protease K and would thereby be removed, resulting in a significant reduction 
in relative abundance when compared with their non-treated equivalents.  Proteins from 
the luminal side of the membrane would conversely be protected from the protease and 
show no change in relative expression.   
 Plotting the identified peptides by their iTRAQ ratios does indeed show two 
distinct populations of peptides, one with lower ratios and one with ratios near 1.0, as 
expected (Figure 6-2).  For these data, the bimodal distribution observed suggests that a 
simple thresholding heuristic could have been utilized to classify the majority of peptides 
as either cytoplasmic or luminal, (e.g. ratio <= 0.5 cytoplasmic).  However, different 
replicates of the experiment indicated variability in the shapes and mean values of these 
distributions, defying the assignment of any specific value as a threshold.  Moreover, 





Figure 6-2.  iTRAQ ratio histograms of tryptic peptides from the protease K 
treatment.  Tryptic peptides from four different groups of ZGMs, 15 min control, 30 min 
control, 15 min protease K treatment and 30 min protease K treatment, were labeled with 
4 different iTRAQ reagents and mixed. The histogram on the left shows 15 min protease 
K treatment vs 15 min control (PK/CT-15 min); the study on the right shows 30 min 
protease K treatment vs 30 min control (PK/CT-30 min). A total of 1079 peptides were 
plotted between iTRAQ ratio 0 and 1.9 with the bin size at 0.05.  
 
 
 Based on the assumption that peptides must be derived from one of only two 
categories, cytosolic or luminal, the model fits two distributions to the data set in an 
iterative manner.  The model then estimates the probability that any observed peptide is 
derived from either the luminal or the cytoplasmic fraction based on the observed iTRAQ 
ratio.  The model is thus similar to the PeptideProphet model, or a similar mixture model 
developed by Alexey Nesvizhskii for studying peroxisomal membrane proteins (7, 8). 
Figure 6-3 shows the results of fitting two separate curves to the observed, bimodal 
distribution of all peptide iTRAQ ratios in each dataset. For these data, a normal curve is 
used to model the lower-ratio cytosolic fraction, and a gamma distribution for the luminal 
fraction. The distributions are fitted to the data in a ―semi-supervised‖ manner: 
fundamentally an EM algorithm is used to learn an optimal fit for the distributions to the 
dataset in an automated way starting from training distributions of peptides known to be 
cytosolic and luminal, but the fit is assisted by setting guiding parameters for intensity 
and shape based on both training data and manual curation.  
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 Briefly speaking, the EM algorithm is an iterative, two-step optimization 
approach in which the parameters of each distribution are used to calculate, at each 
iteration, the probability of each peptide belonging to both the cytosolic and luminal 
fractions. These probabilities are then used to adjust the distribution shapes by weighting 
the contribution of each peptide ratio to each of the two distributions in a manner 
proportional to its probability of being in that distribution. The algorithm proceeds by 
successively re-calculating probabilities after each adjustment of the curve, then adjusting 
the curve based on these weighted probabilities, until a convergence is achieved. The 
probabilities of each peptide are then reported as a Bayesian probability. For the cytosolic 
fraction the probability of the peptide being cytosolic given a peptide ratio r is calculated 
as:  
    
The numerator of this formula may be interpreted as the probability of having the iTRAQ 
ratio of r and being cytosolic, and the denominator as the overall probability of having the 
iTRAQ ratio r. The p(r|cyt) and p(r|lum) terms are the values calculated for the cytosolic 
and luminal distributions, respectively, at a given value of r; finally, the p(cyt) and p(lum) 
terms are the ―prior‖ proportion of cytosolic to luminal peptides in the dataset. The 
luminal probability at any value of r is calculated in an analogous manner. For these data, 
the probabilities of peptides known with high-confidence to be either cytosolic or luminal 
were fixed to ‗1‘ for the corresponding fraction (and ‗0‘ to the other), and modeled in 
combination with the unknown peptides. This had the effect of guiding the model 





Figure 6-3.  Learned model fits to iTRAQ ratio distributions. Shown are histograms 
for iTRAQ ratios for two independent experiments. The distribution of all peptides in 
each dataset is shown as green. The two final curves learned by the model for both 
luminal (red) and cytosolic (blue) distributions are plotted. The dashed curves indicate 
the histograms of the training datasets, used as a starting point for the model. The training 
distributions have been scaled by a factor of ten. 
 
  The statistical model thus provides a way to calculate probabilities for the 
assignment of a topological category for each identified peptide based on its iTRAQ 
ratio.  The approach provides a method for deriving a global topology map of ZG 
membrane proteins that is flexible enough to accommodate variations in data sets due to 
experimental differences such as protease exposure time or changes in mass spectrometry 
run conditions. This model provides a foundation for developing a higher order 




 It is difficult to overestimate the importance of phosphorylation in the 
understanding of cellular biology and disease.  The fact that an estimated 518 kinases and 
130 phosphatases are encoded in the human genome underscores the prominence of the 
modification in cellular processes.  Unregulated cell differentiation is the defining feature 
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of all cancers, and this differentiation occurs primarily as a result of perturbed signaling.  
In fact, protein tyrosine kinases (PTKs) are the largest group of dominant oncogenes with 
structural homology (9).  It is no coincidence therefore that one of the largest groups of 
drug targets are protein kinases, in particular PTKs (10).  The effectiveness of kinase 
inhibitor drugs such as imatinib (Gleevec), gefitinib (Iressa), and erlotinib (Tarceva) 
attest to the therapeutic relevance of kinases, and by association, phosphorylation 
mechanisms. 
 Developing global assays that can monitor phosphorylation pathways is therefore 
an important biological goal.  Recent improvements in the ability to enrich for 
phosphopeptides have facilitated new avenues for analysis, based on global approaches.  
For example, the increase in the number of phosphorylation site identifications has 
permitted evaluation of global phosphorylation consensus sequence patterns (11-14).  
These sequence motifs are important in that they may be diagnostic of the kinase 
responsible for modifying the protein, implicating the identified protein as having been 
targeted by a specific kinase (10, 11).  Such information is useful for mapping signaling 
pathways and understanding the functional role of the protein.  The identification of 
specific phosphorylations on kinases themselves can provide valuable diagnostic 
information, in that the site of phosphorylation can specify specific states of activation of 
that kinase.  MAP kinases (MAPKs), for example, are activated by phosphorylation of 
two sites within an ―activation loop‖ of the kinase, at a threonine and a tyrosine residue 
with the motif TEY (rat Erk2, yeast Slt2), TPY (stress activated protein kinases), or TGY 
(p38, Hog1), or TNY (yeast Smk1) (15).  These domains have been identified in 
proteomics studies (16); the fact that the MAPKs were in activated states when detected 
could be of significant biological interest in a study.  A global phosphoproteomics study 
of drug treated vs control mice bearing human A431 tumors expressing high levels of the 
EGF receptor showed significant modulation of the EGFR signaling pathway.  The study 
found 50 phosphopeptides differentially expressed as a function of treatment with the 
EGFR inhibitor, and a new tyrosine phosphoylation site on EGFR itself (17).  Mann et al. 
studied the EGFR pathway as well, focusing specifically on tyrosine phosphopeptides , 
and identified five new phospho-Y sites on different members of the pathway (18).  In a 
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later study, the group used SILAC to study temporal changes in the EGFR pathway, 
identifying virtually all known epidermal growth factor receptor substrates and 31 novel 
pathway components, as well as the time course of their activation upon epidermal 
growth factor stimulation (19).  In all, the necessity to understand the details of specific, 
localized phosphorylation events is critical for understanding global mechanisms of 
signaling and cellular control.  Global phosphorylation studies are able to provide 
increasingly rich datasets that provide significant insights into these mechanisms, with 
promising clinical therapeutic usefulness.   
 There are still significant methodological and informatics challenges to large-
scale phosphoproteomic studies, however.  The intent of a large portion of this thesis was 
to develop methodologies for addressing several of these issues.  One major issue is one 
of sensitivity.  Given that phosphopeptides are frequently of lower-abundance in the cell, 
their detection is correspondingly more difficult.  This is an issue that is more poignant 
for phospho-tyrosine (pY), given that it is an order of magnitude rarer than serine and 
threonine phosphorylation.  Enrichment strategies have transformed our ability to study 
phosphorylated protein and peptide forms, however, and it is hoped that these approaches 
will soon be efficient enough to permit phosphorylation studies on samples obtained in 
clinical studies.  This goal can be facilitated by the development of computational 
strategies that optimize the use of the data that is generated.   
 Data-dependent neutral loss scanning addresses the issue of poor phosphopeptide 
fragmentation in an instrument, and remains a popular technique.  The work here 
described a new and effective computational strategy for analyzing these data sets, 
demonstrating an increase in phosphopeptide identification sensitivity.  The mass 
spectrometry methodologies were investigated as well, verifying the effectiveness of 
MSA as an instrument technique for generating data, and comparing data processing 
methodologies for handling data generated by both this and data-dependent MS
3
 datasets.  
Datasets of these and various other instrumentation approaches will continue to be 
generated, and the ability to mine them effectively is consequently a significant one.   
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 As new methodological work is developed, there will continue to be a need for 
informatics strategies that complement specific data generation techniques.  For example, 
the problem of very low phosphotyrosine abundance is often enhanced in large scale 
studies in that the pY moiety is more stable than the pS or pT and thus resistant to neutral 
loss (18).  A scanning approach in which the pY immonium ion (216.043 Da) is detected 
and used to direct the acquisition of MS/MS spectra has proven a useful strategy, 
dramatically increasing sensitivity (17).  The capability to do this type of scanning on an 
LTQ instrument using the new HCD methodology may have a significant impact.  An 
informatics approach which accommodates this type of information in peptide scoring 
might be useful.  Other instrument approaches may prove relevant as well.  It has been 
suggested by Wolf Lehmann that in the case of CID, the poor backbone fragmentation 
that results upon loss of the pSer/pThr phosphate moiety is a function of a low collision 
offset setting; increasing the collision offset induces multistep fragmentations which 
increases backbone fragmentation (19).  Instrument settings which are tuned to generate 
particular spectra characteristics can be assessed using the techniques described in this 
work, with the goal of better optimization.   
 As the data from large scale studies become more available, informatics 
techniques which mine data sets for detection of specific target moieties such as the 
kinase activation signatures mentioned above are another possibility.  These types of data 
demonstrate the need to have efficient, automated methods for not only identifying 
phosphopeptides, but confidently localizing the sites of phosphorylation.  
Phosphorylation site localization was a specific theme in this thesis.  An implemention 
and of a published methodology for calculating a confidence score in the site localization 
for all phosphopeptides identified in a study was described, including an extension of the 
work to enable this functionality for MSA and MS
3
 spectra.  The method was used in the 
comparison of the overall mass spectrometry methodologies, but is suitable for use as a 
site-localization scoring implementation in any phosphoproteomics study.  
 Other aspects of large-scale phosphoproteomics data analysis have not been 





 data (19); the degree to which these errors occur in large data 
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sets has not been sufficiently examined.  Examples of these are ‗close to 98/z‘ losses of 
proline (97.053/z), valine (99.068/z), threonine (101.048/z), or cysteine (103.009/z) that 
could easily be mistaken for a phosphate loss.  Neutral loss of these amino acid residues 
occur, particularly on the N-term in the presence of a nearby proline as discussed in 
Chapter 1 (see also Supplemental Table ST-1 in the Appendix).  Methionine oxidation is 
a source for false positive phosphopeptide identifications as well.  The loss associated 
with this PTM is methanesulfenic acid of mass 64/z, and is highly efficient (20).  The 
doubly-charged loss (64/2) is easily mistaken for the triply-charged (98/3) phosphoric 
acid in a data-dependent methodology.  In this event, the charge state of the neutral loss 
peak does not correspond with the charge state of the peptide precursor, and could easily 
be detected with diligent data analysis.  However, the study in (19) provides an example 
in which MS
3
 spectra searched with the -18 Da dehydroalanine or dehydrobutyric acid 
Ser or Thr residue modifications produced significantly scoring false positive 
identifications.  Only when a search was conducted using a variable modification of -48 
Da on the Met residue did the correct peptide get assigned to the spectra.  This type of 




 data alone are interpreted, 
however, and provide an argument for having both types present.  
 
6.6 Final Remarks 
 
 In the late 1980‘s, mass spectrometry of proteins was a novel technique in 
biological research.  Now, twenty years later, it has matured to the point that it is the 
standard technique for identifying and quantifying proteins in high-throughput 
experiments.  The very rapid pace of progress in this field has resulting in an explosion of 
data, which continues to be generated at an ever-increasing rate.  An entire field of 
research has resulted, based on the need for automated computation to make use of the 
mountain of information.   
In one sense, the main body of work in the proteome informatics domain was 
motivate simply by the necessity to keep pace with the data being produced, providing a 
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useable means to interpret it.  Once the fundamental search framework was in place, 
refining it became the most significant task with automation improvements and scoring 
improvements as the focus of the bulk of informatics research in this area.  As new 
methodologies were introduced such as quantification information, the software 
accommodated these data in response.  Any changes to the established paradigm can 
produce difficulties, however.  A SEQUEST- or Mascot-equivalent algorithm for top-
down analysis, or a search engine which has been optimized for different ionization 
techniques such as ECD or ETD, has yet to be established.  Cross-linking studies can 
confound standard search approaches, and many search tools cannot effectively reward 
very high mass accuracy data.  Although progress in mass spectrometry data 
interpretation is very significant indeed, there is a large need for continued development. 
Directed enrichment studies are becoming more established, with large-scale 
efforts that target specific regions of protein space, such as the ‗phosphoproteome‘ or the 
‗glycoproteome‘ of various organisms, organelles, tissues or samples.  The need for 
focused computational efforts which are correspondingly directed at these particular sub-
domains, accommodating the rules and nuances that arise that are specific to these data, 
are necessary.  The work in this thesis begins to address this issue, presenting informatics 
strategies directed at newer data types and methods in the phosphoproteomics domain.  It 
is very likely that, rather than the gross ‗highly expressed or suppressed‘ abundance 
measurement of a protein, it is in the more subtle modification state of a protein, or in a 
more complicated modification ‗pattern‘ in a set of proteins, where the most significant 
biological insights will occur.  When the computational strategies for interpretation of 
these types of data become more sensitive, the likelihood of detecting these more subtle 
levels of control will be possible. 
To be most useful, proteomics data should not be interpreted in isolation.  An 
enormous amount of complementary information can be derived from genomics and 
metabolomics analyses of a biological system.  The ultimate goal of any of the ‗omics‘ 
fields is to provide the fundamental information necessary to understand a biological 
mechanism.  What is most necessary for this higher-order understanding is a functional 
representation of the system being studied, a framework which describes the connection 
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between the fundamental components being measured in a study—the genes and the 
proteins—to the higher level organizational, functional states, networks and pathways 
that dictate the phenotype.  Network modeling approaches are increasingly successful in 
elucidating the fundamental motifs which control biological systems.  Data sets in which 
gene expression, protein expression and metabolite expression have been measured for a 
common system are now being generated, and should provide a more holistic view of 
biological problems. 
In conclusion, we are at the brink of being able to develop a newer, higher-order 
understanding of biological systems.  We are just now developing the ability to assemble 
the complex, diverse information that proteomics and other high-throughput quantitative 
technologies are generating into systems-level conceptual frameworks that are 
biologically relevant, accurate, and predictive.  The end result will be the ability to model 
a ―Virtual Cell‖, with the power to expose the biological complexity of a system in a 
more usable and comprehensible way.  The work presented in this thesis will facilitate 
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Supplemental Table ST-1.  Unique instances of N-term amino acid neutral loss in 
the 9-Mix dataset from Chapter 2.   
 
ms2-sequence ms3-sequence charge #occurrences 
K.DSADGFLK.I D.SADGFLK.I 1 3 
L.PDPQESIQR.A D.PQESIQR.A 2 14 
Y.APELLYYANK.Y A.PELLYYANK.Y 2 4 
K.TVM[147]ENFVAFVDK.C V.M[147]ENFVAFVDK.C 2 2 
K.VVAGVANALAHR.Y V.AGVANALAHR.Y 2 9 
K.DNPQTHYYAVAVVK.K S.PQTHYYAVAVVK.K 2 24 
K.YICDNQDTISSK.L I.CDNQDTISSK.L 2 25 
K.TVMENFVAFVDK.C V.MENFVAFVDK.C 2 8 
K.ELPDPQESIQR.A L.PDPQESIQR.A 2 53 
F.YAPELLYYANK.Y A.PELLYYANK.Y 2 31 
K.LKPDPNTLCDEFK.A K.PDPNTLCDEFK.A 2 11 
R.ETYGDMADCCEK.Q T.YGDMADCCEK.Q 2 1 
K.DDPHACYSTVFDK.L D.PHACYSTVFDK.L 2 17 
N.IPMGLLYSK.I I.PMGLLYSK.I 2 17 
K.VLVLDTDYKK.Y L.VLDTDYKK.Y 2 2 
C.VPCADQSSFPK.L V.PCADQSSFPK.L 2 5 
K.YIPIQYVLSR.Y I.PIQYVLSR.Y 2 2 
R.MPCTEDYLSLILNR.L M.PCTEDYLSLILNR.L 2 2 
R.TPEVDDEALEKFDK.A T.PEVDDEALEKFDK.A 2 3 
R.TPEVDDEALEK.F T.PEVDDEALEK.F 2 12 
R.KVPQVSTPTLVEVSR.S V.PQVSTPTLVEVSR.S 2 7 
S.CVPCADQSSFPK.L V.PCADQSSFPK.L 2 6 
K.EFTPVLQADFQK.V T.PVLQADFQK.V 2 7 
R.IIPGFMCQGGDFTR.H I.PGFMCQGGDFTR.H 2 8 
R.ETYGDM[147]ADCCEK.Q T.YGDM[147]ADCCEK.Q 2 3 












.LACGVIGIAK.- A.CGVIGIAK.- 2 2 
K.TSHMDCIK.A S.HMDCIK.A 2 4 
L.LEACTFHKP.- E.ACTFHKP.- 2 2 
K.DGPLTGTYR.L G.PLTGTYR.L 2 1 
K.EDVIWELLNHAQEHFGK.D D.VIWELLNHAQEHFGK.D 2 2 
K.ELPDPQESIQR.A D.PQESIQR.A 2 1 






R.TPEVDDEALEKFDK.A T.PEVDDEALEKFDK.A 3 9 
T.YFPHFDLSHGSAQVK.G F.PHFDLSHGSAQVK.G 3 1 








I.PENLPPLTADFAEDKDVCK.N 3 2 
V.DDYQECYLAMVPSHAVVAR.
T 
Q.ECYLAMVPSHAVVAR.T 3 1 
K.DNPQTHYYAVAVVK.K S.PQTHYYAVAVVK.K 3 1 
K.AVEHLDDLPGALSELSDLHA
HK.L 
E.HLDDLPGALSELSDLHAHK.L 3 1 
 
 
